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Summary
Reagents for a 2-site radioimmunoassay of ferritin 
have been prepared and the experimental conditions of the 
assay determined. Gestational changes in the ferritin 
concentration of maternal and fetal plasma, fetal organs 
and the placenta were found. No previous studies have 
shown plasma ferritin to decrease with advancing gestation 
in normal pregnant subjects maintained onprophylactic iron 
and that 30 per cent of mothers have depleted iron stores 
at term (Nelly et al, 1977)* Patients with infections, 
intrauterine growth retardation and pre-eclamptic toxaemia 
had elevated ferritin concentrations and in the latter the 
severity of the condition was proportional to the increase 
in plasma ferritin.
Cord bloods had higher ferritin concentrations than 
maternal bloods and increased within 24 hours of delivery.
In premature neonates tne increase in ferritin continued 
over a period of seven days. The neonatal plasma ferritin 
was related to gestation, birth weight and the bilirubin 
concentration. There was no direct correlation between 
maternal and cord ferritin in the circulation but when the 
ferritin concentration of the mother signified that maternal 
iron stores were depleted, there was a significant reduction 
in the cord ferritin concentration (Nelly et al, 1973).
The total content and concentration of ferritin in 
liver, heart and spleen from 24 to 41 gestationa'j. weeks was 
determined and liver was found to contain the greatest 
amount of ferritin. The ferritin content of the three 
organs related to body weight and gestation.
8
The growth retarded livers had low concentrations and 
total contents of ferritin but only the latter occurred in 
spleens which were small for gestational age. The ferritin 
concentration of the liver and spleens of twins appeared 
to be lower than in singletons of equivalent gestation.
In the placenta the ferritin concentration increased 
until the eighteenth week before decreasing until 37 weeks 
when a second increase occurred at term, ho difference in 
ferritin concentration was found between the peripheral 
and central areas but a concentration gradient was present 
between the maternal and fetal surface.
Electron micrographs of term placentae showed that 
ferritin was localised on the rough endoplasmic reticulum 
of the syncytiotrophoblast. The concentration of ferritin 
in term placentae associated with low maternal human 
placental lactogen concentrations or urinary oestriol 
excretions and in small term placentae was not significantly 
different from control organs but the total ferritin 
content of the small placentae was reduced (Nelly, 1976). 
There is evidence to suggest that the placenta can 
effectively prevent the deposition of excess storage iron 
in fetal organs.
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Introduction
Iron plays a central role in mammalian metabolism and 
is present in every living cell. Nan’s need of iron was 
recognised by the ancient Egyptians and is listed in their 
pharmacopoeia (Hoppe, 1955). Iron is essential to life and 
therefore stores are required to protect against blood loss, 
a reduction in intake and for the feto-placental unit in 
pregnancy. The absorption of iron is not finely controlled 
and as no mechanism exists for the excretion of excess iron, 
man is protected from its toxic effects by its removal from 
plasma into storage depots.
Two iron storage proteins, ferritin and haemosiderin 
have been identified in animals and phyto-ferritin and 
phytosiderin in plants and fungi. The quantitation of iron 
stores was rarely applied routinely in the past as it 
was time consuming and often unacceptable to the subject. 
Storage iron has been measured by ashing the whole body and 
determining the iron content (Josephs, 1999), by repeated 
phlebotomy (Pritchard and mason, 1964), by the histological 
or chemical quantitation of non-haem iron in bone marrow 
(Stevens et al, 1953) or liver (beinfeld, 1964), by use of 
the iron chelator, desferrexamine (Wohler, 1964) or by 
dilutional studies with radioiron (Pinch, 1959). Recently 
a less traumatic method has been found and is dependent on 
the findings of Addison et al in 1972 that the concentration 
of ferritin in seruri is proportional to body iron stores.
.In 1394 nchmiedberg isolated a compound from pig liver 
which he called "ferratin" and further demonstrated its
presence in spleen and bone marrow. "Perratin" is nov^  
known to have consisted oi denatured ferritin and 
contaminating proteins. Pure ferritin was probably first 
isolated by Lauiberger in 1937 as the cadmium salt of a 
crystalline protein which was stable in acid and alkaline 
solution and contained about 20 per cent of iron by weight. 
These findings were confirmed by Nuhn et al (1940) who 
reported the composition as 54*5 per cent protein, 12.1 per 
cent nucleic acid which has hever been confirmed and 35 per 
cent hydrous ferric oxide (PeO.OH) and suggested that there 
was an equimolar ratio of iron to peptide. Grannick (1 9 4 2, 
1 9 4 6) has published prolifically on the isolation, structure 
and function of ferritin. He has shown it to be heat stable 
and to form distinctive ocrahedral or tetrahedral crystalline 
structures which are optically isotropic and have a degree 
of twinning. On ultracentrifugation dark brown particles 
with a molecular weight (N.Wt,) of 2,000,000 were formed 
and the colourless supernatant contained less than 30 per 
cent of protein in tne form of spherical molecules, m.Vft. 
500,000. The ferritin solution was however homogenous on 
electrophoresis using a Tiselius apparatus but he noted that 
the content of iron, nitrogen and phosphorus was variable, 
by 1946 Grannick had isolated ferritin as its cadmium salt 
from bone marrow, spleen, liver and gasto-intestinal mucosa 
and shown its presence in the globus pallidus and the 
substantia nigra of the central nervous system. He 
demonstrated that in the presence of reducing agents iron 
could be removed from the molecule without dénaturation of 
the protein which formed apoferritin. He revised the N.V/t. 
and found it to be 4 6 0 ,0 0 0 and described the space lattices
9 9
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of ferritin and apoferritin as being identical* Ho reported 
the iron as being present in mi ; celles, in the ferric form, 
(PeO.OH)B (feO PO3H2 ) and firmly bound to the protein 
which protected the cell from the toxic effects of ferric 
hydroxide, ferritin has a magnetic, dipole moment of 3*8  
Bohr magnetons which is unusual for a compound of iron.
Mazur and Shorr (1950) suggested that as ferritin and 
apoferritin had identical isoelectric points and 
electrophoretic mobilities that iron was sequestered inside 
the protein shell. This was confirmed by Barrant (1954) 
using electron-ffiicroBcopy and by Harrison (1959) with X-ray 
diffraction studies and they furuher suggested that 
apoferritin was composed of sub-units forming a shell round 
the iron mi celle.
The present estimate of the M.Nt. of apoferritin is 
445,000 (Harrison, 1969 and Crichton, 1973). The iron 
content has been found to vary from zero to 4,500 atoms per 
molecule (Crichton, 1973) and based on amino-acid analyses 
there are probably 24 protein sub-units (Crichton, 1973),
Isoferritins were first reported by Richter (1964) 
when he isolated ferritin from neoplastic tissues whicii had 
a different mobility from that of normal tissues and later 
Alfrey (I9b7) isolated two types of ferritin from human 
bone marrow. Most tissues have been found to contain 
multiple isoferritins which seems to reflect different 
families of heteropolymers arising from different 
proportions of two sub-units. The isoferririn population 
of tissue can change with development and disease (Drysdale, 
191 7),
The syntbeaiij oi' i'urritin ma,y be under tne influence
24
of a nuifibcr of genes as suggested by the presence of 
isoierritins and the frequent finding of a s)nall amount of 
a polymeric form (Harrison,a^d74), Hrysdale and munro,
(1 966) have shown that synthesis is insensitive to inhibitors 
of mammalian m-llNA synthesis and that induction v v o u I g  appear 
to be at the post-transcriptional level.
Ferritin could be synthesised by the gradua] 
accumulation of iron within the protein shell (Bielig and 
Bayer, 1915) or the iron micelle could be formed first, 
followed by the enveloping protein coat which would 
stabilise the molecule (Pape et al, 1968), the former 
pathway has gained most support, Hadioisotopically labelled 
amino acids have been shown to be incorporated into the 
ferritin molecule which contained little or no iron and the 
metal content increased with time (Fineberg and Greenberg,
1955).
Iron would appear to induce ferritin synthesis and this 
theory was put forward by Granniol (1948) who fed iron to 
guinea, pigs and found that ferritin accumulated in the 
mucosal cells of the inuestine. This was later supported by 
the worm of Crichton (1971). Reports suggest that 
apoferritin is a catalyst in the oxidation of iron and that 
when the ratio of iron to apoferritin is low the incorporation ■ 
of iron into the molecule is proportional to the 
concentration of apoferritin (Harrison,974). Once 
nucleated the iron core grows rapidly, Granniek and 
ivlichaelis (1 943) earlier reported that iron in the ferric
form wRs not incorporated in^o apoferritin,* 
competitively inhibits the formation of ferritin as it is
absorbed onto the iron miceli.e and is also bound to
apoferritin (macara et al, 197j). this method of formation 
allows iron to be laid down and removed successively from 
the surface of the micro-crystals which have a relatively 
large surface area. The number of sites for deposition of 
iron increases as the core size increases. The iron core 
has a characteristic polyhedral form on elecrronmicroscopy 
(Harrison,bj1 974) « many cores have a uniform density but 
some are divided into smaller particles and have a central 
space suggesting that iron adheres to the inner surface of 
the protein.
The mobilisation of ferritin iron is less well 
understood. Granniek and michaelis,^1943)showed that the 
reduction of iron released it from the protein but 
biological reducing agents have been found inadequate in 
meeting physiological requirements (Bielig and Bayer, 1959). 
idazur et al, (^ 195s) suggested that xanthine oxidase may be 
important for this process in the liver but Crichton,^1973^ 
has been unable to demonstrate the effect in vitro. 
T'errireductase, a flavoprotein which requires reduced 
nicotinamide adenine dinucleotide may be the enzyme which 
reduces and mobilises ferritin iron (Oski and Sirivech,
1971),
Haernosiderin was considered by Granniek to be an 
insoluble breakdown product of ferritin which was visible 
histologically. Ferritin has a magnetic moment of 3.8 
Bohr magnecons and haernosiderin has similar although more 
variable magnetic properties (Harrison ct al,b^1974.) 
i.iatioli and Baker (1963) suggested that ferritin was 
denatured oy oxidising agents whicn were founa in increasing 
concentration as ferritin accumulated causing the inhinition
of catalase activity. The denatured molecules may be 
sequestered in vacuoles, the protein removed by proteolytic 
enzymes, iron micelles polymerised and precipitated as large 
amorphous iron complexes.
The intestinal absorption of iron is not fully 
understood, Barly studies suggested that the intestine 
could absorb and excrete iron (meGalium, 1894) but the 
latter function was soon rejected. In 1943 Hahn et al 
suggested the "mucosal blocm theory" and Granniek (1946) 
suggested that ferritin was in equilibrium with, ferrous 
ions in the intestinal mucosa which were in turn in 
equilibrium with transferrin bound plasma iron. He 
described ferritin as aiding the absorption of iron and 
blocking excess absorption, Crosby (1963) suggested that 
when iron was bound to ferritin in the epithelial cells it 
was not available for absorption and this theory v;as 
supported and expanded by Smith et al, 1 9 6 8. However in 
studying the subcellular distribution of radioiron in the 
intestinal mucosal cells of rats ,/orwood and Jacobs (1972) 
concluded that ferririn formation was not a major controlling 
factor in iron absorption.
In 1968 Buffe , described a new fetal liver
antigen, alpha q-H globulin which was found in the serum in 
primary hepatoma and other malignant conditions. On 
biochemical and immunological grounds it was later thought 
that alpha g-H globulin and ferritin were identical (Buffe, 
1973). It has been suggested that embryonic tumours could 
be monitored oy quantitating plasma ferritin (Buffe, 1973) 
but in a recent study of ovarien germ ce 1.1 tumours 
(Pederson et al, 1 9 7 6) it was found that only 90 per cent
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had elevated levels which may have been due to liver 
métastasés. Ferritin has been isolated from mammary 
carcinomas and in an investigation into the recurrence 
rates 01 this condition v/ang (1 9 7 6) founa that 10 per cent 
of patients had grossly elevated serum ferritin 
concentrations and that they had marginally faster 
recurrence rates. Oarcino-erabryonic antigen was a more 
useful indicator of prognosis.
Ferritin has been quantitated in tissues and 
pathological sera for many years but it was not until 1972 
that Addison et al detected its presence in normal serum by 
an iinmunoradiometric technique which has now been automated 
(Jones and Jorwood, 1975). Since then a number of sensitive 
assays have been described including a 2-site 
immunoradiometric assay (Miles et al, 1974), a classical 
radioimmunoassay (Nutsu et al, 1 974-) which is now
available in commercial kit form ("Travenol", ' ) and an
enzyme-linked immunoassay (Boenish, 1 9 76).
Interest in the assay was aroused by reports that in 
disorders of iron metabolism the serum ferritin 
concentration reflected body iron stores. Jacobs et al
(1 9 7 2) showed that in the pathological conditions of iron
deficiency and iron overload serum ferritin reflected 
iron stores assessed by bone marrow iron content and the 
differential desferrioxarnine test, ./alters et al (1 9 7 3) 
investigated normal subjects and found a correlation 
between serum ferritin and body iron stores determined by 
repeated phlebotomy. Serum ferritin has also been shown to 
correlate with radioiron absorption studies in normal 
subjects (bipschitz et al, 1974). The concentration of
ferritin in serum was found to be proportional to bone 
marrow iron deposits in patients with rheumatoid arthritis 
(Bentley and williams, 1974), chronic renal failure on 
haemodialysis (Hussein et al, 1975) and the beta- 
thalassaemia trait (Hussein et al, 1 9 7 6). Lipschita et al, 
(j 974  ^found that in anaemia from causes other than iron 
deficiency anaemia, particularly when associated with an 
inflammatory process the serum ferritin was above the 
normal range. They also found elevated levels in liver 
disease especially alcoholic cirrhosis and viral hepatitis. 
However when iron deficiency was present with inflammation 
or liver disease the serum ferritin concentrations were 
distinctly lower than that of the overall mean. In 
Hodgkin's disease and leukaemia serum ferritin has been 
found to be inappropriately raised in relation to the amount 
of iron stores but levels in the latter condition may 
indicate prognosis (Parry et al, 1975; Jacobs and worwood, 
1975).
Studies of infants and children have also shown that 
serum ferritin reflects iron stores, biimes et al, 1974 
found in a normal population screen from birth until 15 
years of age that the serum ferritin parallelled known 
changes in iron stores. He also found low concentrations 
in iron deficient children and high levels in children with 
thalassaemia major and sickle cell disease. Children with 
acute infections and acute lymphoblastic leukaemia can like 
adults have disproportionately raised serum ferritin levels. 
It has also been shown that 'In a study of infants at three 
and six months of age plasma ferritin reflects the iron 
content of the diet (Rios et al, 1975). In children with
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thalassaemia major the serum ferritin was found to correlate 
with the liver iron concentration and the volume of blood 
transfused (betsky, 1974)»
The total body iron content in the adult male has been 
reported as 3 to 4g (Barman, 1974) and 4 to pg (Pollycove,
1972)0 Haemoglobin contains about 70 per cent, stores 23 
per cent, myoglobin 7 per cent, enzymes 0.2 per cent and 
plasma transferrin 0.1 per cent of the body's iron*
Storage iron in the form of ferritin and haernosiderin, is 
found in quantity in the cells of the reticuloendothelial 
system of liver, spleen and bone marrow and in the 
parenchymal cells of the liver, In the adult male only 
about 3 per cent of total iron is found in the bone marrow 
(Zilva and Pannall, 1975)» Hstimated of the rates of iron 
release from ferritin and haernosiderin vary but the balance 
of evidence suggests that it is more rapidly released from 
the former (Harrison et a l , 9 7 4).
The adult female has only one third of the iron stores 
of the male and Scott and Pritchard (196?) have reported 
that 24 per cent of American college women have depleted 
iron stores. Butler (1967) found that only 30 per cent of 
Welsh women have optimum iron and .folate stores. Burman,
^1971) has described the considerable variations in the body 
iron content and distribution of iron which takes place 
during the first two years of life. At birth the distribution 
is similar to that of the adult male but by 6 weeks only 40 
per cent of iron was found in haemoglobin and 36 per cent in 
storage form. However from six months until two years the 
distribution was similar to that at birth.
The functions 01 iron are mainly those of its compounds
which form tvro groups of proteins dealing with the 
transport ana storage of iron on the one hand and metabolic 
and enzymatic functions on the other, most of the compounds 
in the latter group are proteins with an iron-porptiyrin 
prosthetic group and haemoglobin is quantitatively the most 
important. It carries oxygen to the tissues, removes 
carbon dioxide from them and is an erythrocyte buffer, 
myoglobin is an oxygen reservoir for muscle at times of 
contraction. The mitochondrial cytochromes are electron 
transporting enzymes and play an essential role in the 
production of cellular energy. Cytochrome 1-450 in the 
microsomal membrane of the liver is involved in the 
oxidative degradation of drugs and endogenous substrates 
(ballrnan, 1974). Catalase and peroxidase reduce 
endogenously produced hydrogen peroxide. Borne iron 
containing enzymes do not contain porphyrin and consist 
mainly of the iron containing llavoproteins associated with 
oxidative metabolism and include succinate dehydrogenase. 
Iron is also required as a co-factor for aconitase activity 
and for the hydroxylation of proline and lysine in collagen 
synthesis (Dallman, 1974). It has also been shown that'iron 
is required for deoxy-ribonucleic acid synthesis and is 
essential for mirosis (Robbins and Pederson, 1970).
Iron deficiency anaemia is a world wide problem and is 
tne comiiionest nutritional deficiency of industrialised 
countries. It has been defined in a number of ways 
including the absence of iron stores, an increase in the 
absorption of radioiron, an abnormally' low serum iron and 
percentage transferrin saturation, a low haerioglobln level, 
the appearance of microcytools, hypochromasia and
fragmentacion and elevation ox free protoporphyrin of the 
red cell, i.ioet of these indices are associated wire the 
abnormalities of the blood picture alone but the syste.;,ic 
manifestations of iron deficiency have recently received 
attention and include the decreased activity of cytochrome 
oxidase in the intestinal mucosa (Dallman, 1974)» The 
abnormalities which arise in the blood appear successively 
Êind the number of people identified as iron deficient 
depends on the definition used which includes the level of 
cub-off (Crosby, 1977). At present there is no scientific 
approach to the definition and interpretive guidelines are 
arbitrary (Bearon, 1974), In one series the incidence of 
iron deficiency varied from 4 per cent to 72 per cent 
depending on the criteria selected (Beaton, 1974).
Severe iron deficiency has a high mortality (Ashford, 
1934) but in general it is not associated with the mortality 
of other nutritional disease states. In the less severe 
form it is associated with lethargy, tachycardia, angular 
stomatitis and koilonychia but Biwood and Hughes (1970) 
have suggested that iron deficiency did not cause any 
important epidemiological evidence of disability until the 
haemoglobin was less than 8g per dl,
Iron is well conserved in the body and losses are 
small. 95 per cent of the iron required for haejnoglobin 
synthesis is obtained from the brearuown of senescent red 
ülood cells, from celluJ.ar wastage during erytnropoiesis 
and from non-hacm iron of viable erythrocytes (Cook et al, 
1970)0 Only about 4 per cent of iron is obtained from 
intestinal absorption. In the adult main about 1mg of 
iron per day is lost in the urine, sweat, bile, faeces and
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desquamated cells; but most is lost in the faeces. The 
loss of iron in exfoliated cells has been debated but it 
would appear that although dOOg of cells are lost per day 
most of the iron has been reabsorbed (Jacobs, 1974).
Infants have a relatively high surface area and the loss 
from the skin is considerably increased and represents one 
third of the total loss (Burman, 1971). In women of child­
bearing age additional losses occur in menstruation. The 
mean overall loss of menstrual iron was 0.5mg per day or 
12rng per period and the amount of blood lost in successive 
periods was consistent (Hytten et al, 1964). However if 
heavy periods are experienced the losses could be 
equivalent to 2 to 3mg per day (Jacobs and Butler, 1965). 
These losses are normally made up by increased absorption 
of iron from the diet.
In men and post-menopausal women Img of iron per day is 
recommended and for menstruating females 2mg per day. Iron 
absorption must not only cover losses but also the needs 
for growth and Lies (1 9 6 3 ) has demonstrated the benefits 
obtained from iron fortified cereal fed to infants. It has 
been suggested that 1.5 to 2mg of iron per day must be 
absorbed by the growing child. Iron deficiency in the 
female at puberty was reported in 1554 in the "Be lorbo 
V'irgineo" (Lancet, 1941). At puberty the iron requirement 
is high due to continued growth and the onset of 
menstruation and 2.5mg are recommended. The iron 
requirement is also high in pregnancy due to the increased 
maternal blood volume and fe^o-placental requirements. An 
average intake of 2.5mg per day has been recommended during 
pregnancy.
The body responds to anaemia whether or not it is due 
to iron deficiency by increasing the absorption of iron 
from the diet (Zilva and Pannall, 1975). The average daily 
diet contains 10 to 15mg of iron buc not all is available 
for absorption, Dietary iron is present in a number of 
forms including haemoglobin and myoglobin from which the 
intact haem molecule is absorbed into the mucosal cell after 
removal of the protein chain, as ferrous and ferric salts 
which are absorbed three times more easily in the reduced 
form (Brise and Hallberg, 1962) and as salts of phytate and 
phosphate which are poorly uuilised. Poods rich in 
utilisable iron are green vegetables, eggs, red meat 
especially liver and bread made wirh iron fortified flour. 
Iron is absorbed in the duodenum and jejuneum.
Considerable demands are placed on the maternal iron 
stores during pregnancy due to an increase in the maternal 
red cell mass which demands about ouOmg of iron, to the 
fetus which requires 250 to 300mg and for placental and 
uterine needs and to cover blood loss at delivery an 
additional 300mg are required. About 500mg of iron will be 
returned to the maternal stores in the purperium; despite 
this 1g of iron is required in the second hall of pregnancy. 
If requirements were equal throughout gestation most suojectf 
could meet the demands by increased absorption (Hahn et al, 
1951) despite the low stores of many women. Storage iron 
was found to meet only one third of requirements in the 
average amer loan woman (Pii.kin et al, 1u72). However most 
of the iron is required during the second half of pregnancy 
and it is doubtful if this large requirement could be met by 
absorption alone as the maximum amount of iron that can be
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absorbed from the average diet is only 3 to 4nig.
The .Vorld Health Organisation in 1968 stated that iron 
deficiency anaemia in pregnancy is a world wide problem 
which has been recognised for many years. Today we may 
classify many more patients as iron deficient than in 1881 
when a normal maternal haemoglobin at term was only 58 per 
cent of the non-pregnant level (V/illcocks, 1881). However 
the problem was eventually recognised and by 1924 McGowan 
recorded a decrease in the condition which he considered to 
result from a better dietary knowledge and the "nearer 
approximation of the life of women to that of men", In 
1936 Corrigan and Strauss recorded the successful treatment 
of pregnancy anaemia witn ferrous sulphate and in 1942 
Hamilton and bright described the prevention of anaemia in 
pregnancy. It was advocated in the British meuical Journal 
in 1964 that iron should be given to all subjects 
throughout pregnancy to prevent ill-health in middle-life 
as a high proportion of post-menopausal chronic anaemias 
begin during the child-bearing years (Hilpatrick and 
Hardisty, 1961).
Recently the universal practice of prescribing iron 
during pregnancy which was recoim.jended 25 years ago has been 
questioned. Hall (1974) has indieared that iron supplements 
are not required routinely in developed countries and Taylor 
and Lind (197o) have suggested that prophylactic iron therap; 
may lead to excess iron deposition in the oone marrow. 
However it has been shown thar 47 per cent of women have 
low haemoglobin levels at rerm when no supplement has been 
prescribed but only 6 per cent were anaemic on iron 
supplements (Jacoos, 1974). Scott et al (1975) believe
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that one of the factors which have reduced the incidence 
of anaemia in pregnancy in Glasgow is an iron supplemented 
diet. The divergence of opinion on tne need for iron 
supplements during pregnancy is due to the absence of a 
definitive screening test for iron depletion. Tests used 
routinely in non-pregnant subjects include haemoglooin 
concentration, serum iron, total iron-binding capacity, 
free red cell protoporphyrin and packed cell volume which 
alter in pregnancy; the individual variation being 
considerable (Hytten and Duncan, 1956). It is therefore 
difficult to differentiate between physiological and 
pathological changes and some consider that as changes can 
be modified by iron supplements many patients are iron 
deficient. This view has been challenged by Hytten and 
Duncan (1956) who suggested that iron supplements should 
not be given solely on the basis of a fall in haemoglobin 
which reflects a disproportionate increase in plasma volume 
and red cell mass and not necessarily iron deficiency. 
Quantitation of the red cell mass would give a definitive 
diagnosis but such a test could not be performed routinely 
although Paintin (1962) after determining the calculated 
values for total red cell volume suggested that "the 
haemoglobin concentration may after all be a better index 
of anaemia". The benefits of an increased plasma volume 
with a low packed cell volume should not be ignored as the 
resulting decrease in plasma viscosity substantially 
reduces the worm of the heart and contributes to the 
maintainance of normal blood pressure as cardiac ouiput 
increases (Hytten and Duncan, 1956). It has been suggested 
that it is best to diagnose and treat iron deficiency
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specifically and that subjects can best be identified by 
using the determination of haemoglobin concentration as a 
screening test and furrner investigate all patients with a 
haemoglobin of less than 11g per dl (Paintin et al, 1966;. 
It is only by assessing the iron stores during pregnancy 
that this debate can be resolved.
The increase in the maternal red cell mass is the 
component most affected by inadequate iron intake but in 
all the most severe conditions the impairment is self- 
limiting. The affect of maternal anaeijjfa on the fetus is 
unclear. It has been stated that still-births, neonatal 
deaths and malfor.i.ations are frequent (Roszmowsmi et al, 
1966) and Butler (1967) has suggested that a strong 
correlation exists between still births and maternal 
anaemia but it has been difficult to prove and some have 
suggested that moderate degrees of anaemia do not affect 
the fetus (Beaton, 1974), H e i n  (1962), ..lacGregor (1963) 
and Butler (1967) have described an increased incidence of 
premature labour in pregnancy anaemia.
The mature human fetus at birth has an iron 
concentration of 78mg per Rg which compares with 70mg per 
Kg of the adult male (Josephs, 1959), In the third 
trimester the fetus accumulates 4mg of iron per day 
(Pribilla et al, 1936). The total iron content of the term 
infant is 152 to 372mg which varies witii birth weight, 
gestation, the time of clamping of the cord and the cord 
haemoglobin (Burman, 1971). The prime determinant of total 
body iron is fetal birth weight (Chang, 1973; Loria et al, 
1977).
Haemorrhage before or during delivery decreased the
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total body iron content (Burman, 1974). In a twin pregnanqv 
transfusion can occur from one twin to the other resulting 
in anaemia and polycythaemia respectively, Antenatally 
haemorrhage can occur from the fetal into the maternal 
circulation, during amniocentesis or at delivery from the 
placenta.
The distribution of iron between haemoglobin and 
storage sites at delivery is similar to that of the adult 
male (Burman, 1971). The fetal liver at birth contains the 
highest proportion of the non~haem iron and has a greater 
concentration than the adult male and may reflect that the 
liver is an erythropoietic organ in the second trimester 
which may still be active at birth (Ohang, 1973), The liver
non-haem iron convent has been assessed mainly by
histochemical methods or by chemical analyses (Chang, 1973; 
Loria et al, 1977), It has been shown that the non-haem 
iron content of the liver also correlates with the weight 
and gestational age of the infant; the former being more 
important. The total content doubles between 38 and 40 
weeks (Chang, 1973) but the concentration did not show 
significant variation with gestation. In the midney 
however both the concentration and the total non-haem iron 
content appeared to increase with advancing gestation.
Loria et al (1977) showed that in light-for-dates
premature and terji babies that the non-haem iron content
of the liver was lower than the equivalent eutrophic 
infant. They also reported that the hypertrophic mature 
infant had a depleted liver iron content and concluded that 
when the fetus attains a body weight of 4 Kg that the hepatic 
iron stores are mobilised.
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Prematura infants have low iron stores at delivery 
and it has been shown that they become anaemic more 
frequently and at an earlier age than their term 
counterparts (,7.11.0., 1968). It has been reported that 
babies of severely iron deficient mothers developed anaemia 
in infancy although the neonatal haemoglobins were normal 
(Strauss, 1933) and Sissons and Lund (1953) suggested that 
the fetal iron content vjas decreased in maternal iron 
deficiency anaemia. However more recent studies have 
suggested that there is no correlation between the 
haemoglobin and serujn iron of the mother and fetus at birth 
and at six months (Kessel and bills, 1963) nor between the 
plasma ferritin concentrations (Rios et al, 1975).
Smith et al (1955) stressed the importance of fetal 
iron stores as during infancy the diet contains little iron 
and suggested that 70 per cent of the haejnoglobin iron at 
one year and 40 per cent at two years was of maternal 
origin but this has been questioned by Burman (1971) who 
thought that the dependence was only apparent up to three 
months of age. However it has been demonstrated that 
premature and light-for-dates infants have higher 
haemoglobin levels when t^ he diet is supplemented with iron 
(Barman, 1971).
Petal iron is acquired from the maternal diet and iron 
stores. Iron is absorbed in increased amounts and is 
utilised oy the fetus (Svandberg et al, 1975). Rapid 
depletion of maternal liver and spleen ferritin but not of 
haernosiderin take place together witli a reduction in the 
maternal ferritin synthesis in the rat (iyllie and Kaufman, 
(1 9 7 1). Iron in the am ni otic fluio. can be absoroed through
the fetal intestine and be utilised by the fetus but this 
route is of minor importance (Orlic et al, 1974).
maternal red blood cells were thought to be the source 
of fecal iron prior to the detection of iron in plasma in 
1923 (Scholten and Veit, 1903). It vuas believed that 
erythrocytes disintegrated in the placenta liberating iron 
and the theory was supported by the presence of haemolysins 
and histochemically identifiable iron in the placenta. In 
1942; Pommerenke et al demonstrated that within minutes of 
transferrin bound radioiron being present in human maternal 
plasma it appeared in the fetal circulation. This work was 
verified and expanded by Vosburg and Plexner,^1930^who 
showed that in guinea pigs the fetal iron content could be 
accounted for from the maternal circulation without the need 
to consider the maternal red blood cells as an alternative 
source of iron. It is now accepted that transferrin of the 
maternal circulation is the immediate source of iron 
transferred to the fetus (Morgan, 1974).
Transferrin is taken up by the rabbit placenta much 
faster than by the maternal bone marrow and the uptake 
increases per unit surface area and with advancing gestation 
The process is independent of the fetus (Baker and i.iorgan, 
1969)0 Receptor sites for the transferrin-iron complex are 
thought to be present on the maternal surface of the human 
placenta (Fletcher and outer, 1969). Iron would appear to 
be taken up by the guinea pig placenta free of the maternal 
carrier protein before being transferred to the fetal 
circulation (Morgan, 1973). The rate of iron transfer 
across the placenta is very rapid and suggests that it does 
not pass through any biological pool of importance (bothwell
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et al, 1953).
The passage of iron across the human placenta increases 
ten fold from mid-pregnancy until term (Fletcher and Buter, 
1 9 6 9). The fetal iron and transferrin saturation are 
greater than that in the maternal circulation and placental 
iron absorption has been shown as an active process 
dependent on placental cellular metabolism ('dong and Morgan,
1 9 7 3). The clearance of iron is the same whether it is bound 
to maternal or fetal transferrin and there would appear to 
be an unidirectional system for pumping iron through the 
placenta (Bothwell et al, 1958).
Histological studies of the distribution of iron in the 
human placenta throughout gestation were undertaken by McKay 
et al (1958). Taey demonstrated that non-haem iron reached 
jnaxiinuffl levels in the second trimester and thereafter 
decreased until just before term when iron was detected in 
the stromal macrophages. In rats it has been shown that in 
early pregnancy a higher percentage of iron is taken up by 
the yolk sac and placenta than in later gestation when iron 
appears to go directly to the fetus (Glasser et al, 1968). 
Fletcher and Buter (l9o9) have shown that although most of 
the radioiron was taken up by tne fetus a significant 
amount was always retained by the placenta.
The present work was an attempt to study iron stores in 
pregnant women, their influence on iron utilisation and 
turnover in the fetus and the part played by the placenta in 
this process.
Plasma ferritin has not^previously been determined in a 
Scott isa population, A group of young males and females of 
reproductive age were selected to determine if the reported
4sex difference in storage iron occurred and also to 
estimate the adequacy of the female iron stores to maintain 
a normal pregnancy. In order to determine the suitability 
of the present ferritin assay to assess iron stores, plasma 
ferritin and bone marrow iron content were quantitated in 
non-pregnant subjects.
quantitation of plasma ferritin was used to define the 
changes which occur in iron stores during pregnancy and in 
the ipuerperium . Few reports exist on maternal iron stores 
throughout pregnancy but de Leeuw et al (I9 6 6) determined 
the bone marrow iron content in early and late gestation 
and in the puerperium of untreated and iron supplemented 
women. No publications are known which report the maternal 
plasma ferritin throughout pregnancy and initially it was 
hoped to correlate ferritin concentrations with bone marrow 
biopsies but the latter was regarded as unethical when not 
specifically merit;ed by the patient's condition.
In disease states changes frequently occur in 
metabolism and a study of these changes often results in a 
better understanding of the normal physiological process.
The effect of coincident disease during pregnancy on plasma 
ferritin was assessed. The pathologies included pre-eclamptic 
toxaemia of pregnancy, diabetes and pregnancy jaundice which 
occur relatively frequently in our population.
The influence of maternal iron stores on fetal stores 
was assessed by relating the maternal, plasma ferritin to the 
cord ferritin concentration. The study had previously been 
undertaken by Rios et al (l97ô) who found no correlation 
between the two levels. It was felt this work merit od 
repetition and supplementation by assessing factors known
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to reduce maternal iron stores. Plasjua ferritin of term 
babies in the neonatal period and in childhood have been 
investigated (Hines et al, 1974; Rios et al, 1973) but neitner 
of the reports related the concentration to gestation, body 
weight or the clinical condition of the newborn. An 
investigation was undertaken to relate these factors to the 
daily changes in plasma ferritin during the neonatal period.
The gestational changes in the content of non-haem iron 
or ferritin iron of fetal organs has been reported (Fletcher 
and Suter, 1969; Burman, 1971) but little has been recorded 
of the specific quantitation of ferritin in the fetal organs. 
The varying rates of accumulation of ferritin in the liver, 
heart and spleen were investigated and the effect of body 
weight, gestational age and retarded growth assessed.
Ferritin has been identified in the placenta (Wohler, 
1955) and gestational changes in the non-haem iron content 
have been reported (iviacXay et al, 1958; Glasser et ai, 1963). 
It was thought that knowledge of the human placenta could be 
expanded by using a specific ferritin assay to relate the 
content to gestation, placental weight and the content of 
placental peptide hormones, human chorionic gonadotrophin 
and human placental lactogen.
Ch£ipter One
PREPARATION OF REAGENTS
AND METHODOLOGY
The quantitation of ferritin necessitated the isolation and 
purification of human ferritin for the production of rabbit anti"human 
ferritin and standard solution, the preparation of iinmunoadsorbent 
and radioisotopically labelled antibody.
Isolation and Purification of Human Ferritin 
from Spleen and Placenta 
The isolation of ferritin is dependent on its high molecular weight 
and heat stability. Most methods involve the initial removal of 
contaminating proteins by heat coagulation followed by precipitation 
of ferritin with ammonium sulphateo Purification has been carried 
out by various methods including crystallisation of the protein from 
cadmium sulphate solutions (Granniek, 1942), chromatographic separation 
on columns of Sephadex and carboxymethyl cellulose (Drysdale and Munro, 
1965) and by ultra-centrifugation (Penders et al, 19/68)., However, 
Penders et al (I968) have criticised the use of cadmium sulphate in the 
preparation of ferritin as poor yields were obtained and they also found 
that repeated colurnnchromatography could split ferritin into a number 
of fractions. The method chosen was based on the reports of a number 
of v/orkers including Drysdale and Munro, 1965; Penders et al, I9 6 8; 
Worwood, 1975; Aherne and Worwood, 1974 and Miles et al, 1974. 
Reagents. 1 » IM Acetic acid
170ml Acetic acid (BDH Analar) made up to 1 litre with 
distilled water.
2o Sodium acetate -vBDH 
5“ Ammonium sulphate - BDH
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4. 0.15M Sodium chloride.
8.7g sodium chloride in 100ml distilled water.
5. 0.05M B a r h i t o n e  b u f f e r  pH 7.5.
10.5g of sodium barhitone in 1 litre distilled water and 
adjusted to pH 7.5 with O d H  IICl.
6. Senhadex 0200 - Pharmacia, Uppsala, Sweden.
7. .DBTLbu^TGr^" 10.5g sodium barhitone, G g  sodium chloride 
and 0.2g sodium aside in 1 litre distilled water and the 
pH adjusted to 8.0 with 5M ÏÏG1. Prior to use 0<,5g of
bovine albumin (Sigma) was added per 100ml buffer.
Method Normal human spleens removed at autopsy and normal placentae 
obtained by spontaneous vaginal delivery were homogenised with 4ml of 
water per g of tissue within an hour of arriving in the laboratory.
The homogenate was heated (70 i 2^C for 10 minutes) with constant 
stirring and then rapidly cooled to room temperature. It was then
centrifuged at 2,500g for 15 minutes and filtered ttoough . Whatman
No. 1 paper. This procedure removed the bulk of 'the contaminating heat 
coagulable proteins. Adjustment of the supernatant to pH 4.8 with 1M 
acetic acid precipitated mainly haemoglobin (Drysdale and Munro, 1965) 
(removed by centrifugation at 2,500g for 15 minutes). The supernatant 
was then made 0.05M with respect to sodium acetate by the addition of 
the solid salt and the pH adjusted to pH 5.5 with IM acetic acid. The 
solution was maintained at 4*^ C and solid ammonium sulphate slowly added, 
with stirring, until the solution was 60 per cent saturated (31 Og per 
litre) and left overnight, By selecting such a concentration of 
ammonium sulphate both the iron rich ferritin and apoferritin were 
precipitated with the minimum of protein contaminants (Drysdale and 
Munro, 1965).
The precipitated ferritin was harvested after centrifuga/tion at 
1,500g for 10 minutes and dissolved in 40ml of 0,1 5H sodium chloride.
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The dark brown solution was centrifuged at 100,000g for 2 hours in a 
Beckman 15-65 ultracentrifuge at 15^C. The durk brown precipitate was 
dissolved in the minimum volume (about 10ml) of 0.05H barbitone buffer 
pH 7.5.
The ferritin solution was further purified by chromatography on a 
Sephadex G200 column (90 z 2.5cm), equilibrated with 0.05M barhitone 
buffer pE 7.5. 5ml of the extract was carefully applied to the column
and eluted with barhitone buffer (0.05M, pH 7.5). Ferritin is so large 
a molecule that it was almost excluded from the Sephadex and therefore 
appeared in the void volume. It was collected in 2ml fractions by an 
LKB fraction collector, 7000 Ultrorac and appeared as a single peak 
when the protein content was monitored at 280nm using an 'LKB llvicord II 
recorder. The fractions were pooled and concentrated under positive 
pressure using an Amicon Model 202 apparatus and Amicon ultrafiltration 
membrane PM10, The concentrated ferritin solution was analysed for 
protein content by the method of L o w r y , 951 )and by themethod of
Laurell (l966)® The purity of the preparation was determined by
\
crossed-immunoelectrophoresis and by sodium dodecyl sulphate SDS )  
polyacrylamide gel electrophoresis. The yield of ferritin from a 
human spleen ranged from 52 to 75mg and from a human placenta from 19 to 
49mg,
Frenaration of Standard Ferritin Solutions The concentrated ferritin 
solution was diluted with BSA buffer to a concentration of 1 Omg per 
litre and dispensed in 500ul aliquots. The standard solutions were 
stored at -20°C and were stable over a two year period.
I
Cro s sG d Immuno e1ec tro nh ore s i s 
The purity of the preparation was checked by crossed 
iminunoelectrophoresis (Canrot, 1972). A chemically clean 8 x 8cm glass 
slide previously coated with 10ml 1.0 per cent agarose (w/v) (B.D.H.) in 
0.075M barhitone buffer pH 8,6. T\=to hours later thr-ee holes (3mm 
diameter) were cut in the gel 2,5cm apart and 1.5cm from the end of the 
plate. The ferritin extract was added to two of the holes and human 
plasma to the third. The proteins were separated electrophoretically 
in a Shandon electrophoresis tank containing 0.075M barhitone buffer, 
pH 8,6; (lOm amp,, IBOv for 2 hours). The gel was then cut into tliree 
sections, one hole per section and transferred, with care to three 
separate 8 % 8cm glass slides and positioned to one side of the plate,
7.5ml of 1 cO per cent agarose (w/v) in 0.075H barhitone buffer, pH 8.6 
and containing 0.2ml of commercial anti-human ferritin (Hoechst) was 
poured onto the plate containing one of the ferritin extracts and care 
was taken to avoid overlapping the agarose slab. The second ferritin 
extract and the human plasma were set up against agarose containing
0.2ml anti-himan plasma proteins (Hoechst), The plates were set aside 
in a humidified cabinet for 2 hours before being subjected to 
electrophoretic separation at right angles to the initial run. The run 
took place overnight in 0,076M barhitone buffer pH 8,6 at 10m amp, and 
180v. The agarose slabs were washed lightly with distilled, running 
water and then placed in 0,1 5M sodium chloride for 30 minutes. They 
were again washed with water, covered vrith moistened Whatman Wo, 2 
filter paper and dried in a stream of hot air. When the paper dried it 
was easily removed from the slide which was again lightly washed with 
water and diûed rapidly in hot air. It was then placed izramido black (o,1f) 
for 3 to 5 minutes and rinsed in 0,8M acetic acid. The plates were then 
air dried and inspected. The plate containing the ferritin extract and 
anti-human ferritin had one large rocket - see Plate 1,1 but none were
visible in the jDlate containing ferritin extract and anti-serum 
against huma.n plasma proteins. The control plate which contained 
human plasma and anti-human plasma proteins had upwards of thirty 
rockets and demonstrated a successful run - see Plate.1^1
Investigation of Ferritin Extract 
by SDS Polyacrylamide Gel, Electrophoresis 
Polyacrylamide gel has a high resolving power and molecules are 
separated on the basis of their net charge and molecular size.
Reagents 1. 30 per cent Acrylamide (BDH) in distilled water.
2. 1 .5M Tris HC1 (Sigma.) containing 0.4 per cent sodium 
dodecyl sulphate (SDS) (b DH) adjusted to pH 8.8.
3» 10 per cent Ammonium persulphate (BDH) - prepared before
use.
4- H:tjLH^_jLHL^r:_kketm.methylet (TFMiD) (BDH).
5. S D ^  Ge 1, To prepare two
plates 6.25ml of Reagent 1, 6.25ml of Reagent 2, and
12.4ml of distilled water weremixed and degassed for 1 to 
2 minutes. 83ul of Reagent 3 and 25ul of TSHFD were then 
added.
6. p.5H Tris HCl conta,ining 0.4 per cent SDS and adjusted to 
pH 6.8.
7. ,SD5 Polyacrylamide-Upper Stacking Gel, 5ml of Reagent 6, 
3ml of Reagent 1 and 12ml of distilled water were mixed 
and degassed for 1 to 2 minutes. 60ul of Reagent 3 and
2Oui of TFMED were than added and thegel mixed,
8. Electrode Running Buffer, 43»2g glycine and 3g SDS were 
dissolved in 31 0.025M Tris base (Sigma),
9c SDS Samnle Buffer. 40g of sucrose, 10g of SDS and 0.1 g 
Bromophenol blue were-dissolved in 100ml 0.1M Tris HCl, 
pH 6.8.
PLATE 1, 1(a)
PLATE 1,I(b)
Plate 1 (a) The arc formed in a crossed immunoelectrophoretic 
analysis of a ferritin extract which precipitated with anti­
ferritin plus anti-plasma proteins.
(b) Crossed immunoelectrophoretic analysis of human 
plasma precipitated v/ith anti-plasma proteins.
1 8
I Oy OoOjüa^oio . 1 g of Oooms.BSie blue and 1 2 . 5 g  o f
Trichloractio acid were dissolved in 100ml distilled 
waterc
II « Destainin/? a g e n t . Acetic Acid: ethanol: distilled water
in ratio of 10:10:80.,
Preparation of Plates Tlie pla, tes consisted of two 8 x 8cm glass slides 
separated by spacer arms and the whole assembly was taped together.
The gel plates were filled to 2,5cm from the top with Reagent 5« The 
gels were gently overlayed with distilled water and left overnd.ght to 
polymerise* Reagent 7y the upper stacking gel, was then layered 
carefully over the lower gels to fill the plates and the sample combs 
were then positioned. The gels were left aside for 1 hour to polymerise, 
Mounting of Plates The gel plates were mounted in the Uniscil 
electrophoresis tajik (Urd.versal Scientific Ltd,) and sample combs 
removed. Running Buffer (Reagent 8) was added to tlie tank and allowed 
to enter the sample wells. Air bubbles were removed if necessary.
The SBS Sample Buffer (Reagent 9) was mixed with sample and distilled 
water added to dilute the buffer 1:4* The samples were then carefully 
layered under the buffer into the sample wells using a Hamilton 
syringe.
The gels were run at 20m amp per plate for 5 hours to allow the
bromophenol blue marker to reach the end of the plate. The tape was
removed from the sides of the plates which were then gently prised
apart. The gels were removed and stained in Coomassie blue overnight
and were then destained with Reagent 11, Platei^shows three specimens
of human sera run along side three spleen ferritin extracts containing
3,6mg protein per ml. Only one band is visible in the separation of the
ferritin extract and it was judged pure. In PlateRTXl- can be seen the 
• <
results of duplicate separations of human serum, two extracts of 
placental ferritin containing 0,6 and 0,1 rag protein per ml and an
Plate 1, II Analysis of 3 specimens of human plasma and triplicate
analysis of human spleen extract of ferritin (3.6mg/ml) by polyacrylamide* 
gel electrophoresis.
Plate 1, III Analysis in duplicate of human plasma, human placental 
extract I (0.6mg/ml), .placental extract II (0.1 mg/ml) and human 
spleen extract (1.3 mg/ml)
'■ I
extract of spleen containing 1 *3mg per ml* The spleen extract gave 
only one hand hut both placental extracts contained contaminants which 
were later identified as alpha^^macroglobulin and transferrin.
B e t a - l i p o p r o t e i n  has o n  on e  o c c a s i o n  b e e n  a c o n t a m i n a n t  i n  an e x tract 
of s p l e e n  ferritin,
Quantitation of Ferritin by the Method of Lowry (1951)
In the initial reaction protein is complexed with copper in alkaline 
solution which together with, tyrosine and tryptophan reduce 
phosphomolybdic and phosphotungstic acids to molybdenum blue and 
tungsten blue*
Reagents 1 ) Alkaline tartrate reagent* 20g of sodium carbonate and 
Oo5g sodium tartrate in 11 0,1M sodium hydroxide*
2) O^QifLPJlRpeiLSulpha 0.1 g copper sulphate (CuSO .
■-5H20) in 100ml distilled water,
3) Working alkaline copper reagent, 45ml of alkaline tartrate 
reagent and 5ml of copper sulphate solution mixed immediately 
before use.
4) Folin and Ciocalteau’s Reagent: BDIL Reagent and distilled 
water (l:l) were mixed immediately before use.
5) Standard Protein Solution. A "Wellcontrol" serum of known 
protein content was diluted with 0,1 5M sodium chloride to a 
protein concentration of 4g per litre. Doubling dilutions 
were made of this solution to give protein concentrations 
from 250 to 2,000mg per litre.
Method lOOul of water, standard and test solutions were added to 
respective tubes and 5ml of worldng alkaline copper reagent added. The 
contents were mixed and left at room temperature for 15 minutes, 500ul 
of diluted Folin and Ciocalteau reagent was then added, mixing after each 
addition of reagent and the absorbance was read at 750nm after 30 minutes 
(Unicara SP 600).
Pl’oduction of Rabbit Antx-human Ferritin
The production of antisera is more of an art than a science' (Hurn 
and Ijandon, 1971 ), Methods which are successful in one laboratory 
often fail when repeated elsewhere and proven Immunisation schedules 
suddenly give poor antisera. However a knowledge of the molecular weight 
and composition of the immunogen and the consideration of adjuvant, 
animal host, route of immunisation, dosage, timing of injections and 
harvesting of anti sera aid the production of a good anti^serum (Hurn, 
1974).
The immunegenicity of a compound is dependant on a molecular 
weight in excess of 5,000, properties of polymerisation, the rigidity 
of structure and accessibility of determinant groups, susceptibility 
to enzymatic degradation and content of phenylalanine, tryptophan, 
glutamic acid, lysine and tyrosine. Ferritin has a molecular weight of 
4-50,000, is composed of 24 A subunits and with the protein shell 
surrounding the metal core should theoretically be strongly antigenic.
The inclusion of adjuvants improves antibody response and the most 
useful was described by Freund in 1951 and consists of a neutral 
detergent, paraffin oil and killed mycobacteria. It is said to work by 
slowly releasing the antigen over a number of weeks,fa, cilitating 
phagocytosis of the antigen by macrophages, causing the advantageous 
formation of local granulomatous lesions and aiding local and generalised 
stimulation of the reticulo-endothelial system (Hurn and Landon, 1971).
It has been suggested that the best results are obtained when the 
adjuvant to aqueous antigen solution is in the ratio of 2 or 3:1 (Hurn,
1974).
Rabbits and guinea pigs have been frequently used to produce 
antisera but sheep, goats and horses yield larger volumes. The species 
used however is often dictated by local circumstances and could explain 
the popularity of the rabbit as host animal.
The route of immunisation has been most commonly intramuscular or
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sub-cutaneous although lymph nodes, intra-articular, intradermal and 
intraperitoneal have also been used. Few scientific comparisons have 
been made but it has been suggested that the most avid antisera was 
obtained when lymph nodes were used although the number of animals 
responding was poor (Hurn and Landon, 1971 ). The multiple site 
intradermal regime (Vaitukaitis et al, 197l) has been recommended for 
the rapid production of antisera when antigen is scarce.
The amount of antigen administered is thought to be important and 
it has been suggested that tlie minimal effective concentration results 
in the most avid antiserujn* It is common practice to give an initial 
dose of 1 mg but more recently it has been suggested that 1 OOug 
initially and booster doses of 50ug could be more effective (Hurn and 
landon, 1971)* The time schedules for immunisation also vary 
considerably but are based on the fact that the lag phase is of the 
order of seven to eight days before immunoglobulin M appears and tha.t 
maximum levels of the qualitatively and quantitatively important 
immunoglobulin G do not occur for four to six weeks. Response to 
booster doses differ in that the lag phase is reduced to four days and 
the maximum response is greater and achieved within ten days.
The purpose of the present investigation was to produce anti-human 
ferritin of sufficient avidity to assay plasma ferritin and therefore to 
save time it was decided to adopt a number of regimes which had been 
described in the literature. To make successful comparisons at least 
ten animals would have had to be allotted to each trial (Hurn and 
Landon, 1971 ) but this was not attempted and only one animal was used in 
each regime. It was therefore not possible to make valid comparisons. 
Reagents 1 , White, adult, female Hew Zealand Rabbits,
2, Freund's Complete Adjuvant « Difco.
3, Human spleen ferritin - 1,4mg per ml.
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Method I A rabbit was immunised according to the schedule of Shmes 
et al; (1974). 0.75ml of the ferritin solution was taken u%) into a 
syringe followed by 0«75ml of Freund's adjuvant and the contents 
shaken vigorously to form an emulsion. This dose was divided between 
two sites and injected intramuscularly. Three weeks later a booster 
injection of 0.25ml ferritin solution and an equal volume of the 
adjuvant was given, ' The animal was bled three weeks later by making a 
small incision to the ear and collecting the blood in a sterile 
Universal container. The serum was stored at -20^0.
11^  The protocol for the second rabbit was that of Miles et al (l974).
The rabbit was injected in multiple subcutaneous sites with 0.5ml 
adjuvant containing 1 OOug ferritin and this was repeated twice at 
weekly intervals. Tliroe weeks after the third injection a final 
injection of lOOug ferritin in 0.1 5M sodium chloride was given. The 
animal was bled ten days later.
Ill The third rabbit .was treated by the regime described by Powell et 
al;(1975 )0 0.75ml ferritin solution was diluted with 1 ml of adjuvant and 
injected intramuscularly at weekly intervals for tliree weeks. The rabbit 
was bled on the foui'th, fifth and sixth week after the initial injection. 
Assessment of specificity of rabbit anti-human ferritin The 
monospecificity of the anti-sera was checked by crossed-immunoelectro- 
phoresis and by the Ouchterlony double diffusion method (1964).
The anti-sera was checked for monospecificity as described under 
the section "Preparation of Ferritin" by crossed-immunoelectrophoresis. 
Tliree plates containing 0.2ml anti-serum were set up against a ferritin 
extract; a ferritin extract diluted 1:1 with human plasma, and with 
whole human plasma. Only the first ti-ro plates gave a single rocket and 
nothing was seen on the third plate. These results suggested that the 
anti-serum was specific for human'spleen ferritin.
The specificity of the rabbit anti-spleen ferritin was assessed by
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the method of Ouchterlony (1964). Four wells were cut 0.5cm from the 
central well which was filled with anti-spleen ferritin. The 
surrounding wells wore filled with human spleen ferritin, human liver, 
human heart and human placental extracts* There was a complete reaction 
of identity of all organ ferritins and only a single precipitin line was 
formed between each well.
Titre of rabbit anti-human ferritin Titre of antibody in the serum was 
determined by gel diffusion against purified human spleen ferritin. 
Doubling dilutions of the anti-servam were set up against spleen ferritin 
at a concentration of 0.6rag per ml. The titre was considered adequate 
for the assay if precipitation occua'edat dilutions of 1:64 of anti­
ferritin.
The titre was also assessed by incubating the anti-human ferritin
with horse ferritin immunoadsorbent - described under "Production of 
125
Iodine Anti-Hujiian Ferritin". Satisfactory anti-sera contained more 
than 1mg of specific antihuman ferritin per ml which could be bound by 
the ferritin immunoadsorbent.
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Preparation of a protein immunoadsorbent
Preparation of Ferritin luirouiioadsorbent 
Soluble antigens coupled to insoluble supports are known as 
immuno ads or bents. The antigens- retain the ability to combine wit}), 
corresponding antibodies and have been used principally in the isolation 
of antibodies and in the quantitation of antibody titres. In the ferritin 
assay the immunoadsorbent is used to isolate specific anti-human ferritin 
and to protect it during iodination.
The insoluble support of the ferritin immunoadsorbent (F-lmAd) was 
3-aminobenzyloxymethyl-cellulose and was synthesised by reacting 
cellulose with N(3-'nitrobensyloxymethyl)-pyridinium chloride (Gurevich, 
1964), The compound was then diazotised with horse ferritin - see 
Figure 1,1o .
The initial reaction was accelerated by drying the cellulose. This 
was accomplished by mixing it with sodium acetate and N(3“-nitrobenzyloxy-- 
methyl)-pyridinium chloride dissolved in ethanol, followed by evaporation 
of the solvent (Gurevich et al, 1961). On heating the reactants
3-nitrobenzyloxymethyl cellulose was formed and pyridine liberated. The 
nitro groups were then reduced to amino grcoups with sodium dithionite.
The amount of antigen bound by the immunoadsorbent is not directly 
related to the total number of amino groujS:present on cellulose but only 
to the number of groups on the surface of the immunoadsorbent. More 
antigen can therefore be bound by increasing the surface area of the 
carrier and this can be done by utilising a process developed in the 
manufacture of rayon (Fieser and Fieser, 1944). Cellulose is soluble 
in an ammoniacal solution of copper hydroxide, Schweitzer's reagent and 
on the addition of water, is precipitated in the form of a suspension 
which can then combine with one hundred and thirty-three times more 
antigen than before (Gurevich, 1964). The "amino-cellulose" in 
suspension was then reacted with nitrous acid to form a diazonium salt 
which then combined with ferritin. Diazonium salts can react with a
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number of groups on the protein molecule including the phenol group of 
tyrosine, the imidazole group of histidine, the S-amino ^proup of lysine, 
the sulphydryl group of cysteine, the indole group of tryptophan. , the
guanidine group of arginine and t h e ^  -andno group of glycine (Howard
and Hild, 1957). The binding of the antigen to the immunoadsorbent is 
strong and is not destroyed by dilute acid.
Reagents All reagents were from BDH, Analar grade unless otherwise
described,
1. Whatman CC41 Cellulose*
2. Ethanol - 90 per cent*
3. H(3-nitrobenzyloxymethyl)-pyridiniuio chloride„
4-p Sodium acetate-anhydrous.
5. Benzene*
6* 0.96m Sodium dithionite*
20g Sodium dithionite in 100ml distilled water*
7c 5H Acetic Acid*
300ml Acetic acid diluted to 1 litre.
8, 0.04M Copper sulphate.
5g copper sulphate (CuSO^cbH^)) in 500ml distilled water* 
9c 0*75M Sodium hydroxide.
2*25g Sodium hydroxide in 75ml distilled water,
10. 0*88 Ammonia,
11, Sucrose*
12, 1 *84M Sulphuric acid*
100ml concentrated Sulphuric acid diluted to 1 litre*
1 3. 2N Hydrochloric acid.
166ml concentrated Hydrochloric acid diluted to 1 litre*
14 * Urea *
15. Horse Spleen Ferritin - Calbiochem, Grade A.
16* 0*211 Borate buffer pH 8*0, 12*37g boric acid and 14*91 g
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potassium chloride were dissolved in 11 distilled water*
1 60ml of 0*1H sodium hydroxide was added to bring the pTI 
to 8.0.
17. g-Hanhthol.
18. Glycine.
19c 0.04M Phosphate buffer containing O.IM sodium chloride,
pH 7.4. 9.5ml 0.08H sodium di-hydrogen phosphate was
added to 40*5ml O.OSM di-sodium hydvogen phospliate.
0.9g sodium chloride was added and the volume made up to 
1 00ml with distilled water.
20. ESA buffer. 0.05M Barbitone buffer containing O.IM
sodium chloride and 5mg albumin per ml, pH 8.0, 10,3g
sodium barbitone, 6 g  sodium chloride and 0.2g sodium 
aside were dissolved in 1 litre distilled water. The pH 
was adjusted to 8.0 ± 0.05 with 5M hydrochloric acid, 
500mg bovine albumin (Sigma) was added to 100ml buffer 
before use.
Method; Tlie preparation of aminocellulose 10g of Whatmn CC41 cellulose 
powder was added with mixing, to 20ml of 90 per cent ethanol containing 
1.4g H{3'~nitrobenzyloxymethyl)”pyridinium chloride and 0.5g arhydrous 
sodium acetate in a porcelain evaporating basin. The mixture was 
initially heated and allayed to dry on a water-bath at 80°C and then in 
an oven maintained at 125^0 for 40 minutes which produced pyridine and 
3-nitrobenzyloxymethyl .cellulose. The product was then placed in a 
Buchner funnel, washed with 600ml of benzene and air dried, Tlie compound 
was further washed with 51 of distilled water to remove final traces of 
pyridine. The nitro groups were then reduced by adding the moist 
cellulose to 150ml of 0.96M sodium^dithionite and heating at 60^C in a 
water-bath for 30 minutes. The amino-cellulose was freed from hydrogen 
sulphide by washing with 800ml distilled water, 600ml 5M acetic acid and
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800ml distilled water and finally dried in a vacuum desiccator and 
ground with a mortar and pestle to give a creamy-yellow powder* The 
compound was stored in a vacuum dessicator at 4^0 and was stable for 
more than one year*
Cupric hydroxide was precipitated when 500ml of 0.04M copper 
sulphate solution was mixed with 75ml of 0.75M sodium hydroxide. The 
precipitate was washed with 21 of distilled water and dissolved in 100ml 
of 0*88 ammonia* 0*33g of sucrose was then added followed, very slowly, 
by 1 g of aminocellulose and the mixture stirred with a magnetic stirrer 
for 30 minutes* 300ml of distilled water was added and a flocculent 
white precipitate was formed when 250ml of 1*84M sulphuric acid was 
slowly added to destroy the copper complex and neutralise the solution 
which was indicated when the solution became pale blue* Tlie precipitate 
was washed with 11 distilled water, suspended in 100ml of water and used 
within 30 minutes,
Diazotisation of Aminocellulose Immunoadsorbent and Coupling to Ferritin 
The following reactions took place in a cold room at 4°C* 20ml of 2M 
hydrochloric acid was added to 10ml of the aminocellulose suspension 
(lOOmg aminocellulose) to produce a pink colour. The reaction took 
place in a glass beaker surrounded by a sodium chloride-ice mixture* 
0,8ml of 0.15M sodium nitritewas then added and the pink colour 
disappeared* The mixture was left for 30 minutes* Solid urea was then 
added to remove nitrous acid which was indicated when starch iodide 
paper did not turn blue. The diazotised cellulose was then washed three 
times with 30ml of ice-cold distilled water and once with 30ml of 0*2M 
borate buffer, pH 8*3, in a refrigerated centrifuge MSE Model 6L, at 4^0 
and 2,000 r*p,m, for 5 minutes. The precipitate was then suspended in 
4ml of the 0*2M borate buffer, pH '8*3 to give a concentration of 25mg 
diazotised cellulose per ml* The success of the diazotisation was 
confirmed when a few drops of the suspension gave a bright orange colour
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when added to j3-naphthol in Û.2M borate buffer.
Fex-ritin-immunoadsorbent (P-ImAd) was synthesised by the addition 
of 100mg of horse spleen ferritin crystals (Calbiochem, Grade a ) to 4ml 
of the diazotised-cellulose suspension (lOOmg diazotised cellulose)*
The solution was mixed and left in the dark at for 3 days with 
occasional mixing. Excess diazo groups were combined with 0.4g glycine 
in 10ml of 0*2M borate buffer by stirring the mixture constantly for 60 
minutes (Miles et al, 1974)* Excess ferritin was removed by washing the 
F“ImAd complex ten times with 10ml 0.04M phosphate buffer, pH 744, in 
the refrigerated centrifuge at 4°C and 2,000 r.p.m* The ferritin 
concentration was determined in the supernatant by the method of Lowry, 
(1951) and thereby the amount of antigen bound to the diazotised cellulose
was calculated. The complex was then washed throe times with 10ml 0.05M
barbitone buffer, pH 8.0 and finally susjxend in 5ml of this buffer to
give a concentration of 20mg cellulose per ml* The suspension was
stored in the dark at 4°G and was stable for at least 12 months* It 
was found that 300 to 390mg of horse ferritin was bound by 1 g of 
cellulose* A commercial preparation of aminocellulose (Miles 
Laboratories) which became available after the method was established 
was treated in the ma.nner described above and was found to bind 21Omg 
ferritin per g cellulose*
Theoretical Aspects of Ferritin Quantitation
Radioimmunoassay (RIA) or saturation analysis was first described 
by Yalow and Berson and independently by Ekins in 1960. This technique 
has since been applied to the quantitation of more than two hundr-ed 
substances present in low concentrations in biological fluids (Ekins, 
1974) and is dependent on the competition of a compound and its 
radiolabelled derivative for a limited amount of anti-body. In 1968 
Miles and Hales described an immunoradiometric assay (IRMA) which 
theoretically has improved sensitivity and precision (Rodbard and Weiss,
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1973) when compared to RIA. IRMA measures compounds directly in the 
presence of excess radiolahelled antibody* A fur then development 
occurred in 1971 with the introduction of 2 site-IRMA also known as 
junction test, sandwich technique or direct radioimmunoassay (Addison 
and Hales, 1971)& The test substance is first insolubilised on a solid 
natrixo An excess of radiolabelled antibody is then added and its 
uptake is directly proportional to the concentration of the antigen.
The three methods have been compared by Woodhead et al, 1974 and Miles, 
1976 and are diagramatically described in Figure 1,2.,
The presence of ferritin in normal serum was unrecognised until 
Addison et al in 1972 described an IRMA method with sufficient 
sensitivity to detect the compound* Radiolabelled anti-ferritin, was 
added to serum and the free anti-body was then insolubilised by the 
addition of an immunoadsorbent of horse ferritin diazotised to amino­
cellulose * The activity in solution was proportional to the ferritin 
concentration* Miles et al,( 1 974)applied 2 site-HMlA to the assay of 
serum ferritin which is dependent on the presence of at least ti-ro 
immunologically reactive groups on the antigen as it is first combined 
with rabbit anti-ferritin which coats the wall of the reaction vessel 
and then with highly specific radiolabelled anti-ferritin. After 
removal of the antibody the activity which remains bound to the side of 
the reaction vessel is directly proportional to ferritin concentration. 
Preparation of Solid-Phase Antibody A number of substances have been 
used as matrices in the preparation of the solid phase antibody 
including agar gel,, cyanogen-bromide activated cellulose, cellulose paper, 
polytetrafluoroethylene discs, polyethylene, polystyrene and polypropylene 
The most popular are the plastic tubes which were first described by 
Gatt and Tregar in 1967. Test tubes made of polypropylene or 
polyethylene take up buffered antibodies, probably by hydrophobic 
bonding (Catt and Tregar, 196?). Catt and Trefgir, 196? determined that
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Reaction steps in RIA, IRMA and 2-site IRMA
for optimum uptake the buffer should be alkaline* The incubation time 
was not critical as identical antibody uptakes were found at one minute 
and sixteen hours* Miles (1976) has reported that washing does not 
significantly remove buffer from the wall of tubes but poor 
replication and a reduced dose-response occurs on storing the tubes and 
it is generally accepted that tvro weeks is the maximum length for storage 
although this may be increased if they are stored frozen and containing 
buffer* However the buffered antibody itself is remarkably stable and 
in the present work has been successfully used in repeated assays over 
a four week period* The tubes have a limited capacity for immunoglobulin 
G (igC) and although there is little alteration in the dose-response 
curve at widely varying antibody dilutions, maximun sensitivity is 
obtained at the highest dilution* Low titre anti-serum gives poor 
results (Miles, 1976) as albumin interferes with the uptake of IgG at 
low dilutions but this can be overcome by purifying the antibody, 
linking the specific antibody to the ma,triz with IgG or by using an 
alternative matrix. After removal of the buffered antibody the tubes 
must be washed with buffer containing albumin to satiuate the remaining 
sites and remove trace amounts of free antibody* The extent to which 
the bound antibody decreases in activity varies with experimental 
conditions but considerable losses usually occur (Joustra, 1 9 7 6).
However as the antibody is taken up in excess these losses may not be 
important* These steps reduce the non-specific uptake of the labelled 
antibody in reaction two and the binding of antigen to free antibody. 
First Reaction Ferritin of diluted plasma is insolubilised by solid- 
phase antibody in the first reaction* Serum and plasma are well known 
to inliibit assays non-yspecifically and this can be overcome by diluting 
standards in antigen free serum or more easily with serum from another 
species which does not cross react. The inliibition is probably due to 
high molecular weight proteins, alphap-macroglobulin and immunoglobulin
M present in serum and not to albumin (Renter et al, 1973). At high 
concentrations of antigen dissociation occui-s from the solid-phase and 
therefore a reduced amount of labelled antibody is taken up in the 
second reaction and a false low concentration is determined* This is 
known as the "high dose hook effect" and occurs when the antigen is in 
excess and the labelled antibody is present in limited concentration 
(Miles, 1976).
Tlie incubation times of the reactions are dependent on the kinetics 
of the system and on the sensitivity required. The dose-response curve 
and sensitivity can be increased by carrying out the first reaction to 
equilibrium which is in the order of twcnty-foir hours (Woodhead et al,
1 9 7 4) and thus obtain maximum uptake of antigen. The effect of longer 
incubation times on the dose-response cui've is more evident in the 
second reaction but this is accompanied by an increase in the zero-dose 
response (Miles, 1976),
The serum is removed after the initial incubation with the solid 
phase and the tubes washed to remove free antigen, rapidly dissociating 
antigen and serum factors which can directly but non-specifically 
inhibit the uptake of radiolabelled antibody. This will increase the 
dose-response and minimise the high-dose hook effect (Miles, 1976) but 
if the washing process is repeated some firmly bound antigen will be 
dissociated, thereby reducing the dose-response.
Preparation of Radiolabelled Antibody The success of 2-site IRMA 
depends on a highly specific radiolabelled antibody for addition in the 
second reaction. As many anti-sera are raised to only partially purified 
immunogens the specificity required of the antibody can only be gained by 
isolation with an immunoadsorbent. The antigen of the immunoadsorbent 
must be of a high order of purity and this may be difficult to obtain :in 
the required quantity. Hour ever as in the case of ferritin the antigen 
of another species may be used provided it has immunological identity.
The iodination of antibody as opposed to antigen offers a rnmfber 
of advantages (Woodhead et al, 1974), Antibodies have a known structure 
and when present in adequate concentration are easily iodinated* The 
problem of radiolabelling some antigens with a low tyrosine content is 
also eliminated* Configurational changes can occur in protein structui'e 
on iodination and in the case of labelled antigen may result in the 
antibody which reacts with the unlabelled compound failing to react with 
the labelled molecule. It ha.s further been shown that labelled 
antibodies are more stable on storage than antigens which can be voiy 
unstable in physiological fluids* Row ever an advantage of 2-site IR M  
is that the serum factor is not importent as incubation with iodinated 
antibody takes place in buffered solution*
Radiolabelling has been mainly undertaken using the gamma emitting
131 125
isotopes of iodine; I and more recently I* The latter has a
number of advantages including a longer half-life of sixty days in
contrast to eight days and a better counting efficiency (Hunter, 1974),
A number of methods are available for the radiolabelling of proteins.
The classical method is that of Hunter and Greenwood,(19G2)who oxidised
125 1 25
Na I with chloramine-T to I which then combined with tyrosine and
perhaps histidine (Hunter, 1974) in the protein molecule. The ^^^I was
then reduced with sodium mctabisulphite, Reuter et al, 1976 has reported
that radiation damage to protein can be reduced using smaller amounts of
chloramine-T than the orifginal method when it was present in excess
amounts. Lactoperoxidase in the presence of hydrogen peroxide has also
been used as an oxidising agent (Thorell and Johansson, 1971) but
although it benefits from being a milder oxidising agent than chloramine-T
the yields are poor (Reuter et al, 1976%, Gaseous chlorine has been
1 25
used to oxidise Na I in presence of protein (Butt, 1972) but the 
percentage incorporation of iodi.ne is less than with the classical 
ohloramine-T method (Hunt;er, 1974), Bolton and Hunter (1972) Ixave also
9described a method which is independent of tyrosine in the protein
molecule* N-Hydrosuecinimide ester of 3-(d-hydro^n/phenyl) propionic
1 25
acid is labelled with I using. chloramine-T and is then extracted and
dried. The compound then conjugates with the free amino groups on the
protein molecule but although the latter has not been in direct contact
1 25
with the oxidising agent nor Na I,the specific activity is low.
Iodination of the antibody linked to immunoadsorbent is 
advantageous as it protects one binding site of the immunoglobulin 
although the second may be destroyed as evidenced by Miles and Hales 
(I9 S8 ) who showed that in the assay of insulin, antibody preparations 
did not bind unfixed insulin with one site and later bind to the insulin 
immunoadsorbent with the second antigen - binding site, Kendrick and 
Franchimont (1976) digested ^^^I-labelled antibody with papain and found 
that only the Fab portion of the molecule was iodinated.
The iodine uptake of the bound antibody is dependent on the amount 
of icuminoglobulin present, as small amounts cannot be successfully 
iodinated (boodhead et al, 1974). A satisfactory specific activity is
1 25indicated when one to three atoms of ' I are bound per molecule of 
antibody. Excess iodination gives rise to poor immunological activity 
(Addison and Hales, 1971) and rapid degradation (Hendrick and 
Franch imo nt, 1976).
The iodinated antibody is freed from the immunoadsorbent by dilute 
acid, guanidine or urea. This can be done by simply washing in a paper 
lined filter funnel or using columns of Sephadex or Sepharose. Methods
1 25
are aimed at removing free Na I which may iodinate non-specific 
proteins, da.inaged imterial and low affinity antibodies from the specific
125
I-antibody, The eluted immunoglobulin is immediately diluted with 
albumin containing buffer or absorbed onto immunoadsorbent in buffer 
and stored frozen at -20°C.
1 25
Second Reaction In the second reaction ' I-labelled antibody in buffer
is added to the reaction tube after removal of serum and standard
solutions. The amount of activity taken up by antigen bound to the
solid phase is directly proportional to its concentration. An
1 ?5
advantage of this method is the addition of ' I-labelled antibody in 
buffer solution after removal of the test solution as the non-specific 
serum effect is eliminated.
125
Increasing the amount of I-antibody to the test increased the 
dose-response, extends the assay range, suppresses the high-dose hook 
effect and the optimum time of incubation (Miles, 1976)* These 
advantages are gained at the expense of an increase in the zero dose 
response and mean detectable dose* However as the zero dose response 
or non-specific uptake is normally less than two per cent it is 
possible to detect very small changes in uptake particularly if counting 
time is extended. The sensitivity of the assay can also be increased 
by carrying out repeated extraction of the antigen provided that the 
binding capacity of the solid pliase is not saturated (Woodhead et al, 
1974).
Increasing the incubation time of the reaction increases the
dose-response and the high-dose hook effect. A fall also occurs in the
high-dose response but this occurs more slowly and is only significant
after seven days (Miles, 1976).
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Unbound I antibody can be simply removed by décantation and the 
tubes washed to ensiu'e complete removal of the free immunoglobulin. 
Repeated washing however causes a decrease in the dose-response and it 
has also been reported that small variations in the washing technique 
can impair the precision of the assay.
Interrelation of Data Data can be interpolated from the graph obtained 
by plotting the radioactivity of the solid phase against the logarithm
V
of concentration. The dose-response approximates a sigmoid curve and 
o.ny response indicating the high dose hook effect is omitted from the
d
standard curve*
Interpolation of data is tine consuming, liable to operator error
and therefore much thought has been given to producing programmes
which would allow computerisation of data, RIA has received most
attention and Rodbard (1969) has mathematically represented a
calibration ciwve by expressing the logit transform of tV.e percentage
bound as a straight line with respect to the logarithm of the
concentration. Burger (l972) and Healy (1971 ) have also produced
programmes for evaluation of RIA data. Identical data processing
methods can be applied to IRMA and 2-site IRMA (Miles, 1976) and
Rodbard (1974) has shown that it can be analysed by fitting zero-dose
response, infinite-dose response, slope and mid-point of the dose-
response curve and carrying out a linear transformation by logit/log
plot, England and Cain (1976) have applied progressive quadratic
analysis to RIA data and this has been successfully applied to data
obtained from a 2-site IRMA of ferritin.
Quantitation of Plasma and Tissue Ferritin
Ferritin was quantitated in human plasma and tissue extracts by
the 2 site-immunoradioraetric method of Miles at al,(1974)* The solid
phase antibody was formed by incubating diluted anti-human ferritin in
polypropylene tubes. After removal of unbound antibody the standard and
test solutions were added and incubation took place at 4^C for twenty-
four houi’s to allow maximum uptake of ferritin by the solid phase
antibody. The tubes were then washed to remove free antigen prior to 
1 25
the addition of I-anti-human ferritin which bound to the ferritin
attached to the solid phase antibody during a forty-eight hour
incubation at 4^C, Unbound material was removed, the tubes washed and
their radioactivity measured by an automatic gamma counter. The amount 
1 25
of I bound by the tubes wss dirbctly proportional to the ferritin 
concentration.
Reagents 1. Anti-ferritin in 0,2M sodium bicarbonate, pH 9.2 (1;10,000), 
Tliis solution was stable for at least six weeks and could 
be reused in ten assays when stored at
2* BSA buffer. 10.3g sodium barbitone, 6.0g sodium chloride
and 0,2g sodium aside in 1 litre distilled water. The pH 
was adjusted to pH 8.0 t  0.05 with 5M hydrochloric acid.
5g of bovine serum albumin (Sigrna,) was added immediately 
before use.
3, NIGR buffer was nrepared as for BSA buffer but rabbit 
inactivated serum (bellcome) was added in the ratio of 
1:20.
4. Standard Solutions. Stock human spleen ferritin (lOmg 
per litre) prepared as described under "Isolation and 
Purification of Human ferritin from Spleen and Placenta" 
was diluted 1:25 with BSA buffer to give a final 
concentration of 400ug ferritin per litre. This solution 
was further diluted to give standards from 2 to 4OOug 
ferritin per litre which when diluted 1:20 with NIGR 
buffer gave values from 0.1 to 20ug per litre. The 
standards were prepared as follows;-
Actual Concn. (ug/l) 400 300 200 150 100 40 20 10 5 2
Stock Std. (ml) 2 1.5 1 3 1 1 0.5 0.1 0.1 0.05
BSA (ml) - 0.5 1 5 3 9 9.5 3.9 7.9 9.95
Assay Concn. (ug/l) 20 15 10 7.5 5 2 1 0.5 0.25 0.1
5. ^^^I Anti-ferritin. 1.0ml of stock rabbit anti-human
ferritin in 5ml BSA buffer. The volume of solution which 
contained 2 0 ,0 0 0 counts per minute was calculated.
6, 0.04M Pliosphate buffer pH 7.3. 10 tablets (Oxoid-Phosphate 
Buffered Saline - Dul^ecco ’A') in 1 litre distilled water.
Preparation of Tissue Extracts Post mortem specimens of f etal spleens, 
livers and hearts were washed free of hlood and stored at -20^C*
Specimens of placentae were cut according to P l a t e a f t e r  the organ 
had been visually examined* The most normal areas were chosen in every 
case* Peripheral and central sections of the fietal and maternal 
surfaces were washed free of blood, lightly blotted to remove excess 
water and stored at -20^0 .
Tissue ferritin, HPL and HCG in the placentae only were assayed by 
initially thawing the specimens overnight at Approximately 1 g
sections were cut, lightly blotted and weighed. 10ml of 0.05M Barbitone 
buffer, pH 8 .,0 was added and the tissues homogenised using an Ultraturrax 
(Janice Kunlrel) apparatus* The homogemte was filtered through bhatmn 
No* 541 filter paper* The ferritin content was assayed by diluting the 
filtrate 1 :5 with BSA buffer* Further dilutions were made with NIGR 
buffer using an automatic diluter (Micromedic Systems Inc*) to give 
final dilutions of 1 :1 ,0 0 0 and 1 :2 ,0 0 0 for placentae and fetal hearts 
and 1 :2 ,0 0 0, 1 :5 ,0 0 0 and 1 :1 0 ,0 0 0 for fetal livers and spleens*
Placental HPL was assayed in the filtrate of the homogenate which 
contained approximately 1 g tissue per 10ml 0.05M Barbitone buffer pH 8,0 
and also in a 1 :5 dilution of the filtrate*
Placental HCG was assayed in a 1:10 and 1:20 dilution of the 
filtrate of the tissue homogenate*
Method 1* Conical, polypropylene tubes (Sarstedt No* 39/l0) were placed 
in plastic racks which held 100 tubes, Tlie racks were 
designed in the laboratory and consisted of two sheets of 
perspex joined only at the four corners* Holes were drilled 
so that the tubes fitted snuggly; tops being one cm above the 
rack* The design allowed for rapid washing procedures as 
overflow material was contained in a drip tray and racks 
could be quickly decontaminated by washing in running water,
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0.5ml of 1:10,000 anti-human ferritin in 0.2M sodium 
bicarbonate? pH 9,2 was dispensed into each tube from an 
Oxford automatic pipette* The tubes were incubated for 24 
hours at 4^0.
2 . 0  The anti-sera was aspirated from the tubes and stored for 
further use. The tubes were then washed tv-rice with B.O.A. 
buffer and twice with glass distilled water and were finally 
sucked out twice with a Pasteur pipette attached to a water- 
pump but no attempt was ma.de to totally remove fluid. They 
were used within 3 hours*
3 n 200ul of HICrR bui'fer and diluted standard, control or test 
solutions were added to the anti-body coated tubes using a 
high speed automatic diluter (Micromedic Systems Inc.) 
Standard solutions, in triplicate were diluted 1;20 with BSA- 
buffer and neonatal plasmas 1:100 with NIGR buffer* 
Appropriate dilutions of 1:1,000 to 1:100,000 of tissue 
extracts were made with NIGR buffer* Test samples were 
carried out in duplicate* Tubes were incubated at 4°C for 
24 hours.
4* Solutions were aspirated from the tubes and washed once with
BSA buffer. They wore then sucked out twice but were not
completely dry,
1 255e An aliquot of I-anti-ferritin was thawed and diluted in 
approximately 5ml of BSA buffer. The approximate amount of 
antibody which gave 2 0 ,0 0 0 counts per minute was taken up by 
the Micromedic diluter and dispensed into the tubes with the 
calculated volume of additional BSA buffer to give a total 
volume of 200ul. The tubes were incubated at 4°C for 48 
hours.
1 256. The free I-anti-ferritin was removed from the tubes which
fîS
were then washed twice with 0.04M phosphate buffer pH 7*4.
The tubes were loaded into an LKB (hallao) gauma sample 
counter (Model 80000)'and counted for 4 minutes «
7 * A dose-response curve was prepared by plotting radioactivity 
against the logarithm of the ferritin concentration* The 
graph approximates a sigmoid curve* The concentration of the 
test solutions were initially interpolated from the graph 
but latterly, a Hewlett Packard calculator (Model 981Oa) was 
used which had been programmed for a prO£pressive quadratic 
equation* Counts were typed into the imchine and concentrations 
were calculated directly*
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PRODUCTION OF ^^^lODINE ANTI-HUMAM FERRITIN
'1251 anti-human ferritin was produced by first isolating the specific anti- 
ferritin immunoglobulin from whole rabbit serum by incubating with horse
spleen ferritin immunoadsorbent (F-ImAd) followed by iodination of the
"1 Of"
antibody-ferritin-irnrnunoadsorbent (Ab-F-ImAd) complex with ‘"'^'1 according
to Hunter and Greenwood (1962)0 The elution of the labelled antibody
was initially carried out by a modification of the method of Addison et al
(1972)* The Ab-F«ImAb complex was first washed in a double lined filter
paper with buffer and followed by a dilute acid solution to remove low
125affinity antibodies* The " % anti-ferritin was then eluted with a 
stronger acid solution* Due to the specialty of the anti-serum which has 
been produced it was not necessary to re-isolate the labelled anti-ferritin 
on F-ImAd as described in the original paper as sensitivity was maintained 
by freezing the anti-ferritin at -20°C immediately after elution. The
anti-sera lost a little of its sensitivity after eighteen months storage at
-20°C but this was regained when the method of Miles et al (1974) was used
125 125
to elute 1 anti-ferritin from the TlAb-F-ImAb complex* Sephadex
was used to support the complex which was washed successively with barbitone
125
buffer and sodium acetate* The bulk of anti-ferritin was recovered by
extraction with dilute acid and little with a linear hydrogen ion gradient
125which was there after omitted* This is in contrast to the %  anti-ferritin
which was liberated from human F-ImAd with the gradient ion elution (Miles 
et al, 1974).
REAGENTS All reagents were from BDH-AnalarGrade unless otherwise stated*
Rabb 11 an t. i ~h uma n f e rri t in - produced as previously described *
Rabbit Serum - inactivated - Difco
Ferritin-Immunoadsorbent - (E-ImAd)-produced as previously described* 
Phosphate Buffer pH 7*4 containing 0*15^ sodium chloride*
125I
Ghloramine-T-Solution,
125
(Sodium Iodide in dilute sodium hydroxide
pH 8*11* IMS 30- Radiochemical Centre, Amersham)
13mg of Chloramine-T dissolved in 5ml 0.3M 
phosphate buffer immediately before use®
Sodium meta bisulphite solution® 13mg of sodium metabisulphite dissolved
in 2m 1 0 .,3M phosphate buffer immediately 
before use*
Potassium Iodide Crystals*
0*1M Barbitone Buffer, pH 8*0 containing Oo22M sodium chloride and lOg
per litxe albumin.
2 o0 6g sodium barbitone? 1*2g sodium chloride and
0*04g sodium azide - Dissolved in 100ml distilled water,
The pH was adjusted to pH 8*0 - 0.05 with 5M hydrochloric- 
acid and 1g of bovine serum albumin (Sigma ) added.
BSA Buffer 0.05M Barbitone Buffer, pH 8.0 containing 0.11M sodium
chloride and 5g per Hire albumin*
10.3g sodium barbitone 6 .0g sodium chloride,and 
0.2g sodium azide. - Dissolved in 1 litre distilled
water*
Hydrochloric Aci^
The pH was adjusted to pH 8*0 - 0*05 with 5M hydrochloric 
acid and 5g of bovine serum albumin (Sigma ) added*
pH 3.0
pH 2.0
Distilled water was adjusted to pH 3*0 - 0.05 and pH
2 .0  - 0 .0 5  with 5M hydrochloric acid.
0„5M Potassium Iodide 83g of potassium iodide dissolved in 1 litre distilled water,
0*1M Sodium Acetate pH 4.5 8*2g of sodium"acetate dissolved in 1 litre distilled
v/ater and adjusted to pH 4.5 with 0.1M acetic acid.
0.001M Hydrochloric Acid
IZ
Method 1 (after Addison et al, 1972)
0.1ml of F-IrnAd was washed four times in a centrifuge at 2,500g with 0.3M 
phosphate buffer, pH 7-4 to remove free ferritin* 2ML of anti-human 
ferritin serum was then added to 1 5ml capacity stoppered test tube.
The non-specific binding was monitored by adding 2m1 of rabbit serum to 
0.1ml of washed F-ImAb. The tubes were left at 4*^ C for four days with 
occasional mixing* The complexes were then washed four times with 0®3M 
phosphate buffer, pH 7»4 and finally suspended in 1rnl of the buffer*
The protein content was measured by the method of Lowry (1951) as described 
under "Ferritin Isolation". The non-specific binding was between 30 to 
35 per cent of anti-ferritin binding.
Iodination was performed in a polystyrene tube (0.75em diameter) cut to
contain 1.0ml. A small glass mixing device was made from a sawn off portion
of a paper clip which was then encased with glass by heating the metal in
the thin portion of a Pasteur pipette and sealing at both ends. The tube
and beetle were held in position on a magnetic stirrer with placticene and
the whole w^ as within a fume cupboard with extractor fan in operation. ImCi 
125
Ci of X  (lOul) was added to the tube followed in rapid succession by 
50ul Ab-F-ImAd (5 0 to lOOug anti-ferritin) and lOuI Chloramine-T* The 
reactants were mixed for 30 seconds before the reaction was stopped with 
20ul sodium meta bisulphite. A filter funnel (diameter 2.5cm) was lined 
with a double thickness of Whatman No.541 filter paper which was moistened 
with 0*3M phosphate buffer, pH 7 «-4 containing a few crystals of potassium 
iodide. A few drops of O.O5M barbitone buffer pH 8.0 was added to the 
reaction tube before transferring the total volume with a Pasteur pipette 
to the filter paper.
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The complex was washed v;ith 200ml O.O^M barbitone buffer, pH 8.0 and 
100ml hydrochloric acid, pH 4ml of hydrochloric acid, pH 2*0
was then added and the eluate collected in 4m1 0 .1M barbitone buffer 
containing 0*4mg albumin. This process was repeated for a second time* 
Aliquots of the fractions giving 7 % 10^ counts per minute were rapidly 
frozen at -20°C*
Method II after Miles et al (1974).
125Anti-human ferritin was iodinated with 1 while bound to the F-ImAd
125complex as described in the previous section* The 1 IAb-F»ImAd
complex was transferred to 10 cm column of Sephadex G50~fine which had
previously been washed with 0*5^ potassium iodide and 0*05M barbitone
buffer containing lOg albumin per litre and equilibrated with the buffer*
The complex was transferred to the column with a Pasteur pipette and was
washed successively with 20ml 0*05M barbitone buffer, 10ml 0.1M sodium
12B
acetate, pH 4*5 and 10ml 0.001M hydrochloric acid* The ""I anti-human 
ferritin was eluted with 20ml of a linear hydrogen ion gradient from 0.001M 
to 0.01M KOI. 1ml fractions of eluate were collected in 1ml BSA buffer 
and stored at -20^C« Figure 1,3demonstrates the elution pattern of the 
radioactivity.
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Fig.I, 3
The elution pattern of radioactivity from an Ab-F-Im Ad
125complex iodinated with I.
The column was washed with BSA-buffer ( No» 5-20), 
acetate buffer, pH 4.5 ( No. 21-50), 0.001M HGL 
( No. 51-4o) and hydrogen ion gradient 0.001 M HCL 
to 0.001 M HCL ( No. 4l-6o)
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Quantitation of Plasma Iron 
Plasma iron uas reduced to the ferrous form with ascorbic acid and 
liberated from transferrin by acid diluent,. After protein precipitation 
with trichloracetic acid the colour was developed using a sensitive 
colour reagent Pcrro--Zine„ The method was adapted from Giovaniello et 
al (1967) and Stcokoy (1 9 7 0).
Reagents
Acid Reagent l6o6ml of concentrated hydrochloric acid was added to 
750ml distilled water followed by 1 g neocuproin hydrochloride 
(2 ,9"Dimethyl-1 ,1 0"phenanthroline hydrochloride) (bDH) and made up to 
1 litre. Stored at 4^C,
Acid Diluent 2g ascorbic acid (BDH^Analar) was dissolved in 200ml acid 
reagent immdiately before use.
Colour Reagent 0,2g Forro Zine Powder (5-(2-Pyridyl)-5,6-bis 
(4“phenylsulphonic acid)-1 ,2,4-Triasinc) (Each Diagnostics, USA) was 
dissolved in 1 litre distilled water and stored at 4^0 ,
Saturated Sodium /'cotate 140g of sodium acetate (BDE-Analar) was added 
to 100ml distilled water and placed in a water bath at 56^0 until 
dissolved. Stored at 57^0.
1,2M Trichloracetic acid (eDH - Low in Iron for Haematology),
Stock Iron Standard (bDH) Ferric chloride solution containing 17,Smmol 
per litre.
Uorking Iron Standard Standards were prepared to cover the range 5»0 
to SO.Ounol per litre,
Method
0 .2ml of distilled water (blank), plasma or standard solution was added 
to 0.2ml of acid diluent in a 2ml disposable tube. The contents were 
mixed in a Vortex mixer and left for 15 minutes. 0,2ml of 1.2M TO A vras 
then added, the contents mixed and centrifuged at 2 ,000g for 10 minutes,
0 .4ml of the supernatant was than added to 0 .52ml of colour reagent
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followed by 0.05ml of saturated sodium acetate. The contents were 
raized and then left for 10 minutes. The colour was then determined in 
a micro cuvette (20mm light path^ . 0 .8ml capacity) at 560nm on the 
Unicam SP 600,
7
Oiian t i t  at ion of Tr ansferrin and the Percentage Iron Satur a t ion
Plasma transferrin was quantitated using the immunological 
technique of single radial diffusion. The transferrin diffused 
radially from a small cylindrical well into a thin layer of agar gel 
which contained anti-transferrin. A precipitin ring was formed of which 
the diameter was directly proportional to the concentration of 
transferrin (Mancini et al, 1964), The percentage iron saturation was 
calculated from a knowledge of the iron and transferrin concentrations.
It was assumed that the molecular weight of transferrin was 76,000 
daltons (Morgan, 1974) and that one molecule of transferrin hound two 
molecules of iron.
R e a g e n t s
Barbitone buffer, pH 8,6 I - 0,05 
Buffered Agar Gel ~ 0,9 per cent 
Rabbit Anti-transferrin ~ Behringiferke,
Standard Human Transferrin - contained in Standard Human Serm - 
Behringwerke.
Method
A test tube of agar (10ml) was placed in a boiling water bath until 
the gel melted. It was than allowed to cool to 50-60^0, 0,1ml anti-
transferrin was added and the solution immediately poured onto a glass 
slide (B X 8cm) and allowed to set - about 50 minutes, bells werecut 
1mm in diameter and 1 ,5cm from the nearest well. Plasm was diluted 
with 0,16m sodium chloride 1 :2 0 and 1:40 for maternal specimens and 
1:20 for neonatal specimens. The wells were filled with standard and 
test solutions, iîi duplicate, using a micro-cap pipette (Drummond) until 
the meniscus just disappeared. The plates were left for 48 hours at 
room temperature in a humid atmosphere to allow complete diffusion. The 
diameter of the diffusion circle was read in mm using a MacSwinney rule 
and plotted linearly against the logarithm of the transferrin
fM ty
concetration,. The concentration of transferrin in the unknown was 
determined from the graph, After the concentration of iron and 
transferrin had been quantitated the percentage saturation was
calculated using the formulae x  10'^ x  iJ^ on umol/l
plasma transferrin mg/l
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Quantitation of Haemoglobin 
' Haemoglobin was converted by the action of ferricyanide to 
methaemog'lobin wbiob was then converted to cyanmetbaomoglobin by the 
action of potassium cyanide.
Reagents
1 , Isoton II ™ Coulter Electronics 
2, Zap“Oglobin - Coulter Electronics 
Method
A well raized specimen of whole blood (E,D.T*A,) was diluted 1:501 
with isoton» 6 drops of Zap-oglohin was added to 2Oral of the diluted 
blood and the haemoglobin concentration was determined directly on a 
Coulter Haeraoglobinoraeter.
r j  A
ASSAY of 2,5 - DIPHOSPHOGLYCERIC ACID (2^5-DPG)
 — —  — -—     ^ --- — -
*Three enzymatic reactions were involved in the assay (Lowry, 1964 and 
Sigma., 197^) «
1. 2, 5-DRG is hydrolyzed to 5-Phosphoglycerate (5-PGA) and inorganic
phosphorus (P).
The enzyme which catalyzes this reaction is present in purified 
preparations of phosphoglycerate mutase (PGM) and is termed 2,5-PPG 
phosphatase.
■ 2-Phosphoglycolic acid is needed as a stimulator for this reaction.
2.5-DPG phosphatase ■-
2, 5-DPG  ----------------   ) 5_PGA+P
2-Phosphoglycolic acid
2* 5-PGA reacts with adenosine -5'-triphosphate (ATP) in the presence
of 5“Phosphoglycerate phosphokinase (PGK) to form 1,5-DPG and
adenosine « 5 '-diphosphate (ADP).
5-PGA+ATP PGK ^ 1,5 -DPG+ADP 
5* 1,5-DPG oxidizes inicotinamide adenine dinucleotide-reduced (NADH)
to NAD in the presence of glyceraldehyde -5-phosphate dehydrogenase 
(GAPD) and is reduced to glyceraldehyde -5-phosphate^G-5-pl
1.5-DPG-fNADH -™2^£^g-5-F+NAD 
(HIGH ■ (LOW
^5^0) *540)
The decrease in absorbance at 540nm caused by the oxidation of NADH
to NAD reflects the amount of 2,5-DPG originally present.
REAGENTS
NADH pre-weighed vials containing 1rag NADH (Sigma) were kept in the 
dark at room temperature.
Triethanolamine Buffer Solution (Sigma Stock No.665-5)
0.2M triethanolamine, magnesium ions and EDTA, Stored at 4^0,
ATP (Sigma Stock No. 55-5)
500mg of disodium salt of ATP were dissolved in 5ml buffer. This
solution was stable when stored at -20^0 in 1ml aliquots.
GAPD/PGK enzyme mixture (Sigma Stock No.566-2)
A suspension in ammonium sulphate of glyceraldehyde-5-phosphate
dehydrogenase (rabbit muscle) 800u per ml end 5-phosphoglycerate 
phosphokinase (yeast), 450u per ml»
Phosphoglycerate mutase (Sigma Stock No. 665-5)
A suspension in ammonium sulphate of phosphoglycerate mutase 
(rabbit muscle), 2,400u per ml.
Phosphoglycolic acid (Sigraan Stock No. 665-2)
0
50mg vial reconstituted with water* Stable at -20 C and stored 
as 1 ml aliquots*
0*5M Trichloroacetic acid 8g of T.C.A* were dissolved, in 100ml distilled 
water and stored at 4^0.
Preparation Supernatant* 1,0ml of fresh blood was pipetted into 5*0ml of 
cold TCA and shaken vigorously* After standing for 15 minutes at 4^C 
the mixture was centrifuged at 2 ,0 0 0g* The clear supernatant was analysed* 
(Blood used should bo extracted within 2 hours but the TCA supernatant was 
stable for 7 days)^
Quantitation Haemoglobin* Haemoglobin was estimated on the blood specimen 
by adding 20jil blood to a test tube containing 5ml of 0*4^ ammonium hydroxide, 
The contents were mixed and the absorbance read immediately at 542n,rn,. The 
haemoglobin content was calculated using the equation:
^^542 X 28.2 = gHb/IOOml
Analysis A Irag vial of NADH was reconstituted with 8*0ml triethanolamine 
buffer.
Into 2 tubes marked BLANK and TEST the followipg were pipetted:-
BLANK TEST
NADH solution 2*5ml 2*5ml
ATP 0^1ml 0.1ml
Distilled Water 0«25ml -
TCA supernatant - 0*25ml
The tubes were mixed by inversion and 0»02ml GAPD/PGK and 0.02ml 
Phosphoglycerate mutase added to both tubes.
The contents were mixed and left for approximately 5 minutes.
The initial absorbance at ^^On.m* of blank and test against 
water was determined on a Unicam GP 800.
The solutions were returned to tubes and O.lml Phosphoglycolic 
acid added to both. The contents were mixed by inversion and 
left for 50 minutes at room temperature to allow the reaction 
to go to completion* The final absorbance was then determined
at 540 n ,m against water*
Calculation blank OD initial OD - final 0D*
test OD = initial OD - final OD
corrected test OD - test OD - blank OD
2, = corrected test OD x 770 nmol/gHb
gHb/IOOml
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O.uantitatlon of Murnan Placenta] Lactoaen (HPt,)
HPL was assayed in plasma and tissue extracts by radioimmunoassay 
1 25
using 1 labelled antigen and absolute alcohol to precipitate the 
antigen-antibody complex.
Reagents O.OGK Barbitone Buffer pH 8 ,6 .
Assay Diluent 0.06K Barbitone buffer pH 8 ,6  containing 0.5mg/ml 
■ crystalline human serum albumin.
Antiserum Rabbit anti-H P,L raised by injecting a New Zealand
White Rabbit with a saline solution (lmg/ml) pure HPL 
(National Biochemical Co.) emulsified vrith Freunds 
adjuvant.
The antisera was used at an initial dilution of 1:200 
with assay diluent.
Stock Standard HPL 0.1ml of HPL in assay diluent at a concentration of 
240mg per litre was stored at -PO^C,
Working HPL Standard 0.1 ml of stock standard HPL was diluted 1;10 with 
assay diluent to give a concentration of 24mg per litre. 
Doubling dilutions were made to give concentrations from
0 ,5 7 5 to 24,0mg per litre,
125 125
I HPL ' I HPL was prepared using the method of Hunter and
Greenwood (1962 ).
Method
1OOul of citrated plasmaj standard or test solutions were dispensed
1 25
into tubes followed by lOOul of 'I“HPL, 600ul of assay diluent and 
2OOul of HPL anti-serum. The contents of the tubes were mixed and 
incubated for 1 hr. at room temperature. 2ml of absolute alcohol were 
added to all except the "blank" tubes, before mixing and reincubating 
for 10 mins. The tubes were centrifuged at 1 ,300g for 10 mins. and the 
supernatant removed by inverting the tubes. The precipitate was counted
on an automatic fyiinrna counter (Walloc, LICB) and the percentage of the 
fraction hound was calculated. The latter was plotted against 
concentration on semi-log paperr
Quantito.tion Human Chorionic Gonadotronhin (HCG)
1 25
HOC wao assayed in tissue extracts by radioiminunoa.ssay using ' I 
HCG as labelled antigen and a second antibody to precipitate the antigen 
antibo dy c omp1ex,
Reagents Phosrhato Buffer, pH 7,3 containing 0„16P sodium chloride and 
2g per cent albumin.
Stock Standard HCG A Horld Health Organisation preparation of
HCG containing 5,500 iu per ampoule was used,
\torkirig HCG Standards Ranged from 1 .7 to 424m Iu per litre.
Anti-HCG Rabbit anti-human LH (HCG) obtained from Relicome
was made up to 1 Ornl with Phosphate buffer, pH 7,5 (1;20,000),
1 25
I-HTOG obtained from Prof. Bagshawe, Dept. Medical Oncology,
Charing Cross Hospital, Fulham,
1 25
Working l-HCG A 0,5ml aliquot of the stock materia], was 
diluted 1150 with Phosphate buffer, pH 7*3 to give a 
concentration of 1 ng per ml*
Rabbit Inactivated Gerum Wellcome, Diluted 1:120 with 
Phosphate buffer, pH 7,3.
0,1 M Rthylenediaminetotra-acet.i c acid 9 .3 0 6 g HD TA ( BDH- 
Analar) were dissolved in 250ml distilled water*
Donkey inti-Rabbit Gerum (Wellcome) Diluted 1:12,5 with 
Phosphate buffer, pH 7,3.
Method
1OOul of citrated plasma, standard or test solutions were dispensed
1 25
into tubes followed by 10Oul of I-HCG, 4OOul of assay diluent and 
10Oul of HCG antiserum. The contents of the tubes were mixed and 
incubated ay 4^0 for 48 hrs. 1 OOul of fabbit serum, 1 OOul of 0* 1M HDTA 
solution and 1 OOul of donlcey anti-rabbit serum-were added to all except 
the "blank" tubes. The contents were mixed and incubated at 4^0 for
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24hrs, After centrifugation at 2,000g for 45 rains, at 4^C, the 
supernatant was removed by suction and the precipitate counted on an 
automatic gamma counter (v/allac-LîCB 8000), The percentage of the 
fraction bound was calculated and plottedagainst concentration on semi- 
log. paper*
PREPARATION OP PLACENTAL TISSUE FOR ELECTRON MICROSCOPY
The whole block immunoperoxidase technique of Nalcane (1970) was used 
to visualise placental ferritin*
REAGENTS:
FORMALIN/SALINE: 10 per cent formalin in 0*1,5 M sodium chloride
TRIS BUFFER: 6*05g Tris Buffer (Sigma 1503) in 1 litre distilled water
pH to 7.6 with HCLe 
TRIS BUFFERED SALINE; (TBS) contained 20ml Tris Buffer (pH?*6) and
180 ml 0*15 M sodium chloride*
DIMETHYL SULPHOXIDE (DMS) 10 per cent in distilled water*
GLUTARAIjDEHYDE 5 per cent in distilled watere
DIAMINOBENZIDENE TLTRAHYDROCHLQRIDE (DAB) 5mg DAB in 10ml Tris buffer (pH?.6)
DAB/ peroxide 5 mg DAB in 10ml Tris buffer (pH7o6) -t- 0*1 ml 2 per cent H O
METHOD l) The tissue was fixed for 8hrs in 10 per cent formalin in
saline.
2) Washed overnight in TBS
5) Treated with 10% DMSO (ihr)
4) Washed TBS (5 min)
5) Treated with rabbit anti-human placental ferritin (24hrs)
6) Washed TBS (24hrs)
7) Treated with peroxidase labelled swine anti-rabbit serum
(Mercia) (2^ 1 hrs)
8) Washed TBS (24hrs)
9) Post fixed in 5 per cent glutaraldehyde (4hrs)
10) Washed overnight TBS
11) DAB (l_2hrs)
12) DAB/HgOg(l5mins)
15) Washed with distilled water(2hr)
14) Treated with 1 per cent osmium tetroxide (4hrs)
15) Processed on resin-Epon
nChapter ïv/q
FX-PEP.IMENTAL IFjTHOPOLOOY
A number of variable factors exist in the quantitation of ferritin 
which require evaluation for the assay to be performed at maximum 
sensitivity and nrecision*
Study of Factors Affecting the Ferritin Assay
Determination of Solid-nhase Anti-ferritin Concentration 
1 25
' I"Hujnan anti-ferritin was diluted in 0o05’M barbitone buffer, 
pH 8,0 and 0*2M sodium bicarbonate, pH 9.2, The uptake of the antibody 
from the former diluent was umcceptably variable and the latter diluent 
was used in subsequent assays* Anti-ferritin was diluted 1:100, 1:1,000, 
1:5j000, 1:10,000 and 1:20,000 in 0«2I4 sodium bicarbonate, pH 9,2* 
Standard ferritin solutions diluted 1:20 with HRS buffer and four 
plasmas diluted 1:20 with BSA were assayed using tubes coated vrith the 
varying antibody concentrations. Figure II ,1 indicates that the dose
response curve vms inversely proportional to the antibody dilution up
a
to 1:10,000 and that the best response v:as obtained at that dilution*
The zero dose response vras significantly lower only at the 1:100 
dilution, Hovrever vrith a second anti-serum in which the optimum 
dilution vfas also 1:10,000 the zero dose response decreased with 
decreasing antibody concentration*
The mean of the plasma ferritin concentrations at solid-phase 
antibody dilutions of 1:1,000, 1:5,000 and 1:10,000 was 1.7 (i 0.4),
8.4 (± 0.2), 45.0 (i 2.6) and 213.3 (± 15.3) ug per litre. The 
coefficient of variation are vrithin acceptable limits and support the 
results obtained by varying- the solid-phase antibody concentrations*
This suggests that the tubes Ixave'a limited capacity for antibody which 
is in excess of assay requirements and that alteration in antibody
I.'IOJOOO
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The effect on the dose-response curve of the 
concentration of solid phase anti-ferritin at 
1:100, 1:1,000, 1:5,000, 1:10,000 and 1:20,000
diluted with 0.2M sodium bicarbonate, pH 9*2
8
dilution had only a small effect on the dose-response
Effect on solid-nhase antibody u.ptake due to variation in reaoti on tube 
The effect on solid-phase antibody uptake due to variation in batch 
number of clear polypropylene tubes (Sarstedt ho, '39/lO) was investi,yated 
using' three different batches» Calibration curves were set up in the 
normal manner and no statistically significant changes were found in 
either the dose-response curve or the zero-dose response, ihe tubes 
were also manufactured in orprge and purple polypropylene and as colour 
coding could have simplified the assay these tubes were also assessed. 
There was however a reduction in the dose-response curve, an increase in 
the zero-dose response and an unacceptable variation of the triplicate 
countSe Clear polypropylene tubes were therefore used for the 
investigation.
Variation in incubation time to coat reaction tubes
The effect of varying the incubation time in the uptake of anti-ferritin
to form the solid pliase antibody was studied by adding 0,5ml of a
1:10,000 dilution of anti-ferritin in 0,2M sodium bicarbonate, pH 9,2
for 10 minutes, 18 hours and 24 hours. The tubes were washed twice with
BSA buffer and twice with distilled water and used immediately. After
incubation with standard ferritin solutions for 24 hom-s, 20,000 counts 
125
per minute of I anti-ferritin were added to each tube. Incubation 
took place for 48 hours before aspirating the labelled material and 
washing the tubes twice with phosphate buffer, pH 7,3. It can be seen 
from Figure 11,2 that the zero-dose response shows a small increase when 
the incubation time is increased from 10 minutes to 18 hours but that 
the increase is minimal thereafter. There was a more pronounced 
alteration in the dose-response ciirve in relation to length of 
incubation time. The best response was obtained at 24 houins. There iTviy 
be however factors other than length of incubation involved as in a
Fsrrltin
II, 2
The effect of time on the uptake of solid-phase 
anti-ferritin»
(+ 10 minutes, ® 18 hours and X 24 hours)
previous experiment when 30 minute and 24 hour incuh at ion times wore 
compared the shorter time gave a statistically significant increase in 
the dose-response curve.
The effect of vary!ng the incubation times of the two reaotion steps 
Standard ferritin solutions were incubated for 4, 24 and ^ 6  hours In 
the first reaction but after the addition of ‘ I anti-ferritin (20,000 
counts per minute) all tubes were incubated for 48 ^ours. The second 
reaction step was investigated in the same manner in that standard 
solutions of ferritin were incubated for 48 hours but after the addition 
of anti-ferritin (20,000 counts per minute) the incubation times
were 4, 24 and 96 hours. The tube activities were plotted against 
linear concentration and appear in Figm'e 11,3» It can be seen that the 
%ero-dose response is only significantly reduced in Reaction one during 
the 4 hour incubation time but that it is proportional to the incubation 
time in Reaction Two. In Reaction One there is a considerable increase 
in the dose-response cui've between the 4 and 24 hour incubation times 
but that little is gained by prolonging the time to 96 hours. In 
Reaction Two the variation in incubation time on dose-response was more 
pronounced, increasing by 100 per cent between the 4 horn* and 24 hour 
incubation times and by a further 50 per cent when extended to 96 hours.
Variation in the number of washes between reaction steps
T}ie effect on the dose response curve by varying the number of times 
that tubes were washed between reactions was investigated. Tubes were 
washed 0, 2 or 10 times after the first reaction witli BSA. buffer and 
then twice with phosphate buffer, pH 7,3 after the second reaction.
This was reversed in the second part of the study when tubes were washed 
tifice after the first reaction and^O, 2 or 10 times after the second 
reaction. The results appear in Piaure 11,4 with tube radioactivity 
plotted against linear concentration whore it can be seen that there is
Reaction I
Ferritin figj litre
Fig. II, 3
The effect of time on Reaction 1 and Reaction 2, 
Tube were incubated for 48 hours in the alternate 
reaction.
(- 4hours, 24hours and ~96 hours)
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Fig- 11,4
Effect of varying the number of tube washes in Reaction 
1 and Reaction 2, In the alternate reaction tubes 
were washed twice.
(----- 0,-----2,and-------10 washes).
a marginal decrease in the zero-dose response by increasing the number 
of washes. The.effect of the washing procedure on the dcne-response 
curve was less in Reaction one than Reaction two, the most obvious 
effect being between zero and 2 washes in the latter reaction.
The effect of storage a n d r a ) l 3 . n t on ferri'Sp.n _concq j .tration 
five specimens of plasma were assayed for ferritin content and then 
stored at -20^G for 12 m.onths. The initial concentrations wore 5,0, 
1Gh8, 45,6, 192 and 230ug per litre and after 12 months 5*4, 10*5,
52,0, 181 and 2?8ugpar litre which, would indicate stability of ferritin 
over this period* Storage at room temperature for one week and at 4°G 
for 4 months had no effect on ferritin concentration* Tissue extracts 
were stored at 4°C for 6 weeks and wore found to be stable*
Specimens of blood were collected in plain, universal containers 
and in the presence of lithium heparin and ethylediamine tetra-acetic 
acid* No difference was found between serum and plasma nor between 
plasmas with varying anti-coagulants*
Assessment of the effect of protein on the dose-resnonso curve 
The effect of bovine albumin and rabbit serum on the assay of ferritin 
was determined by diluting standards from 0 to 400ug ferritin per litre, 
in triplicate, 1:20 with BSA buffer, BS4 buffer containing 40g bovine 
albumin per litre and N.RS buffer to give final concentrations from 0 to 
20ug ferritin per litre* Table2,I gives the mean of the triplicate 
counts together with the standard deviation (SI)) and coefficient of 
variation (CV). There was no significant difference between the mean 
counts but the CV was less when dilutions had been made with NRS buffer 
and for this reason standards and test ferritin solutions in excess of 
300ug per litre were diluted with buffer* .
Snecificlty
Human plasma, placental, liver, spleen and heart extracts were assayed
Table 2,1,
Effect of Protein on the bosc-Reononoe Curve
Ferritin BSA-Buffer BSA + 4/ Albumin NRS Buffer
ug/litre Counts/
min.
SB CV
f -
Counts/
min.
SB CV
/
Counts/
min.
SB CV
/
0,00 319 13 4*1 305 16 5.2 304 19 6.6
0,10 455 17 3*7 388 4 1^ .0 449 16 3.5
0.25 536 14 2,6 506 30 5.9 508 3 0.6
0.50 748 19 2,5 761 48 6,3 739 22 3.0
1 .00 1 ,212 26 2,1 1,122 54 4.8 1,122 38 3.4
2.00 2,068 34 1,6 1 ,872 67 3.6 1,921 27 1 .4
5,00 4,556 58 1.3 4,470 12 0.0 4,546 24 0.5
7.50 6,099 83 1,4 6,160 43 0.7 6,031 103 1 .7
10.00 7,739 438 5.7 7,865 228 2.9 7,335 1 00 1 .3
15.00 10,344 101 1,0 10,682 325 3.0 10,339 137 1.3
20,00 11,709 231 2,0 11,869 318 2,7 11,641 140 1 ,2
Standard solutions of ferritin diluted 1:20 to give final concentrations 
from 0 to 20 ug/per litre in l), BSA buffer 2) BSA buffer +40g 
bovine albumin per litre and 3) NRS buffer.
The mean of triplicate counts together with standard deviation (Sb) 
and coefficient of variation (CV) are given^
in triplicate at three dilutions the results were linear when plotted 
arithmetically and appear in Figure II,5* No significant difference was 
observed in the results obtained at the tln'eo dilutions*
Plasma containing 500ug ferritin per litre was diluted 1:20 with 
BSA buffer* Doubling dilutions in tin.plicate, were thereafter made with 
BSA buffer and ITRS biffer* O^'he difference obtained by diluting with the 
tv70 buffers was not statistically significant*
1 25Effect on the assay of method of nreuaration of I-anti-ferritin
Radiolabelled antiferritin was prepared on the sarno day by the method of
Addison et al (1972) and Kilos et al ( 1974-). They were used in
duplicate assays when 20,000 counts per minute wore added to the tubes 
containing cloven calibration points, eight internal quality control 
standards whose values had been established in previous assays using
125
I anti-ferritin prepared by Addison's method and 27 test plasmas*
Hie calibration curves obtained showed a margdnal decrease in the 
zero-dose response with the Miles's material (324 as compared to 440 
counts per minute) and an increase in the dose-rosponse curve using the 
same material* The 10ug per litre standard gave 5,454 counts per 
minute when labelled with the Miles's material and 5,918 counts per
minute when labelled with Addison's material* The quality control
specimens had mean concentrations of 3.9 (1 0*6), 11*3 (i 0*4), 18*0
(1 2.8), 44*2 (± 2 *5 ), 82.5 (± 2*1), 192*5 { t  3.5) and 212,0 (± 1.4) ug
per litre when the two materials were compared* The values were also 
compared for test plasmas over the range of 3 to 500ug per litre* The
where d is the difference between
mirs and N is the total number of estimations) between paired specimens 
w.^ s 4*4 for an overall mean of 81 *Oug per litre*
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Fig. II, 5
(a) Assay of ferritin in successive dilutions of three 
specimens of plasma.
(b) Assay of ferritin in successive dilutions of heart, 
spleen, placental and liver extracts.
EvaluatTon of Assay Porformanoe 
Analysis of Standard Curve
A standard curvo anpears in Elp'iirc 11,6in which the mean of triplicate 
counts together with 2 standard deviations are ^^ iven. Radioactivity as 
counts per minute are plotted against the logarithm of the concentration. 
20p000 counts per minute were added to each tube and the zero dose 
response was 345 counts per minute representing 1 .8 per cent of the 
counts added. The tube of the lowest standard, 0.1 ug per litre had 
radioactivity of 545 counts per minute or 2.8 per cent of added 
activity. The maximum of the working range was the 10ug per litre 
standard which liad an activity of 12,425 counts per minute or 62.2 per 
cent of the added counts. There was therefore a twenty-tliree fold 
increase over the working range from 0.1 to lO.Oug per litre.
The coefficient of variation (CV) varies little throughout the 
calibration when standard concentrations are above lug per litre and 
average 1.2 per cent. This can be seen in Table2,1 when MRS buffer was 
used as diluent. The average CV when the standard ferritin concentration 
was lug per litre or less increased to 3,4 per cent.
Sensitivity of the Assay
“The terra sensitivity as applied to an assay technique commonly refers 
to the ability of the system to measure small amounts with acceptable 
precision. This concept may be formalised by defining the sensitivity 
of an assay as the precision of measurement of a zero quantity"
Ekins & Mewman,( 1 970) The sensitivity can more readily be defined as 
the mean detectable dose and was calculated using the standard curve 
shown in Figure II,6 after an 18 hour incubation of solid phase antibody. 
The zero dose response was 470, O.lug ferritin per litre 618 and lO.Oug 
ferritin per litre 15,045 counts nor minute. Twice the root mean 
Squared deviation was 5° counts per minute and the mean detectable dose
I
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of Human 1
represents the mean of triplicate counts -
Standard Curve Ferritin Assay. ^Each point
3was found to be 38ng per litre equivalent to 529 counts per minute. 
Accuracy of the Assay
The accuracy of the ferritin assay was determined by addiny a known 
quantity of human spleen ferritin to a plasma with a known low ferritin 
content of 10ug per litre. A ferritin solution, containing 100ug 
protein per litre in MÎS buffer was diluted 1:2, 1:4, 1:8, 1:16 and 
1:52 with the plasma. The recoveries were 95 per cent ± 2.0 per cent 
at 55ug per litre, 97 per cent (j; 1.8) at 5 2.5ug per litre, 95 per cent 
(i 5,4) at 21 .3ug per litre, 96.4 per cent (± 1.5’) at 16.lug per litre 
and 92 per cent (± 5,1) at 12„8ug per litre.
Precision of the Assay
"Precision is the random error, the variation of results obtained by a
method when the same sample is run repeatedly" - Henry,( 1964), The
precision of the ferritin assay was investigated within a single batch,
between batches and between laboratories.
The results for the within batch variation when specimens were
repeated between 4 to 10 times are shown in Table2,2 . The mean,
standard deviation, and coefficient of variation have been determined
and it would appear that there is little variation between 23 to 270ug
per litre but that an increase does occur at lower concentrations. The
precision was also investigated in the manner of Halliday et al (1975)?
by performing 112 duplicate analysis on plasma specimens of variable
ferritin content in a single assay. The standard deviation (SI)) of the
different plasma concentrations were calculated according to Snecdecor
(1 9 5 2) from the differences between duplicate determinations.
S  A ^
SB “ —  where d is the difference between dunlicates and N is the
I'l
number of estimations. The precision of the overall assay by this 
method of analysis was found to be 5,8, Table2,5 gives a detailed 
breakdown over the various ferritin ranges.
Table 2,2*
Replicate dotcrmirationa of plasma forritin 
"within batch"
No. determinations Kean ug/l \SD ug/l
18 5.4 0.5 12.0
4 25.2 1 .0 4.5
4 47.5 5.9 8.5
10 67.7 5,2 7.8
4 229.5 18.4 8.0
4 270.2 17.7 6.6
Table 2,5.
Duplicate determinations of 1] 2 specimens of •plasma 
of varying ferritin concentrations in a single batch
Ferritin Range No. Mean SD CV
ug/l Pairs ug/l ug/l
1-10 11 6.2 0.9 14.7
11-20 15 15.5 1.4 9.2
21-50 56 57.5 2.7 7.4
51-100 51 66.2 5.5 5.5
101-200 14 151.5 5.2 4.0
200-400 7 272.0 8.7 5.2
between batch variation was determined by quantitating ten 
specimens in duplicate in 9 to 30 separate assays over an eighteen 
months period. The means, standard deviations and coefficients of 
variation are shown in To.ble2,4 and it would, appear that although the 
standard deviation increases with the ferritin content the relative 
variation is constant over the range 10 to 250ug per litre. The 
variation is however considerable at concentrations less than 5ug per 
litre but clinically this is unimportant as it is well below the normal 
range of plasma ferritin concentrations.
The variation between laboratories was investigated when 4 plasma 
specimens and a ferritin standard solution were distributed to 11 
laboratories from the ¥elsh National School of Medicine by 
Dr. Mark Morwood in 1977. Specimens were analysed by the method in 
current use using the standard spleen ferritin provided for the 
investigation and the laboratory’s own standards. The results which 
were later returned appear in Table2,5 - The author’s results when 
using the standard ferritin provided and compared with those of the 
other 10 laboratories are in good agreement despite the different 
methodologies. A  number of laboratories use an IRMA, reaction and not 
the 2-site IRMA of the present work. When specimens were compared 
against the laboratory’s own standards, 3 of the 4 results had 
acceptable precision. The 4th specimen was just within two standard 
deviations of the overall mean but when repeated on 13 later occasions 
the mean concentration was found to be I63,4ug per litre (2D ± 19.7),
Table 2,4
Renlicate determinations of nlaonio. ferritin between batches
Uoc Assays Mean ng/l SD ng/l CVf-
23 4.6 2.0 43.5
11 5.1 1.9 37.2
9 11.4 1 .8 15.8
25 13.0. 2.0 15.4
10 22.3 3.1 13.9
30 48.3 t.6 9.5
13 79.2 8,3 10.5
13 163.4 19.7 12.0
20 200.4 11 ,8 5.9
30 243.4 27.5 11.3
Table g e
Between 1aboratory variation i n  the nuantitatiqn 
0 plasma ferritin (Anthor 's work underlined)
a ) Specimens assayed ayainst ferritin standard supplied (M ) 
(Results in ug ferritin per litre)
Laboratory A2 A3
“ “ -1
A4 A5
A 21 65 97 6
B 28 101 167 < 2
C 23 77 187 5
D 17 71 142 4
E 22 71 167 5
F 13 56 161 <10
G 20 66 132 3
H 21 69 152 4
K *“
L 38 78 113 9
M 52 128 195 18
Mean ± S.D. 26 ± 11 78 ± 21 151 ±  30 7 ± 5
b) Specimens assayed against laboratory’s own ferritin standard 
(Results in ug ferritin per litre)
laboratory A2 A3 A4 A5
A 30 90 . 118 9
B 35 134 203 2
C 15 60 142 5
D 15 67 136 2
E 26 75 192 4
F 17 56 161 9
G 28 88 170 7
H 26 87 230 6
K 33 91. 175 7
I, 34 73 111 9
M 29 80 128 13
Mean ± R.D, 26 ± 7 82 ± 21 1 61 1 38 7 1 3
Comparison of ferritin concentration by the Lowry method (1951) and the 
Laurell rocket technique (1966) After the first ferritin extract had 
been intensively purified and its concentration determined by the 
chemical method of Lovrry (1951 ) it was used as a primary standard in the 
quantitation of subsequent ferritin extracts by the Laurell rocket 
method (1966), It was considered that if the concentration derived by 
the chemical method was greater than that by ,the immunological method 
contaminant proteins were present. This proved a simple and rapid 
method for indicating the success of the ferritin extraction but 
depended on the purity of the initial ferritin extract,
10ml of 1,0/^ agarose (BDH) (w/v) in 0,076 barbitone buffer, pH 8,6 
and containing 0,2ml anti-human ferritin (ïïoechst) was poured onto an 
8 2 8cm glass slide. Holes were cut to contain 10ui volumes. The 
standard ferritin solution was diluted with 0,1 5M sodium chloride to a 
concentration of lOOmg per litre. Doubling dilutions were subsequently 
made to give arange from 25 to 10Omg per litre. A micro-cap pipette 
(Drummond) was used to fill the holes with test and standard solutions - 
the end point was taken when the liquid mensciis disappeared when the 
plate was at eye level, Tlie run took place overnight under the same 
conditions as described for crossed-imraunoelectrophoresis. The peak 
heights of the standard solutions were measured and plotted against 
the concentrations to allow quantitation of the test solutions 
see Plate 2,1
Plato 2.1.
Quantitation of Ferritin by the Laurell
Rocket Technique
Chapter Three 
CLINICAL STUDIES OF MORbAL SUBJECTS
The variation in plasma ferritin concentration was 
investigated with relation to reproduction in a healthy 
population. Studies were made of male and non-pregnant 
female subjects in the reproductive age group, in patients 
throughout pregnancy and in the purperium and of paired 
mothers and babies at term, Ferritin concentrations were 
also related to the 2;3-diphosphoglycerate content of red 
blood cells of pregnant patients.
Variation in plasma ferritin between the sexes 
The non-pregnant group consisted of 61 women between 
the ages of 18 and 33 years who were in good health and 
attending a family planning clinic for advice on 
contraception. None of the patients were taking oral 
contraceptives at the time of blood sampling. The male 
patients consisted of 24 fourth year medical students aged 
19 to 21 years and 78 male partners of infertile marriages 
aged 23 to 46 years. All patients were clinically normal 
and were not receiving iron supplements.
The variation in plasma ferritin concentration in male 
and female subjects is shown in Figure III, 1, 2 and there 
was evidence of a skew distribution. There was no 
statistically significant difference in concentration 
between the 24 medical students (mean 92.4, SL ± 38.9ug 
per litre) and the 78 other male subjects (mean 92,0,
SD t 50.pug per litre).
The arithmetic mean for the combined male subjects
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was 92.3ag per litre with a standard deviation (SD) of 
48,0 and the logarithmic mean 79.8 with a range of 24.0 to 
265.Oug per litre. In the non-pregnant female the 
arithmetic mean concentration was 36.7 (8D ± 23.9ug per 
litre) and logarithmic mean 31.5, range 9.3 to 106.7 per 
litre. There was a statistically significant difference 
( p c O ,001 ) in ferritin levels between male and female 
subjects,
Variation in plasma ferritin in early pregnancy 
and in the P^ e r p e r i u m
Seventy-one healthy pregnant patients between 15 and 
20 weeks gestation who attended the antenatal clinic at 
the Royal maternity Hospital were studied. They were aged 
between 17 and 34 years. Fifty-six of the patients bad 
been started on prophylactic iron supplements (average 
lOOmg of elemental iron per day) prior to referral to the 
clinic and all patients received iron supplements 
thereafter, Heparinised blood specimens were also obtained 
from 62 patients on their sixth postnatal day who were age 
matched with the early gestation group. Ho patient 
received iron therapy after delivery. Patients in both 
groups were judged retrospectively to have had normal 
pregnancies. They all had singleton pregnancies and normal 
babies were delivered at term.
Farly preynancy ferritin concentrations The arithmetic 
mean of plasma ferritin at less than 20 weeks gestation 
was 42,0 (SD + 42,6)ug per litre and logarithmic mean 
36,6ug per litre (range 4.9 to 270.0),
Postnatal ferritin concentrations On the sixth postnatal 
day the arithmetic mean ferritin concentration was 39.6 
(SD ± 28,9)ug per litre and the logarithmic mean 32,5ug 
per litre (range 7.7 to 124.0),
Comparison of early gestation and postnatal ferritin 
concentrations The distribution of plasma ferritin 
concentrations in early pregnancy and on the sixth 
postnatal day are shown in Figure Comparison of the
two groups indicate that when patients are maintained on 
iron supplements throughout pregnancy the iron stores, as 
indicated by the plasma ferritin, are not significantly 
altered between early pregnancy and the immediate 
postnatal period (p<cC.80) and compare with concentrations 
obtained for non-pregnant, female subjects.
Variation in plasma ferritin and other indices of iron 
metabolism throughout normal pregnancy
Twenty healthy primigravidae who attended the 
antenatal clinic at Glasgow Royal Maternity Hospital 
consented to venepunctures at frequent intervals throughout 
their pregnancies and on the sixth postnatal day. The 
patients attended between 9am and 12 noon and after 
resting in the left lateral position for 13 minutes their 
blood pressure was recorded and 10ml of blood withdrawn 
into lithium heparin tubes. All patients had been started 
on prophylactic iron supplements (average lOOmg of elemental 
iron per day) prior to referral to the antenatal clinic. 
These patients were judged retrospectively to be normal as 
they had maintained a normal blood pressure throughout
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their pregnancies and no glycosuria nor proteinuria had 
been detected. All patients were delivered between 38 and 
41 weeks and had infants of normal birth weight.
The plasma ferritin variation with gestation The plasma 
ferritin concentrations related to gestation did not fit a 
normal distribution and a logarithmic transformation was 
made for comparisons. The logarithmic mean and the range 
related to gestation appear in Figure 111,5. Id Table 3,1 
the arithmetic mean concentration of ferritin is - given and 
included are values of the non-pregnant group previously 
described. There was no significant difference in plasma 
ferritin levels between non-pregnant women and iron- 
supplemented pregnant patients of less than 25 weeks 
gestation, or six days after delivery. However with 
increasing gestation the ferritin concentrations fell and 
highly significant differences were found at 26 to 30 weeks 
(p< 0.001), at 31 to 35 weeks (p<0.00l) and at term ‘
( p < 0.001) when compared to non-pregnant values.
Plasma iron concentration related to gestation The results 
indicate that with prophylactic iron therapy before 20 
weeks there was no significant difference in plasma iron 
concentration throughout pregnancy, but on the sixth post 
natal day there was a fall which was statistically 
significant ( p c 0.005).
Plasma transferrin concentration and saturation related to 
gestation Plasma transferrin concentrations were increased 
within the first 20 weeks when compared to the non-pregnant 
group ( p c 0.001) and this significant increase continued
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until term (p<r 0,001), The percentage saturation was 
calculated from the plasma iron and transferrin 
concentrations assuming a/molecular weight of 76,000 
daltons (Morgan, 1974") for the latter and that one 
molecule of transferrin binds two molecules of iron. There 
was no significant difference in percentage saturation 
between non-pregnant women and early pregnancy patients 
on iron (p< 0.3) but between 26 and 35 weeks there was a 
a highly significant fall when compared to less than 20 
weeks gestation (pcO.005). Between 36 to 40 weeks the 
percentage saturation increased and little difference was 
found between this group and the early pregnancy group 
(p<c0.05), A second fall in transferrin saturation was 
found on the sixth postnatal day ( p < 0.001),
Haemoglobin concentration related to gestation Haemoglobin 
was significantly reduced between 21 to 35 weeks when 
compared to early pregnancy (pcO.OOl); it increased at 
36 to 40 weeks although the level remained lower than that 
found in early pregnancy (p< 0.005) and in the puerperiumi 
the concentration was still significantly lower (p<0,005).
At term only one of the 20 patients studied serially had a 
haemoglobin of less than 11g per dl and concentrations 
ranged from 10.5g to 13.4g per dl.
Ho correlation was found between the concentrations 
of plasma ferritin and plasma iron, transferrin or 
haemoglobin.
Summary Normal pregnant women maintained on prophylactic 
iron supplementation showed a progressive fall in plasma 
ferritin to low levels in late pregnancy. Significant
1falls in plasma transferrin saturation and whole blood 
haemoglobin were also found, The transferrin concentration 
remained elevated from early pregnancy until term.
Table 5,2
Ferritin Concentration (uj? per l ) 
in tha Post-natal Period 
(Number of patients in parentheses)
Day Total Control Estrovis Bromocriptine
1 24.7 ± 17.6 25.8 ± 21 ,0 26.6 1 16.0 23.2 ± 15.2
(4 5 ) (15) (15) (15)
6 50 ,9 i 17.1 34.3 i 17.3 33.1 ± 19,2 25 .7 ± 14.6
(43) (14) (14) (15)
14 33.7 i 24.3 39.3 ± 25.5 34.9 ± 23.9 26,5 ± 23.5
(44) (15) (15) (14)
42 30.7 ± 22.8 23.2 i 13.8 34.8 ± 22.1 34 .8 ± 31.9
(28) (10) (10) (8)
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Factors Influencing: Plasma Ferritin 
in the Pu.erperjum 
Forty-five women were studied at Day 1, 6, 14 and 42 of the 
puerperium, All patients were selected at delivery as having had 
pregnancies uncomplicated by major obstetrical emergencies, a normal 
haemoglobin at term and the delivery of a normal singleton baby. None 
of the patients were breast feeding and 15 in each group received 
bromocriptine, estrovis or ascorbic acid as a placebo to suppress 
lactation. The ante- and post-natal haemoglobins and blood loss at 
delivery were recorded.
The ferritin concentrations of the three treatment groups appear 
in Tabled,2 together with a summation of all the results. There was no 
statistical difference between the groups although the bromocriptine 
group did seem to take longer than the others to attain a maximum. It 
was retrospectively found that a mild degree of iron deficiency anaemia 
(ïïb<.11,0g per dl) had occurred in early or mid-pregnancy in 2 of the 
patients in the control group, 4 in the estrovis group and 6 in the 
bromocriptine group. Post-natal haemoglobin levels of less than 11,0g 
per dl at 6 or 42 days occurred in one of the control group and six of 
the bromocriptine group. The ferritin concentrations for these patients 
who had ante- or post-natal anaemia compared to those with normal 
haemoglobin levels appear in Table5>5 and although ferritin 
concentrations are lower in the anaemic group and tend to fall in the 
post-natal period the scatter is such that the results are not 
statistically significant. Ferritin levels of less than lOug per litre 
were found in 5 of the 12 patients on day 14, 5 out of 8 on day 42 of 
the antenatal anaemic group and 4 out of 7 on day 14 and all 3 patients 
on day 42 of the postnatal anaemic group. Only 2 of the patients with 
normal haemoglobin concentrations had low ferritin levels on day 14 but 
3 had low levels on day 1 . It can however be seen that a significant
Table 5 ,5  
>>
The Effect of Iron Deficiency Anaemia (Hbc11,0g/dl) 
in the Ante- and Post-natal Periods 
on Ferritin Concentration (ug/l)
(Number, of patients in parentheses)
Day
Post - 
natal
Normal
Hl3>11,0g/dl
Ante-Natal' 
Hb<11 ,Og/dl
Post-natal 
Hb< 11 .Og/dl
1 24.1 ± 15.1 
(28)
19.2 ± 12.3 
(12)
21.8 ± 15.0 
(7 )
6 33.4 ± 17.8
(2 7)
24.3 ± 15.2 
(12)
21.0 ± 10.5 
(7)
14 34.2 + 20,7 
(28)
25.1 ± 21.7 
(12)
18.6 ± 16.6 
(7 )
42 36,5 ± 23.7  
(19)
17.5 ± 16.6 
(8)
7.3 ± 1.5 
(3)
m 0
increase in ferritin occurs in the normal group between the first and 
sixth day (p.< 0,05) which is maintained on the fourteenth and forty- 
second day.
The effect of blood loss at delivery was correlated with the 
ferritin concentration and the results appear in Table3,4 . There was 
no statistical difference between the groups which was not entirely 
unexpected as the maximum blood loss was relatively small. This was 
unavoidable as the group were selected because of their normal 
deliveries. In order to keep sufficient numbers in the groups and to 
take account of individual iron stores the differences between Day 1 
and Days 6, 14 and 42 were determined for each patient and these results
appear in Table3,5 . Again there is a fall in the difference in ferritin
concentration with increasing blood loss but due to the variability in 
the results it was not significant. However three of the five patients 
who had lost more than 200ml of blood at delivery had lower ferritin 
levels than on the first post-natal day^ on Day 42.
The plasma iron on Day 1 was 13.1 i 7.2 umol per 1 for 44 patients, 
on Day 6 was 6.6 ± 4.0 umol per 1 for 29 patients, on Day 14 was 10.7 j;
5.5 umol per 1 for 40 patients and on Day 42 was 14.1 ± 4.1 umol per 1
for 26 natients. The fall on Day 6 was statistically significant 
(p<0.00l).
Summary In women with normal haemoglobin levels the plasma ferritin 
reaches a maximum on the sixth post-natal day and this concentration 
is maintained at least until the sixth week. The plasma iron appears 
to fall on the sixth day before increasing to first day post-natal 
levels on the fourteenth day of thepuerperium. Relatively small losses 
of blood at delivery are often associated with low ferritin levels in 
the post-natal period
Table 5,4.
Ferritin Concentration (iig per l ) 
in Relation to Blood Loss 
(iTumber of patients in parentheses)
Blood Loss (ml) -^100 101 -200
------------------------------------------------- —
201 -500
Bay 1 25.1 ± 12.1 20,0 ± 14.0 29 .9 t 22.7
(14) (17) (11)
Bay 6 37.1 i 15.5 24.3 t 14.7 34.0 i 20.1
(13) (17) (11)
Bay 14 37.2 ± 25.8 26.1 i 17.8 59.5 ± 28.2
(13) (17) (11)
Bay 42 40,1 ± 27.4 29.2 ± 21 .0 21.7 ± 21.8
(9) (12) (5)
Table 3,5 •
Difference in Ferritin Concentration (ue per .1 )..
Related to Blood Loss
(Number of patients in parentheses)
Blood Loss (ml) ^  100 101-200 201-500
Bay 6“1 13.7 - 15.9 4.3 - 11.4 6.7 - 9.5
(ll) (17) (11)
Bay 14-1 12.7 - 21.8 6.9 - 18.0 8 .4 - 16.9
(12) (17) (11)
Bay 42-1 16.1 - 23.2 10.8 t 27.3 -5.0 i 25.3
(8) (12) (5)
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GESTIONAL CHANGES IN PLASMA FERRITIN RELATED TO RED CELL" - 
2:3- DIPHOSPHOGLYCERATE AND PYRUVATE KINASE ACTIVITY.
Serial studies were carried out to determine the relationship between 
plasma ferritin and red cell 2:3- diphosphogly cerate (2:3-DPG) 
concentration and pyruvate kinase (PK) (2.7.1.40) activity in normal 
pregnancies. Heparinised blood specimens were obtained from nine 
patients before 20 weeks and from an additional six patients from 
23 weeks until term. Five patients were investigated post-natally. 
Patients were judged restrospectively to have had normal pregnancies 
and all were delivered between 38 and 41 weeks of infants of normal 
birth weight. Each patient had been started on prophylactic iron 
supplements (average 100mg elementalironper day) prior to referral 
to the clinic.
The results of the study appear in Table 3,6. The plasma ferritin 
decreased until 33 to 38 weeks (p-<*0 .03) which was followed by rise 
at term. 2: 3- DPG increased at 21 to 24 weeks (p<0.l) before 
falling to the lowest limitsfound in pregnancy at 25 to 28 weeks 
(p<r0.001). Haemoglob .lin fell significantly until 25 to 32 weeks 
(p<0.02) before rising until term. PK activities varied with 
gestation. The enzyme activity fell significantly until 25 to 28 weeks 
( p < 0 .05) and remained at low activity until term (pc0.02).
In 8 of the 15 pregnancies studied serially low ferritin concentrations 
of less than 10 ug per litre were found on at least one occassion.
In seven patients the 2:3-DPG levels were normal, but in the eighth^ 
2:3- DPG while initially low (raean-2SD) reached normal levels although 
the ferritin remained low. In three pregnancies low 2;3DPG levels 
were recorded on a single occassion. All three patients had normal 
haemoglobin.levels and only the one described above had a low ferritin 
level. No correlation was found between plasma ferritin and 2:3DPG 
concentration nor PK activity.
TABLE 3,6
GESTATIONAL CH^WGES IN PLASMA FERRITIN RELATED TO RED CELL
2:3- PPG, HAEMOGLOBIN AND PK
POST
Gestation (weeks) 16-20 21-24 25-28 29-32 33-36 36-T NATAL
No.of Patients 9 9 15 15 14 15 5
Ferritin umol/1 33.6
(26.0 )
24.9
(14.2)
20.0
(10.3)
18.4
(17.0)
15.6
(8.0)
21.6
(13.1)
37.7
(21.2)
Hb g/dl 12.1
(0.7)
11.6
(0.6)
11.5
(0.5)
11.5
(0 .8)
12.0
(0.7)
12.3
(0.7)
12.6
(0 .6)
2:3 DPG umoj^Hb 17.6
(3.1)
20.2
(2.1)
16.1
(2.5)
17.9
(2.5)
18.4
(2.7)
20.2
(2.3)
16.4
(1.9)
PK iu/g Hb 5.52
(0.84)
5.24
(0.59)
4.56
(1.11)
4.96
(0.97)
5.03
(0.85)
4.65
(0.75)
4.68
(1.38
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Correlation between Maternal and Cord Ferritin Concentrations 
and other Parameters of Iron Metabolism in Normal Pregnancies 
at Term
One hundred and ninety-one pregnancies were 
investigated and blood was obtained from the mother within 
30 minutes of delivery and from the cord on delivery of the 
placenta. The patients were unselected other than 
appearing to be clinically between 38 to 41 weeks, had 
only minor complications throughout their pregnancies and 
were expected to produce normal, term babies by spontaneous 
vertex delivery, 76 patients were later removed from the 
series due to the baby being assessed as premature, light- 
for-dates or the sera being haemolysed. Finally 115 
matched maternal and cord bloods were available from 
mothers who had completed a normal pregnancy and had been 
delivered of a normal baby at term. The mean baby weight 
was 3.72Kg (SP ± 0.45) and the mean placental weight 620g 
(SP t  108). The mothers were aged between 16 and 41 years. 
The parity, social class, sex of the baby, gestation and 
the immediate maternal antenatal haemoglobin were recorded.
The biochemical parameters of iron metabolism of 115 
paired cord and maternal sera appear in Tabled,7 ,
Maternal ferritin concentration at term The arithmetic 
mean of the maternal ferritin concentration, obtained from 
115 sera was 40.4 (SP ± 33.l)ug per litre but the values 
obtained did not ^ive a normal gaussian distribution. 
Logarithmic transformation 'of the data gave a logarithmic 
mean 30.3ug per litre with a range of 6.4 to 144.Oug per 
litre. There was no correlation between the maternal
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ferritin concentration and the weight of the hahy or the 
placenta.
Cord ferritin concentrations of term babies The arithmetic 
mean ferritin concentration of the 115 cord sera was 20 0.0 
(SD t 108.0)ug per litre and the logarithmic mean I69ug per 
litre which gave a range of 55.0 to 2 9 6 .Oug per litre. The 
cord ferritin concentrations, like the maternal ferritin 
levels did not correlate with either the baby weight 
(r = 0 .0 2 ) or placenral weight (r.==" 0..05).
Correlation between maternal and cord ferritin concentrations 
There was no direct correlation between the 115 paired cord 
and maternal ferritin concentrations (coefficient of 
correlation, r = 0.07). When the relationship was 
investigated at low maternal ferritin concentrations of 
less than lOug per litre which we found to be two standard 
deviations below the non-pregnant mean (Kelly et al, 1977) 
or at less than 12ug per litre which included a larger 
population, the corresponding cord ferritin levels were 
144.1 (SD + 51.3) and 154.8 (8D ± 6 3 .3 )ug per litre 
respectively and were statistically lower ( p < 0 ,0 2 ) than 
cord ferritin of 218.0 (SL ± 119.5)ug per litre associated 
with maternal ferritins, greater than 30ug per litre. The 
results are summarised in Table 3,8 .
Cord ferritin concentration in male and female babies 
The 59 male infants had a mean cord ferritin of 216.1ug 
per litre (SL ± 1 2 0 .2 ) which was greater than that of the 
56 females with a mean concentration of 1 8 7 .lug per litre 
(SD i 9 0 .5 ) but the difference was not statistically
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significant (p<r0 .2 ).
The effect of parity on maternal and cord ferritin 
concentrations In Table 3^9 the ferritin concentrations are 
compared with regard to parity. There was no significant 
difference (pcO.l) when the maternal ferritin levels of 
the priraigravid patients (mean 47.6 ± 3 3 .jug per litre) 
were compared to patients who had one or two previous 
pregnancies (mean 35.6 t  3 0 .1ug per litre) but when compared 
to those who had three or more previous pregnancies (mean 
23.4 Î 18,3ug per litre) the difference was statistically 
significant (p<r0,02). There v/as however no difference in 
cord ferritin concentrations when related to parity.
The effect of gestation on maternal and cord ferritin 
concentrations The maternal and cord ferritin concentrations 
were related to gestation at delivery and the results are 
shown in Table3^ia There was no statistically significant 
difference between maternal or cord ferritins of patients 
delivered between 38 and 4 I weeks.
Effect of maternal a%e on maternal and cord ferritin 
concentrations The results were also analysed with respect 
to maternal age. Although there was some reduction in 
maternal ferritin up to the age of 30 years the only group 
which was significantly different from that of 16-18 years 
(mean 58,2 ± 34.8ug per litre) was the 26-30 years group 
(mean 36.4 t 21,2ug per litre; p<0.05). There was no 
significant difference between the cord ferritin groups 
when related to maternal age, ^
08
The effect of social class on maternal and cord ferritin 
concentrations Patients were divided into social class.
93 patients were found to be in social class I to IV and 
22 in class V. The results of maternal and cord ferritin 
concentrations appear in Table 3, 11. No statistical 
differences were found in maternal ferritin concentrations 
between social class I to IV, mean 42.4 (SP t 33.0)ug per 
litre but social class V was significantly lower (p <0,005) 
with a mean of 21.2 (SP ± 14.3)ug per litre. There was no 
difference in cord ferritin concentrations when related to 
social class.
Maternal haemoglobin concentration at term The mean 
maternal haemoglobin was 12.2 (SP ± 0.8)g per dl at term 
and the actual range was 10.5 to 14,8g per dl. Haemoglobin 
levels of less than 11.Og per dl were found in 3,5 per cent 
of mothers although patients had received iron supplements 
throughout pregnancy. When the maternal ferritin was low 
the haemoglobin concentration was also significantly reduced 
(p<0.05) as shown in Table 3, 8.
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Comparison of maternal and cord serum iron concentrations 
at term The mean maternal serum iron at term was 16,6 
umol per litre (SD t  7.0) and was significantly lower, 
p < 0.001 than the mean cord serum iron of 27.0 umol per 
litre (SL ± 7.5) as shown in Table 3,7 , There was no 
correlation between maternal and cord serum iron 
concentrations nor between these concentrations and baby 
weight.
Table 5,8 illustrates that when the maternal ferritin 
was less than 1 2ug per litre the corresponding maternal 
serum iron was 1 3 .O (SL ± 5.8) umol per litre and was 
statistically lower (p< 0,005) than the serum iron of 18,6 
(SD t 7 .1 ) umol per litre associated with serum ferritin 
levels of greacer than 3 0ug per litre. Although cord 
ferritin levels were significantly reduced when the maternal 
ferritins were low no difference was found in the 
corresponding cord serum iron concentrations.
Conmarison of maternal and cord transferrin concentrations 
and percentage saturations The mean maternal transferrin 
concentration at term was 3,659mg per litre (SD t 942) and 
was statistically greater (pc 0.001) than the corresponding 
cord transferrin concentration of 1717mg per litre (SL ±
3 9 3 ). The maternal percentage iron saturation of 
transferrin was 19.0 per cent (SD t  9.6) and was statistically 
lower p-< 0.001 than the cord percentage saturation of 58.8 
(SD ± 1 7 .3 ). Although low maternal ferritin concentrations 
were associated with the reduced maternal transferrin 
saturation of 12.5 per cent (SD± 9.2) when compared to the 
higher maternal ferritin group with saturation of 23,1 per
110
cent (SD t 14.6) the corresponding cord transferrin 
saturations like the cord serum iron concentrations were 
not statistically different between the groups associated 
with low and high maternal ferritin concentrations. There 
was no correlation between maternal and cord transferrin 
concentrations nor the iron saturation of transferrin and 
baby weight.
Summary In subjects who had a normal pregnancy and were 
maintained throughout on iron supplements the cord serum 
ferritin, iron and percentage transferrin saturation are 
in excess of maternal concentrations at term but the 
transferrin concentration is lower. The maternal ferritins 
do not correlate directly with cord concentrations but low 
maternal levels are associated with low cord levels. The 
maternal ferritin concentration is statistically lower in 
multiparous and social class Y  mothers but is unaffected 
by maternal age, or gestation between 38 to 41 weeks, ‘
Cord ferritin concentrations are unaffected by the sex of 
the baby, or maternal parity, age, social class or 
gestation between 38 to 41 weeks.
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Relationship Between Serum Ferritin, and Bone Marrow Iron Stores 
Bone marrow biopsies were undertaken on male and non-pregnant 
female patients as part of the routine investigations of their 
clinical condition. Blood specimens were obtained at the same 
time for serum ferritin, iron and transferrin determinations.
Bone marrow films were stained for iron (Perl's stain) and graded 
by one consultant haematologist as follows: 0, no stainable
-■j-
iron; -, sparse staining; + and ++, gradings of normal staining; 
and +++, gross staining see Plate 5,1. An iron deficient marrow
"j"
was graded 0 or -, a normal marrow + or ++ and excessive deposition 
as +++•
In 50 patients there was good correlation between the iron content 
of bone marrow and serum ferritin see Figure 111,6 and Table 5,12.
There was a significant difference between the ferritin groups 
(p-^HD.OOl). In cases of megaloblastic anaemia, chronic infections, 
inflammatory .conditions or malignancies ferritin levels were higher 
than the controls for the respective bone marrow iron contents, 
see Table 5,15* In the control group with good correlation between 
bone marrow iron and ferritin concentration the serum iron and 
percentage transferrin saturation rose with increasing bone marrow 
iron content, but the groupings were best identified by serum ferritin. 
Twenty-Three patients had megaloblastic anaemia and all bone marrow 
biopsies contained iron. In this group the bone marrow iron content 
was associated with a higher plasma ferritin than in the 
corresponding control group and there was no difference in the 
ferritin level of the ++ and +++ marrows. Transferrin increased 
and the percentage transferrin saturation decreased with the 
increasing iron content of the marrow.
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TABLE 5,12
Indices of Iron Metabolism and Bone Marrow Iron 
(Numbers in parentheses)
Bone Marrow Iron o,i +4- 4-4" 4-
Ferritin ug/l 11.1 i 6,0
(14)
55.3 -  25.7 
(16)
202.6 -  69.1 
(11)
458.7-226.4
(9)
Iron umol/l 5.5 ± 4.3 
(13)
12.6 i 9.3 
(16)
18.2 i  12.9 
(11)
18.6 - 9.6 
(9)
Transferrin m g / l 2877 - 655 
(13)
1709 i 345 
(14)
1835 - 321 
(10)
1825 - 622 
(8)
Saturation f o 8.3 - 7.0 
(13)
27.3 -  21.8 
(15)
32.2 ± 24.4 
(10)
59.4 - 15.7 
(8)
Table 5,15
Bone Harrow Iron and Indices of Iron Metabolism in Group I; 
Megaloblastic Anaemia and Group lit 
Chronic Infection, Inflammatory Conditions and Malignancy 
(Numbers in parentheses)
Bone Marrow- Iron
Group I + 4-+ 4-4-4'
Ferritin ug/l 116.8 i 82.7 
(6)
592.9 - 244.2 
(8)
518.1 i 224.2 
(9)
Iron umol/l 22.8 -  7.3 
(6)
22.1 - 14.2 
(7)
16.8 i 8.0
(9)
Transferrin m'g/l 1575 -  304 
(6)
1775 - 424 
(6)
1855 - 669 
(8)
Saturation ^ 53.5 - 30.7 
(6)
42.7 - 25.5 
(6.)
55.6 i 12.7 
(8)
Group II 0 i 4- 4-4-
Ferritin ûg/l 137.5 - 217.3 
(13)
265.1 - 245.5 
(8)
514.7 - 215.2 
(6)
Iron umol/l 8.3 - 5.0 
(11)
15.5 - 16.5 
(8)
14.6 i 15.5 
(5)
Transferrin mg/l 2243 - 561 
(10)
1977 - 652 
(8)
1615 - 552 
(6)
Saturation ^ 15.3 -  11.5 
(10)
24.5 - 26.0 
(7)
22.8 i 25.1
(4)
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Twenty-seven patients had chronic infections, inflammatory 
conditions or malignancies and in this group the highest 
plasma ferritin levels were associated with the lowest amount 
of stainable iron in the bone marrow. The transferrin 
concentrations decreased with increasing marrow iron, but there 
was little variation in the other indices of iron metabolism 
in the plasma when the bone marrow contained increasing amounts 
of iron.
Bone marrow iron content correlates with the plasma ferritin 
concentration. However, in cases of megaloblastic anaemia, 
chronic infection, inflammatory conditions and malignancies 
increased plasma ferritin concentrations occur which do not 
correlate with the stainable iron in the bone marrow.
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Chapter Four
I
STUDIES OF ABNORMAL PKSGNMCIFS, NEONATES,
FSTiOL ORGANS AND PLACENTAE
The variation of plasma ferritin with regard to maternal 
pathology and neonatal development have been assessed. Factors 
influencing the ferritin content of fetal organs and the placenta 
were investigatedo
Maternal Iron Metabolism and Disorders of Pregnancy 
Plasma ferritin, iron, transferrin and percentage saturation 
were quantitated in a number of disorders specifically associated 
with pregnancy - toxaemia of pregnancy, intrauterine growth 
retardation, ante., partum haemorrhage, premature labour, hyperemesis, 
and multiple pregnancies; and in the more general clinical 
conditions of infection and the metabolic disorders associated 
with diabetes, abnormal liver function and anaemia. All patients 
were prescribed iron supplements (lOO mg elemental iron) from 
early pregnancy.
Specific disorders of prenancy; Toxaemia
Toxaemia of pregnancy or pre-eclamptic toxaemia (p ET) is a syndrome 
associated with an elevation of blood pressure (diastolic?90 mmHg) 
with either oedema and/or proteinuria and arises in the third 
trimester. In severe PET the diastolic blood pressure is greater 
than 110 mmHg or is 90 mmHg with proteinuria of more than 0.5g 
per 24 hours*
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,One hundred and twenty-four patients with clinically defined 
PET were studied between 26 weeks and term and included 19 
women with severe PET, When the volume of plasma was sufficient 
iron and transferrin were also quantitated, /
The results from the 124 PET patients appear in Table 4,1 
and listed separately are the findings for the severe PET group. 
The mean plasma ferritin was higher in severe PET group when 
compared to the total PET group (p-c.O.Ol), No significant 
difference was found between the groups in iron, transferrin 
or percentage saturation* Twenty-six patients, 24.8 per cent 
with nild to moderate PET had plasma ferritin concentrations 
of less than lOug/per litre which compares with 30.0 per cent 
in normal pregnant women at term, but only two, 10.3 per cent 
of patients with severe PET had low ferritin levels.
At 36 to 40 weeks gestation the ferritin concentration of the 
81 patients with mild/moderate PET was 23.3 - 17*2 ug per litre 
and for the 12 patients with severe PET the elevated level was 
maintained at 6 5 .1 - 3 8 ,0 ug/per litre (p<^0 ,0 0l).
TABLE 4,1
INDICES CE IRON METABOLISM IN PET
(Numbers in parenthesis)
GROUP FERRITIN
ug/1
IRON
umol/l
TRiiNSFERRIN
nig/l
SATURATION
I
Total PET 37.1 t  39o5 20.41 9.7 3400 1 833 24.8  1 12.9 !
( 124) ( 113) (101) ( 93)
Î
Severe PET 70.0 -  30=7 21.3  1 8 .2 3149 1 666 25.8 1 13.8
( 19) (12) (18) (10) !
1
IJi
Intrauterine Growth Retardation
Ninety-three patients who on clinical or biochemical grounds gave 
evidence of intra-uterine growth retardation were investigated. Thirty- 
eight women gave clinical evidence of carrying small babies (LFD),
22 had lost weight without any other complicating factor and 33 had low 
plasma HPL and/or urinary oestriol (O^) concentrations. The results 
appear in Table 4,2. Plasma ferritin (p-=cO.Ol) and iron (p«=:0.02) appear 
to be lower and the transferrin higher (p-=^0.00l) in the "weight loss" 
group when compared to the other two,groups. At 36 to 4o weeks the plasma 
ferritin was 52.4 1 6?.6 ug per litre in the LFD group, 26.3 " 12.6 ug 
per litre in the weight loss group and 68.4 1 67.2 ug per litre in the 
low HPL/O^ group showing little variation when compared to the longer period 
of gestation. Considerable variability was encountered in the plasma 
ferritin concentration but it would appear to be elevated in the LFD (p<c0.05) 
and in the low HPL/O^ groups (p<=0.005) when compared to normal pregnant 
patients with 20.7 ~ 11.2 ug per litre at 36 to 4o weeks.
Antepartum haemorrhage
The effect of ante, partum haemorrhage on iron metabolism was investigated 
in 21 patients who were admitted to hospital with varying degrees of blood 
loss. Specimens for analyses were obtained after treatment had commenced 
and therefore only reflect the adequacy of the medication. At 36 to 40 weeks 
the plasma ferritin was 26.3 - 13«6 ug per litre, iron 10.9 - 6.2 umol per 
litre, transferrin 33^1 - 612 mg per litre and transferrin saturation
12.1 - 8.2 per cent. The ferritin and transferrin concentrations compare 
with the normal patients but iron (p<O.Ol) and percentage saturation (pcO.01 ) 
are lower.
TABLE 4 ,2
Indices of Iron Metabolism in Intrauterine Growth Retardation 
(Number of Patients in parentheses)
Group Ferritin Iron Transferrin Saturation
ug/ 1 umol/l mg/ 1
LFD 5 2 .4  - 6 7 .6  
(38)
1 9 .7 " 9 .2  
(20)
2988 t 811 
(37)
2 3 .2 1 9 .5  
(20)
Weight loss 2 6 .3 - 1 2 .6  
(22)
1 8 .7 - 8.4
(13)
3465 - 537 
(14)
1 8 .5 - 7 .6  
(13)
Low HPL/0^ 68.4 - 6 7 .2  
(33)
2 0 .3 t 10.1 
(23)
3182 1 575 
(27)
21.9 - 10.9
(23)
Serial results which were available for one patient gave a plasma 
ferritin of 15.4 at 7 days, 1 9 .0 at l4 days, 22.4 at 21 days and
3 2 .0 ug per litre at 28 days after treatment had commenced. Only two
of the twenty-one patients had ferritin concentrations of less than 10 ug .1
{
per litre before delivery, |
I
Premature Labour ' I-----------------------------------------------------------------------------------  I
Fifteen patients in premature labour, between 26 and 36 weeks gestation f
were investigated after admission to hospital. None of the patients were j
I
found to have low plasma ferritin levels on the first analysis and between |
4- i
36 and 40 weeks the plasma ferritin was 20,6 - 7*3 ug per litre, iron |
I
1 6 .6  - 6 .9  umol per litre, transferrin 3392 - 333 mg per litre and 
transferrin saturation 13.2 - 3*4 per cent. All results were within the 
limits of normality.
Hyperemesis
Fifteen women with hyperemesis between 21 and 36 weeks were investigated.
On initial testing the plasma ferritin was 24,7" 32.9 ug per litre and 
six of the patients, 40 per cent, had concentrations of less than 1.0 ug 
per litre. At 36 to 40 weeks the plasma ferritin was 21.1 - I7 .I ug per 
litre, iron I7 .O - 6,1 umol per litre, transferrin 3096 - 302 mg per 
litre and transferrin saturation 22,4 - 9.4 per cent which compared with 
values found for control patients. Only three patients 20 per cent, had 
low ferritin concentrations before delivery.
Multiple pregnancies
Twins were diagnosed in 20 pregnancies. In the third trimester the plasma 
ferritin was 43,2 - 46.3 ug per litre, iron,17*7 » 12.3 umol per litre, 
transferrin 3072 - 397 mg per litre and transferrin saturation l8,4 1
12.1 per cent.
1 4 n Ii. i j
i
I 1
At 36 to K^) weeks only the plasma iron had marginally increased to ')
+ i2 1 .9  " 17*1 umol per litre. Three patients had low ferritin levels '
in early pregnancy but at terra only one had a low concentration and at I
f
36 to 40 weeks the maternal ferritin of twins was higher than that of |
singletons (p-=:0 .0 2 ). |
!
Infection associated with pregnancy I
Urinary tract infections occur frequently during pregnancy and twenty 
of these patients were studied between 21 weeks and term. On initial 
testing the plasma ferritin was 8 9 *3 - 8I.6  ug per litre which was higher 
than the normal control group (pcO.001), iron I6 .I - 10.2 umol per litre, 
transferrin 3354 - 650 mg per litre and transferrin saturation I8 .8  - 
11.8 per cent. Twelve patients were investigated before delivery and the 
plasma ferritin remained elevated 5 8 .8  - 3 8 .6 ug per litre, (p<^0 .0 0l).
No change was found in the other indices of iron metabolism. Only one 
patient had a low plasma ferritin of 10 ug per litre at term.
Metabolic disorders associated with pregnancy: Diabetes mellitus.
Eleven patients with diabetes mellitus were investigated from 26 weeks 
and one from I5 weeks until term. This latter patient had an initial 
plasma ferritin of 3 ug per litre, but by J > 0  weeks it was normal.
25 per cent of patients presented with low ferritin levels. At 36 weeks 
to term the plasma ferritin was 33*3 - 16.4 ug per litre, iron l8.7 - 
8.4 umol per litre, transferrin 3485 - 553 mg per litre and transferrin 
saturation 18,9 " 7*6 per cent for seven patients. One patient had a 
low ferritin concentration. The indices of iron metabolism of pregnant 
diabetics are not significantly different from normal apart from a marginal 
increase in plasma ferritin (p^:0 ,0 2 5).
8Disordered liver function.
Seventeen patients with abnormal liver function tests including elevated 
plasma bilirubin, alkaline phosphatase and alanine transaminase were 
investigated. The pattern of results and clinical symptoms suggested 
that most had "jaundice associated with pregnancy". One patient 
presented at 21 weeks, one at 26 weeks, two at 32 weeks and thirteen 
at 36 to 38 weeks. The initial plasma ferritin was 57*6 - 6O .6  ug per 
litre, iron 1 1 .7 - 1 0 .3 umol per litre, transferrin 2986 - 1021 mg per 
litre and transferrin saturation 13.2 - 12.6 per cent. The plasma 
ferritin was elevated in one patient at 260 ug per litre, and the mean 
concentration was greater than the control group (p/C0 .0 2 ), but in five 
mothers (29 per cent) it was less than 10 ug per litre when they were 
first investigated.
Anaemia
A pregnant woman with a haemoglobin of 11.0 g per dl or less is considered 
anaemic. Thirty-eight women who attended the out-patient clinic had low 
haemoglobin levels when the determination was made on finger-prick specimens, 
Venous blood specimens were thereafter obtained for the determination of 
ferritin, iron, transferrin and haematological tests. The results were 
grouped according to the findings of the blood film which were undertaken 
by the haematologist. They were divided into three categories depending 
on whether they were purely iron deficient with a hypochromic, microcytic 
film, secondly megaloblastic or a mixed iron déficient megaloblastic 
picture or thirdly infection with polymorphs and leucocytosis identifiable 
in the film. The results appear in Table 4, 3 and the distribution of 
the ferritin concentrations is shown is Figure IV,1.
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Table 4»3
Indices of Iron Metabolism in Anaemia of Pregnancy 
(Numbers in parenthesis)
Anaemia Hb Ferritin Iron Transferrin Saturation
g/dl ug/l umol/l mg/l ^
Iron Deficiency , ,
Anaemia 9.4-0*7 8.6-5.0 10,0-6*0 3652-1050 10.6-7.3
(21) (22) (18) (12) (17)
(8) (11) (10) (a) (9)
Anaemia +
Infection 10,1-0,8 56,2-40.0 11.6-3,6 313241184 15.4-2,7
(4) (5) (5) (3) (4)
Megaloblastic , I
Anaemia 9,6-0,6 35.2-31.5 17.2-6.4 2767-707 20.1-7.9
PlatnuÊ Fmrritin in Anaemia
120
80
40
MegahbkiÊtk InfectionIron
Deficiency Anoemio
FiR. IV, 1 .
Plasma ferritin in Iron deficiency and jnegaloblastj^ 
anaemia and infection
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In the iron deficient group the ferritin, iron and transferrin 
saturation were reduced, but when megaloblastic anaemia was present the 
results were within normal limits. When the deficiency was purely due 
to folic acid or vitamin deficiencies the ferritin concentration was 
higher than when iron deficiency was also present. The anemia of chronic 
infection presented results of elevated ferritin, but reduced iron 
concentration and were similar to the findings in patients with urinary 
tract infections.
Summary.
Elevated plasma ferritin concentrations were found in patients with severe 
toxaemia, urinary tract infections, those who were clinically small for 
dates or who had biochemical evidence of inadequate placental function. 
Premature labour was not associated with reduced iron stores as evidenced 
by normal plasma ferritin concentrations and although some patients with 
hyperemesis had low ferritin levels this was not statistically significant* 
In twin pregnancies mothers had raised ferritin concentrations which were 
also found occassionally when patients were jaundiced but low levels were 
also found. Anaemic patients had lov/ ferritin concentrations when the 
condition was due to iron deficiency, but when it was caused by a 
megaloblastic condition or infection the levels were elevated.
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Plasma Ferritin Concentration in the Neonate
Three hundred and sixty-five specimens of heparinised plasma from 1^8 patients 
between 27 and 41 weeks gestation were analysed to determine the plasma 
ferritin concentrations. The specimens were obtained by heel prick or 
venipuncture and the plasma used in the investigation was the volume 
remaining after the requested biochemical tests had been performed.
Plasma ferritin concentration in relation to gestation.
In Table 4, 4 the results of the plasma ferritin concentration are shown 
for premature and term babies in relation to their age in days.
Logarithmic transformation was applied to the data as it gave a non-gaussian 
distribution. The mean ferritin concentration of term babies was greater 
than that of the prematures until the sixth day, but thereafter the results 
were greater in the latter group. Statistically significant differences 
were found between the two groups. There is a highly significant correlation 
between plasma ferritin and gestation (r=0.57î pcO.OOl).
The term babies demonstrated no statistical difference in the ferritin 
concentration from Day 2 to 36 when compared to Day 1 but wide variations 
were found for each day. The concentration on Day 1 was considerably 
greater than that of the terra cord specimens with a mean of 169 (range 
55 to 296) ug per litre reported on page106("Cord ferritin concentrations of J/ 
term babies").
The variation in ferritin concentration within the premature group was 
analysed in relation to Day 3 which had an arithmetic mean concentration of 
185 C~ 7 6) ug per litre and from the seventh until the thirty-sixth day the 
concentrations were significantly elevated. On Day 7 the arithmetic mean 
concentration was 413 - 55 ug per litre (p-<0.00l), Day 8-l4 was 393 - 147 ug 
per litre (pcO.OOl) and on Day 15-36 it was 419 - l44 ug per litre (pcO.OOl).
TABLE 4,4
Plasma Ferritin in Term and Premature Babies in Relation to Age
Gestation 38-41 weeks 27-37 weeks P
Day Bo. Mean
ug/l
Range
ug/l
BOe Mean
ug/l
Range
ug/l
1 11 245 90-665 6 156 34-710 ’^ 0 .3 0
2 10 245 110-545 7 187 99-353 < 0 .20
3 19 299 110-812 12 187 64-542 -cO.Ol
4 43 270 122-602 19 207 100-429 *=:0.005
5 49 270 100-735 21 191 57-566 < 0 .0 2 5
6 35 299 134-665 8 255 103-627 < 0 . 2 0
7 18 270 122-602 8 396 289-543 <0.02
8-14 25 329 189-570 13 358 229-559 <  0.20
15-36 7 184 51-662 11 380 193-749 c  0.10
p is degree of significance when the 27-37 week 
group is compared to the 38-41 week group.
The ferritin concentration in the plasma of premature babies was analysed 
with respect to gestation and the results are shown in Table 4, 5*
Statistical significance was found between 35 to 37 week group and 27 to 34 
week group at Day 4-6 only (p'CO.OOl).
Plasma Ferritin* in relation to body weight
The plasma ferritin concentration was analysed with respect to the birth 
weight of the infant between Day 2 to 5 during this time period little 
change occurred in plasma ferritin in either the premature or term group.
The results are given in Table 4, 6 and suggest that there is a significant 
correlation between pi,: . a ferritin concentration and body weight (r=0,47; 
p-<OoOOl), No significant difference in the plasma ferritin concentration 
of twins was found when compared to singletons. Nine twins between 28 and 33 
weeks gestation had a level of 185 - 46 (range 120 to 258) ug per litre on 
Day 4 or 5 and five twins of 37 to 38 weeks gestation had a concentration of 
285 - 110 (range 202 to 460) ug per litre over the same period. In general, 
normal levels were also found when the baby was light-for-dates and examined 
over an identical time scale. Ten babies between 39 and 40 weeks gestation 
had low birth weights and the plasma ferritin was 291 - 138 (range found 
37 to 5 0 0)ug per litre and of the eleven premature babies who were also light- 
for-dates the concentration was 209 - 1I6 (range found 80 to 460)ug per litre. 
Only one of the twenty one babies had a level' outwith the normal limits.
Low plasma ferritin concentrations were rarely found and were not identified 
with one clinical condition. Nine of the I58 babies examined had low levels 
and three were premature and one mature, but light-for-dates, five infants 
had levels of less than 60 ug per litre and four were between 60 and 100 ug 
per litre.
TABLE 4,7
Plasma' Ferritin in Relation to Plasma Bilirubin ,1
(Number of specimens in parentheses) !
Group C  150
Bilirubin
15 1 -2 0 0
j m  01 /1
2 01 -250 2 5 1 -350
Mature 243 - 77
(22)
276 - 97
(3 9)
315 - 102 
(4 5)
353 - 110 
(2 1) i
Premature 135 - 55 
(8)
237 - 98 
(21)
271 -  72 
(13)
394 - 104 
(6) I
Total 214 - 86 
(3 0)
262 -  98 
(60)
314 ~  121 
(58)
362 - 104
(27) I
4
TABLE 4,5
!
■'I
i
i
Plasma Ferritin in Premature Infants 
(Number of specimens in parentheses )
Gestation
weeks
Day 1-5 
Ferritin yig/l
Day 4-6 
Ferritin ^ g/l
35-37 231 - 105 
(1 5)
271 i 102 
(1 4)
31-34 125 - 70
(4)
206 -  92 
(18)
27-30 180 t  78 
(6).
178 - 51
(14)
27-34 158 1 76
(10)
194 - 77 
(32)
TABLE 4,6
Plasma Ferritin in Relation to Body Weight
Body Weight Numbers plasma Ferritin
kg iig/l
1.0 - lo5 11 197 “ 54
p< 0.01
lo6 ~ 2.0 14 215 - 128
pcO.05
2.1 - 2.5 16 278 i 92
p -cO.2
2.6 - 3.0 22 271 - 104
p 0.2
3.1 - 3.5 22 293 - 89
p 0,2
3.6 - 4.0 9 351 i 142
p is degree of significance when compared to
3.6 “ 4.0 Kg group
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When serial specimens were available the concentrations were found to increase
I
but remained lower than the normal 'gestational range. The plasma ferritin 
of 24 premature infants who were asphyxiated at birth, Apgar 6 and 1 minute 
was ug per litre on Day 4 to 6 and of 14 term babies was 266(^7 'i)
ug per litre. No difference was apparant between the asphyxiated infants 
and the overall gestational equivalent. Six babies had infections and the 
mean plasma ferritin was 348(- 218) ug per litre. Three of the babies had 
levels of 375Î 5^0 and 650 ug per litre, but the number of subjects was 
small and the findings could not be considered statistically.
Plasma ferritin in relation to plasma bilirubin concentration*
The plasma ferritin concentrations of premature and term babies in whom 
there was no evidence of a blood group incompatibility, are given in 
Table 4,7 in relation to the maximum plasma total bilirubin. In both groups 
the ferritin concentration increased in proportion to the rising bilirubin 
level. The mature infants had higher ferritin concentrations when the 
bilirubin was less than 250 umol per litre, than premature infants, but this 
was not maintained when there was a further increase in bilirubin concentration, 
Plasma ferritin in babies with blood group incompatibilities 
Thirteen babies had ABO or Rhesus incompatibilities and gave a positive 
Coombs' test. Seven babies required exchange transfusions at 4hrs~7 days 
after birth. Five babies whose birth weight ranged from 2,16 to 3*79 Kg 
(mean 3*10 » 0.50 Kg) and who did not require transfusions (plasma bilirubin 
111- 73 umol per litre) had elevated plasma ferritin concentrations of 
409 - 8l ug per litre. At birth the blood of a baby who had three 
transfusions in utero was almost entirely of donor origin.
/!■J
The birth weight was 2,30 Kg at 33 + weeks and the baby did not require 
an exchange transfusion. The bilirubin remained low, 72 umol per litre, 
but the plasma ferritin was grossly elevated at 1,000 ug per litre on Day 1 
and 1 ,2 7 0 ug per litre three hours later.
The results of the pre- and post-exchange ferritin concentrations for 
seven babies are given in Table 4,8, The three donor bloods which were 
analysed contained 3i^3 and 34 ug of ferritin per litre. The plasma ferritin 
of the pre-exchange specimens was significantly greater than the normal range 
(p<r0 ,0 0 3) but the level decreased on exchange transfusion due to low 
concentration of donor plasma. However, further specimens showed that the 
ferritin did not remain at the lower level. In Patient 1 the plasma ferritin 
was 300 ug per litre at 28 hours, in Patient 2 it was 490 ug per litre at
60 hours, in Patient 3 it was 325 ug per litre at 82 hours and in Patient 7
it was 430 ug per litre at 72 hours. The highest ferritin concentration in
this group was found in Patient 3 at I9 days when the level was 1,830 ug per
litre and the bilirubin 32 umol per litre.
Plasma Iron Concentration in the Neonate: Table 4,9
The plasma iron decreased rapidly in term babies within the first 48 hours
and thereafter a rapid increase followed and this concentration was
maintained during one month which was the period of study. There was considerable
individual variation. No cord levels were available for the premature
group but similar low concentrations were found in the first two days to be
followed by a rapid increase on Day 5 which was maintained until Day 3 6.
Due to the lack of numbers daily changes in transferrin concentration could 
not be analysed but the concentration of term infants from Day 1 to 7 was 
1 ,4 3 2 - 330 mg per litre (N=39) which compared with term cord concentrations 
of 1 ,7 1 7 - 393 mg per litre (N=113).
TABLE 4,8
‘ Rhesus-isoimmunised Babies Requiring Exchange Transfusion
Patient Weight
Kg
Age at 
Exchange
Pre-Exchange Post-Exchange
Ferritin
ug/l
Bilirubin
umol/l
Ferritin
ug/l
Bilirubin
umol/l
1 3.37 <  4 hr s 363 260 277 128
2 3.36 48.hrs 620 392 205 230
3 2 .8 1 ^  4 hrs 990 132 268 104
4 3.04 4 days 420 388 323 260
5 . 3.81 4 hrs 238 164 140 83
6 2 .9 8 7 days 740 472 332 248
7 - ^  4 hrs 610 333 208 163
Mean 372 309 231 177
- 1SÛ 249 121 70 73
TABLE 4,9.
(Number of specimens in parentheses)
Group Premature Term
Cord 
Day 1-2 
Dgy 3 
Day 4 
Day 5 
Day 6 
Day 7 
Day 8-14 
Day 15-36
11.5 - 9.4 (8)
31.1 - 29.2 (6)
37.8 Î 17.8 (9)
31 .8 t  23*0 (9)
60.2 - 29.5 (4)
24.2 - 6.5 (4)
35.7 - 27.7 (8)
24.0 i 16.4 (4)
27.0 i 7.5 (115)
14 .7 - 9.5 (10)
26.0 i 23.6 (9)
24.6 - 19.0 (25)
25.2 - 16.6 (22)
19.2 i 18.7 (I8)
13.7 i 11 .8 (11)
26.1 - 21.2 (18)
22.1 i 16.5 (8)
12S
During the first week the transferrin concentration of the premature 
group was 1,303 - 388 mg per litre (N=19) and v/as not significantly 
different from the terra group.
Summary
The concentration of plasma ferritin in the neonate is related to 
gestational age, birth weight and plasma bilirubin level. In the 
premature infant the ferritin increase with age. In this series twins, 
light-for-detes and asphyxiated babies had normal ferritin concentrations, 
but there were indications that infected babies may have raised levels.
1 2 6  I
Ferritin Deposition in Fetal Organs |
The ferritin content of hearts, livers and spleens from 26 fetuses |
I
obtained at autopsy were quantitated as described under "Quantitation |
of Plasma and Tissue Ferritin", page 63 • Six of the babies were I
stillborn, I6 died in the neonatal period and four at I3 , 20, 30 |
and 36 days after delivery. Clinical details of the babies appear |
I
in Table 4,10. There were 14 males and 12 females in the study. |
Twenty-two babies were born prematurely and four were delivered at |
terra, between 38 and 40 weeks. Five infants were cosidered to be f
' ■light-for-dates according to the criteria of Battaglia and Lubchenco |
(1967). Nineteen babies were from singleton pregnancies and seven j
from twin pregnancies. The weights of the fetuses and their organs j
related to gestation are summarised in Table 4, 11, j
Fetal organ ferritin related to gestation |
The concentration and total organ content of ferritin related to |
gestation at death are shown in Table 4, 11. A term infant with gross |i
congenital abnormalities including hypoplastic lungs, oesophageal |
atresia . and absence of kidneys and gall-bladder was omitted from the t
I
results as the ferritin content of the liver (I3.3mg) and spleen (234ug) |
appeared much reduced and may have resulted from the malformations described, {
i
There was considerable variation in organ concentration and content at all
f
stages of gestation. |
èThe total ferritin content of the liver increased with advancing gestation %
I
(r=0,63; P"= 0,001) as shown in Figure IV, 2, There was a statistically I
I
significant increase in ferritin content between 24 weeks and term (pec0,003). ^
Table 4,10 
Clinical Details of Fetuses
Fetus Sex Weight 
( Kg)
Gestation
(Weeks)
Age at 
Death
Weight
Liver
(g)
Weight
Heart
(g)
Weight
Spleen
(g)
1 F 0 .6 8 24 SB 33 3 1
2 F 0 .7 8 23+ 10 hrs 36 7 1
3 M 0.73 23+ ' 12 hrs 28 3 1
4 F 0 .9 3 23+ SB 43 3 1
3 F 1 .0 6 28 9 hrs 4l 4 1
6 F 1 .0 6 28+ 4 days 4o 8 2
7 F 1 .3 6 29 SB 77 10 3
8 . M 1 .3 8 29 30 days 60 11 3
9 F 1.48 29+ 33 days 73 12 7
10 F 1 .0 9 31 6 days 32 10 3
11 F 0 .7 6 31 SB 48 6 2
12 M 1 .2 9 31 1 day 4l 8 2 .3
13 M 1.88 32 1 hr 63 14 3
14 F 1.66 32 4 days 71 11 3
13 M 2.01 33 20 hrs 80 16 6
16 M 1 .7 8 33+ 13 days 66 13 3
17 M 1 .6 0 33 SB • 32 10 4
18 M 1 .9 0 33 SB 36 10 7
19 F 2 .3 8 33 12 hrs 133 20 20
20 M 1 .8 9 36 8 rains 90 11 10
21 M 2 .1 3 36 18 hrs 78 9 3
22 F 2 .0 8 36+ 4 days. 72 13 6
23 M 2 .9 4 38 20 days 240 17 8
24 M 3.68 40 4 days 185 22 11
23 M 2.40 4o 1 .3 hrs 127 19 10
26 M 2 .3 8 41 13 mins 90 16 10
Table 4,10 (cont) |
!
Pathology {
I
I. PET, Hydrops, CED |
i
2* IVH, Atelectasis, Asphyxia, Twin la |
iI
3. Asphyxia, Atelectasis, Twin lia
4. Petal Bleed |
i
3. IVH, Atelectasis i
i
6* Pneumothorax, IVH, HMD i
]
7* Intra-uterine pneumonia, Premature Rupture Membranes
8. Recurrent Pneumonia, Anaemia ;
9* Pulmonary fibrosis, Pneumonia, Pneumothorax
10. HMD, Pulmonary Haemorrhage, Pneumothorax, Twin Ib 'I
II. Anencephaly, Twin lib '
12. IVH, Atelectasis, HMD I
1 3. Asphyxia, Potter lib
14. HMD, Atelectasis
1 3. IVH, Asphyxia
1 6. IVH, Pneumonia, Twin lie •
1 7. PolycythaemicTwin Id , t
1 8. Anaemic Twin Ild I
1 9. Rhesus-isoimmunisation
20. Asphyxia, Anencephaly
21. Tentorial tear, Subdural haemorrhage
22. IVH, HMD
2 3. Pneumonia, Pyelonephritis ^
24. HMD, Pneumothorax
2 3. Asphyxia, Osteogenesis imperfecta
2 6 . Multiple Congenital Abnormalities
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Fin. IV, 2
Fetal liver ferritin content related to gestation
/j û
The liver ferritin concentration did not increase v/ith gestation
I
(r=0o^4; p=c0.20). The mean concentration between 33 to 35 weeks 
suggested that no increase had taken place but as this group of seven 
contained twins with the lowest levels found in the series, this finding 
would appear to be false. The liver of the Ehesus-isoimmunised fetus 
was twice the normal weight but the ferritin content was only 9*2 per cent 
above the mean as the concentration v/as only 33 per cent of the gestational 
mean. Five singleton fetuses were asphxiated at birth and three had 
increased concentrations and total contents of ferritin in the liver which 
were two to four times the gestational mean. The values for the remaining 
two fetuses were within normal limits.
The total ferritin content of the heart appeared to increase with organ 
weight (r=0.66; p<0.00l) see Figure IV,3 and like the concentration was not 
related to advancing gestation (Table 4,11). There was a statistically 
significant increase in the total ferritin content of heart between the 
24 to 29 week group and the term group (p<c0 .0 3 ) but no significant difference 
was found in concentration. Between 24 to 32 weeks no increase was found 
in the total ferritin content although the weight of the heart increased.
This appeared to be explained by the fall in concentration which occurred 
between 30 and 32 weeks.
The total ferritin content of the spleen increased with gestation (r-0.60; 
p-cO.005) between 24 weeks and term (pc;0.03) see Table 4,11. The most 
significant increase of 402 per cent occurred between 32 and 33 weeks and 
coincided with the largest increase in weight, l48 per cent and concentration, 
110 per cent. The concentration of ferritin also increased with advancing 
gestation (r=0.338) and is illustrated in Figure IV,4.
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Fetal heart ferritin content related to 
organ weight
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Fetal spleen ferritin concentrations related 
to gestation
and equivalent to 35 weeks gestation,
128 I
The twins who had low concentrationsof ferritin in the liver also had 
decreased concentrations in their spleens. The spleen ferritin 
concentration of the Rhesus-isoimraunised fetus was normal but as the organ 
was three times the normal weight, the content was grossly elevated. No 
clinical condition was consistently associated with any gross variation 
of spleen ferritin.
Fetal organ ferritin related to body and organ weight
The ferritin concentration and total content of liver, heart and spleen 
related to body weight of the fetus at the time of death are given in Table 
4, 12. The weights of all three organs were proportional to the increase 
in total body weight although no account was taken of gestation. Liver 
r=0.90i pcp.OOl; heart r=0.87, pcO.OOl; spleen r=0.?1, 0.001 ) «,
The total content of ferritin correlated with body and organ weight, but
only the ferritin concentration of spleen related to body weight (r=0 .7 0; p<0.00l)
However between 1,100 to 1,500g and 1 ,6 0 0 and 2,000g no increase in concentration
occurred in any of the organs and in the heart and spleen it decreased
although the weights increased. The clinical and biochemical data are
given in Table 4, 1$ for 3 light-for-dates babies. Only 1 of the 3 had a
small spleen (-1SD) but 3 had low total contents of ferritin. Two babies
had small hearts, 3 had low ferritin concentrations and contents but 2
had elevated concentrations and contents of ferritin. One infant had a
small spleen but 4 had low concentrations and total contents although one
was only marginally reduced and one baby had in increased concentration but
a normal content.
Six livers and five spleens were small for the gestational age of the fetus.
The ferritin concentration and content of these organs are contrasted in 
Table 4, l4, with normal weight organs of equivalent gestation.
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TABLE 4,14
FERRITIN IN NORMAL AND LIGHT WEIGHT ORGANS
Gestation
weeks
28
29
31
32
33 
36
Mean 
+
ISD
Organ
Wt.K
41
77
71
63
80
90
70.7
16.8
Normal Weight Liver
Ferritin Ferritin
mg/liver
660
643
612
1,120
1 ,6 2 0
911
928
392
Light Weight Liver
2 7o1
49.6
43.3
73.0 
1 2 9 .6
8 2 .0
6 3 .3
3 6 .4
Organ
28
40
41 
48 
32  
72
46.8
14.8
J-' err it in
386
513
988
393
391
4o6
48o
231
Ferritin
mg/liver
10.8
12.6
40.5
1 9 .0  
20.3 
2 9 .2
22.1 
11.1
V/t.g ug/s ug/spleen Wt.g ug/g ug/spleen |
29 3 213 1,063 1 207 207 ^
51 3 216 648 2 88 173 :
32 3 166 828 2 .3 171 427 ;
33 6 400 2,400 3 73 223 :
37 11 688 7,368 6 368 3,408 '
Mean 6.0 337 2 ,3 0 2 2 .9 222 888 1
Î ISD 3 .0 216 2 ,9 1 3 1 .9 201 1,412 Î
As numbers are small no definite conclusions can be drawn but it would 
appear that when liver growth is retarded both the total content and 
concentration of ferritin are reduced. The former is not unexpected as 
in the group as a whole there was a strong correlation between ferritin 
content and organ and body weight. However in one liver at 31 weeks 
both concentration and total content were well within normal limits.
Three of the five small spleens had normal concentrations but the contents 
were 30 per cent or less of the normal weight gestational equivalent.
Organ Ferritin of twins
The ferritin concentration in the livers and spleens of three sets of 
twins was considerably lower than in singletons but this difference was 
not found in the heart. The hepatic weight, ferritin concentration and 
content were all less than the gestational mean values. The lowest liver 
ferritin contents of the series were found in the "N" twins previously 
described under "Fetal organ ferritin related to gestation", page 126, 
who had a placental transfusion in utero. The seventh fetus whose twin 
survived and was not available for comparison had values greater than the 
mean for all three organ parameters and was of average body weight. The 
ferritin content of the spleens of the three sets of twins was 10 to 36 
per cent of the gestational mean and the concentration in five of the six 
was 7 to 63 per cent of the gestational mean. The seventh twin v;ho had a 
normal total ferritin content in the liver also had a normal level in the 
spleen.
Table 4, I3 contains the findings of the three sets of twins who were 
available for comparison. Twins SI and II were the most immature of the 
series and died from asphyxiation and atelectasis. Despite the larger 
liver of SI the total ferritin content was 28per cent less than SII.
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The heart of SI was 24 per cent heavier than SII and the concentration |j
was similarly increased with a resultant ?4 per cent rise in the total 
ferritin content. No differences were found in the spleens which were 
of identical weights. The body weights of Twins HI and HII were below 
the tenth percentile for their gestational age. HI had hyaline membrane 
disease and a bilateral pneumothorax and HII was an anencephalic fetus.
No difference was found in the liver ferritin concentration and that of 
total content was due to the discrepancy in the organ weights. HII 
had the smaller heart but the ferritin concentration was such that the 
total content was 596 per cent greater than that of the larger heart.
This did not occur in the spleen as HI had the larger spleen which had 
the higher concentration. The "N" twins were still-born resulting 
from a placental transfusion. NI was polycythaemicand the body weight 
was less than the tenth percentile for gestational age, and Nil anaemic.
The latter was the heavier twin which reflected in the weights of the liver 
and spleen. The heavier liver had a higher ferritin concentration but 
this was reversed in the spleen although the total ferritin content of 
both liver and spleen was greater in the heavier twin.
Fetal organ ferritin in relation to placental ferritin.
Four placentae of fetuses made available for investigation were also 
analysed for ferritin content and the results are shown in Table 4,16. As 
expected little variation was found in the placental ferritin concentration 
within the 24 to 33 week gestation range, but "Placenta 3" was the exception, 
It was a very large organ for the weight of the baby with a grossly elevated 
ferritin concentration which was twice the 93th centile for term placentae 
and five times the gestational mean.
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The fetus, which was still-born, had contracted intrauterine 
pneumonia and had an enlarged liver and spleen although the heart 
was of normal size. The ferritin concentration of the liver 
was grossly elevated but the ferritin content was normal.
Normal concentrations and contents of ferritin were found in 
heart and spleen. The ferritin studies on the remaining three 
fetuses were all within the normal gestational limits.
The placental weights were correlated with the organ ferritin 
content in 26 pregnancies and no correlation was found with liver 
content (r=0 ,0 7) or heart content (r=0,04) but a degree of 
correlation was recorded with spleen content (r=0.32); pCO.O^).
Summary.
The total ferritin content of liver, heart and spleen is 
proportional to increasing gestation and organ weight, but only 
the spleen ferritin concentration increases with advancing gestation, 
The results suggests that a growth retarded liver has a decreased 
ferritin concentration and total content but onlu the latter would 
appear to occur in the spleen. The ferritin concentration in the 
livers and spleens of twins appears lower than the singleton of 
identical gestation but this was not found in the heart. There is 
some evidence to suggest that enlarged placentae with increased 
ferritin concentrations are associated with elevations in the 
total ferritin content of the fetal liver.
1
«D m
Ferritin in Normal and Abnormal Placentae 
The ferritin concentration of normal and abnormal placentae was 
determined and related to that of human placental lactogen (HPL) 
and human chorionic gonadotrophin (HGG).
Eleven placentae which were normal macroscopically and were associated 
with uneventful pregnancies were obtained between 38 and 40 weeks 
gestation and formed the control group. Eight term placentae of 
less than 300 g and 10 term placentae associated with low maternal 
plasma HPL's and urinary oestriols were also investigated. Sixteen 
placentae between 24 to 37 weeks were obtained from pregnancies 
terminated by spontaneous premature labour or by induction or 
Caesarean section prompted by the maternal or fetal condition. Sections 
from the maternal and fetal surfaces at the centre and periphery of 
each organ were obtained from all placentae of more than 24 weeks 
maturity and treated as described under "Preparation of Tissue Extracts", 
On termination of normal pregnancies at less than 20 weeks gestation 
6 placentae were obtained. The organs were generally incomplete and 
as only small amounts of material were available one section was obtained 
from each organ.
Ferritin in Normal Term Placentae
The normal term placentae weighed 627 (- 70)g and the total ferritin 
content was 3 8 .9 (~ 13*6) mg per organ. There was little difference 
between the maternal peripheral concentration 6 9 .1 (« 21,7; range 
44,0-1IO0O) ug per g and the maternal central concentration 63.0 
(Î 18,2; range 42.0-109.0) ug per g or between the fetal peripheral 
39*1 (~ 2 3.9 ; range 2 8.0-111.0 ) ug per "g and the fetal central ferritin 
concentration 3 2 .6 (- 2 3.8 ; range^2 7.0-102.0) ug per g. In both 
the peripheral and central areas however,
3 3
and at the centre 9.3 (- 13.l) ug per g and did not differ
of normal weight but associated with low HPL and oestriol 
concentrations during pregnancy are contrasted with normal 
placentae in Table 4,17. No difference was found in the ferritin 
concentration of the two abnormal groups when contrasted with 
the control group* Concentration gradients occured between the 
maternal and fetal surfaces in 6 of the low weight placentae 
but in the remaining two no difference was found. The mean 
concentration gradient at the periphery was 19.0 (- 19.5) ug per 
g
significantly from the control group (p<0,98 andp<0.3, respectively). 
The abnormal placentae of normal weight showed concentration 
gradients in 7 of the 10 organs and no variation in 3. The 
concentration gradient at the periphery was 14.8 (- 9.9) ug 
per g and 9.6 (- 10,l) at the centre and did not vary 
statistically from the control group (pc0,7 andc0.2 respectively).
The ferritin content of the low weight placentae was 22.1 (- 8 ,4 ) 
mg which was significantly lower than the control placentae 
(p<0,0l) and in contrast to that of the abnormal placentae of 
normal weight which contained 39-.3 (- 15.4) rag and compared with 
the control group with 38.9 (“ 1 5.6) mg.
'however, a concentration gradient existed between the maternal i
[
and fetal surfaces in nine placentae but in tv/o no difference I
I
was found. The mean concentration difference between the . |
surfaces at the periphery was 18,5 (- 20.4) ug per g and at |
/+ \ I
the centre was 22.7 I- 28.1) ug per g. The results are |
illustrated in Figure IV,5. j
Ferritin in Abnormal Terra Placentae I
The ferritin concentration of the small placentae and placentae \
F e rr it in  Concentration  
of N o rm a l  Term Placentae
120r
£ F£ M C  FC
M E =M a te rn a l  Edge FE=Fetal Edge
MC= " Centre FC= " Centre
Figo IV, 5
Ferritin concentration gradient of normal term 
placentae.
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Ferritin in 24 to 37 weeks Placentae
The ferritin concentrations of placentae between 24 to 37 weeks 
gestation appear in Table 4,18 and were found to be significantly 
lower than normal, term placentae (p^0 ,0 5  at 36-37 weeks ,p<0.02 
at 33-33 weeks and'<’Q,G5 at 24-28 weeks). Concentration 
gradients between the maternal and fetal surfaces were found 
in all 16 placentae and at the periphery was 13,1 (- 12,8) ug 
per g and at the centre 14,5 (~ 18,7)' ug per go There was 
no significant difference between the concentration gradients 
in these premature placentae and normal term placentae. Table 
4,18 gives the ferritin content of the premature placentae 
which contained only 39 per cent of the ferritin of normal term 
placentae. These placentae cannot however be considered 
normal as there was evidence of placental insufficiency, 
indicated by low maternal HPL and oestriol concentrations and 
minor degrees of infarction (less than 10 per cent) were noted 
in a number of organs.
Placental Ferritin in Relation to HPL, HCGr and Gestation
The concentration and content of placental ferritin, HPL and HC&
in relation to gestation is summarised in Table 4,19. The
ferritin concentration, the mean of four concentrations for each
placenta of more than 24 weeks gestation, was found to be low
at 8 weeks, but, reached term levels between 11 and 18 weeks.
Thereafter the concentration fell significantly until 37 weeks
(p<0.02) when a second increase occurred. This pattern of
variation with gestation did not occur for HPL nor HCG,
The concentration of HPL in the placenta was found to increase
rapidly between 18 and 28 weeks and then at a slower rate until
35 weeks when a small fall occurred which was not significant 
(p<0,6) and was maintained until term.
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The fall in HPL between 11 and 18 weeks was not significant as '}
there was considerable variation in early pregnancy. There |
was little variation in the placental content of HPL between |
24 weeks and term. The concentration of HPL in the four j
placental regions are given in Table 4 , 20 . There was wide |
variation both within and between placentae at all stages of |
Î
gestation. HPL, like ferritin shows a concentration gradient I
I
between the maternal and fetal surface in the majority of |
I
organs. However, in two normal term placentae and in one
I
abnormal term placenta the concentration at the periphery was t
in the reverse direction to that of ferritin which followed i
f
the normal pattern. Reverse HPL gradients in both peripheral f
H]
and central areas occurred in one normal terra placenta, two I
abnormal term placentae and two at 36 to 37 weeks and again |
either the normal ferritin concentration gradient was present |
or no difference in concentration was found. The HPL content
of control, term placentae 194 - 68 mg was no different from \
+ I
that of small terra placentae, 149 - 41 mg and abnormal terra î
S'
placentae of normal weight, 238 - 96 mg, f
The HOG concentration of placentae varied widely in early i
I
pregnancy when very high levels could occur. At 33 weeks low I
Ilevels were found which gradually declined until term. The |
■ . i
placental content of HCG did not vary betifeen 33 and 40 weeks. \
The concentration of HCG in the four placental areas is shown !
in Table 4,21, )
A concentration gradient only existed in the 25 to 29 weeks 
group when high levels were found and decreased from the maternal 
to the fetal surface.
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The HCG concentration at this gestestation varied from 12 to 799 units 
per g. The total HCG content of the control term placentae was 7- 
6 X lO^units,' of the low weight terra placentae was 6.9- 5*7 x lO^units 
and of the abnormal placentae of normal weight was 11.oi 9»1 units.
Localisation of Placental Ferritin Synthesis.
Ferritin was localised in the plhcenta by electron microscopy using 
rabbit anti-human placental ferritin in an immunoperoxidase method.
Ferritin was found on the rough endoplasmic reticulum of the syncytiotrophoblast 
see Plates 4,1 and 4, II.
A diagramatic representation of placental structure is given in Fig IV,6 
(Garrey et al, 1971) which indicates that the syncytiotrophoblast, the 
outer trophoblastic layer is a multinuclear syncytium with no distinct 
cell boundaries and is in direct contact with maternal blood. The inner 
layer of the trophoblast, the cytotrophoblast or Langhan's layer forms a 
single layer of cuboidal cells. The placental organ is made up almost 
entirely of a multitude of chorionic villi most of which protrude into the 
intervillous blood spaces - Fig IV, 7 (White et al, 1932)# The detailed 
structure of a placental villus from a 2 cm human embryo is shown in 
Fig IV,8 but the brush border on the syncytiotrophoblast is not visible.
The fetal vessels are filled with primitive erythrocytes (Maximow and Bloom, 
1958).
Ferritin would appear to be synthesised on the rough endoplasmic reticulum
at the surface of the syncytiotrophoblast. Even at high magnification
there islittle evidence that it is synthesised in the deeper layers— Plate 4,11,
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Plate 4,1
Electron Micrograph of Normal Placenta 
(Magnification x 6,000)
*i
w
Plate 4,11
Electron Micrograph of Normal Placenta 
(Magnification x 17,500)
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This picture could arise from the failure of reagents to penetrate the 
deeper layers and further work will be required to investigate this 
possibility*
Summary
The ferritin concentration of placentae increased until 18 weeks when 
a fall took place which was maintained until 38 weeks when a second increase 
occurred. No difference was found in the ferritin content of the normal 
and abnormal term placentae but when the organ weight was low the ferritin 
content was much reduced, A concentration gradient was present between 
the maternal and fetal surfaces but no difference v/as found in any of 
the. groups between the peripheral and central areas. The gestational 
changes in placental ferritin concentration did not correlate with those 
of HPL nor HCG, The concentration gradients of HPL and HGG between 
the maternal and fetal surfaces were similar to ferritin.
In normal term placentae ferritin was located in the granular endoplasmic 
reticulum of the syncytiotrophoblast,
\  , ,13
Chapter Five 
Discussion
, "Perhaps the critical information needed to decide the 
interpretation of the 'physiological anaemia of pregnancy* is 
whether or not the average young woman has a sufficiency of 'storage 
iron' : the falling concentration of haemoglobin could hardly be
attributed to iron deficiency if there were demonstrable stores 
in the body of unused iron" - Hytten and Leitch (1971),
. The assessment of iron stores throughout gestation would 
determine the adequacy of iron intake and the variability in the 
utilisation of iron by the mother and the feto-placental unit. The 
concentration of ferritin in serum has been found to give a quantitative 
measure of iron stores in normal, iron-deficient and iron-overloaded 
subjects (Jacobs et al, 1972). Iron stores can be precisely assessed 
by repeated phlebotomy and the results correlate well with those 
obtained by plasma ferritin (Walters et al, 1973)* A simpler technique 
is to measure urinary iron excretion after administration of 
desferrioxamine but there is considerable overlap between normal and 
iron-deficient subjects. Estimates of iron stores obtained by this 
method have been shown to correlate with results obtained by repeated 
venesection (Olsson ^1972). Storage iron has also been evaluated 
semi-quantitatively by staining the bone marrow for iron and estimates 
correlate with plasma ferritin levels (Lipschitz et al, 197^). The 
most sensitive indirect measure of iron stores is by assessment of iron 
absorption and Cook et al (197^) found good correlation with plasma 
ferritin concentrations in normal subjects.
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Plasma ferritin is therefore established as a measure of storage iron 
in normal, iron-deficient and iron-overloaded subjects (Jacobs and 
Worwood, 1975) «>
An Assessment of Iron Stores in Normal Subjects.
The evaluation of iron stores in pregnancy has been limited and 
mainly determined, only semi-quantitatively and in a small number of 
subjects by staining for non-haem iron in bone marrow. The most 
comprehensive report is that of de Leeuw et al (I9 6 6) who studied 
women in early and late pregnancy and in the puerperium. However Beaton
(1974) has suggested that this method of assessing iron stores is "less 
precise and potentially misleading" when the subjects is not in iron 
balance. Svandberg (1975)studied iron absorption in pregnancy using 
a sensitive whole body counter. He found that in early pregnancy 
decreased absorption took place in comparison to non-pregnant subjects 
with equivalent bone marrow content of iron. In thepuerperium increased 
iron absorption occurred which was independent of storage iron* There 
is therefore a need for further assessment of storage iron during 
pregnancy by a method which can be widely applied and does not require 
the administration of radioisotopes. The quantitation of ferritin in 
maternal serum being non-invasive and requiring only a simple venesection 
would appear to be the method of choice.
Normal male and non-pregnant female subjects
The published ferritin concentrations in serum or plasma are 
consistently 2 to 4 times higher in normal men than in non-pregnant 
women and support similar ratios which were found using repeated 
phlebotomy measurements (Pritchard and Mason, 1964; Walters et al 1975):-
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Reference Ferritin ug/l
■ Maie Female
Addison et al (1972) 52 (12-128) 29 (10-5 6)
Jacobs et al (1972) 69 ( 6“l8 6) 55 ( 5-162)
Walters et al (1973) 105 (56-224) 56 ( 2- 8 5)
Cook et al (1974) 94 (27-529) 54 ( 9-125)
Hussein et al (1975) 188 (110-550) 58 (15-155)
Finch et al (1977) 127 (66-244) 46 (20-107)
Kelly et al (1977) 80 (24-265) 52 ( 9-107)
(Mean with range in parentheses)
The reported ranges vary considerably particularly for males which 
could reflect a difference in methodology but perhaps more importantly 
reflects the different criteria used to select the normal population 
studied. However the results reported in the present series agree 
well with those of Cook et al (19?4) using the same assay»
The ferritin concentrations of men and non-pregnant women in the 
present series were found to be proportional to the non-haem iron 
content of bone marrow and statistically significant differences were 
found between the levels associated with each grading. Lipschitz 
et al (1974) also used four gradings in categorising the iron content 
of bone marrow and similar ferritin concentrations were identified 
with equivalent gradings in both surveys. In patients with megaloblastic 
anaemia, chronic inflammatory conditions or malignancies disproportionately 
elevated plasma ferritins were found in relation to the iron content of 
bone marrow. Similar findings have been reported by others - (Jones 
et al, '1975; Lipschitz et al, 1974).
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On the basis of the plasma ferritin concentration and on the finding 
of Walters et al (1973) that 1ug of ferritin per litre of plasma 
represents about 8mg of storage iron, the average Glasgow woman in the 
reproductive age group has a store of 256mg of iron which is equivalent 
to the iron content of one unit of blood. This figure compares with 
that of 254mg obtained by Pritchard and Mason (1964) and 210mg by 
Walters et al (1973) in different populations and using the repeated 
phlebotomy technique.
10.2 per cent of our women had plasma ferritin levels of less than 
lOug per litre (mean-2SD) and were deemed to be iron deficient. A 
study of Lancashire women aged l6 to 50 years revealed that 15 per cent 
were iron deficient on the basis of their plasma ferritin levels 
(Fairhurst et al, 1977)« These figures are lower than that for 
American college women of whom 24 per cent were found to have depleted 
iron stores on the basis of bone marrow iron contents (Scott and 
Pritchard, 196?)• In Sweden 20 per cent of female subjects were 
considered iron deficient (Garby, 1973) although in a later Swedish 
series when all women had haemoglobins greater than 12g per dl only 10 
per cent were iron deficient using the same method of investigation 
(Svandberg, 1975)* The percentage of women who are truly iron deficient 
varies with the different populations studied and also with the criteria 
used for identification (Beaton, 1974). It is however apparent that 
iron stores are small in women of child-bearing age and are inadequate 
to meet the requirements of pregnancy which have been estimated to be 
1,000mg. Svandberg (1975) has determined that 6.5mg of iron is required 
daily in the last ten weeks of pregnancy and could not be met from the 
diet. The plasma ferritin concentrations found in our non-pregnant female
population supports the present practice of prophylactic iron 
therapy during pregnancy.
Iron requirements in pregnancy.
Iron supplements are generally prescribed at a first clinic visit.
A slightly higher incidence of congenital abnormalities was found in 
babies born to mothers who received iron during the first $6 days of 
pregnancy but there was no evidence of adverse effects when iron was 
taken after this time (Forfar, 1973). It is a practice in Glasgow 
Royal Maternity Hospital that patients receive an average of lOOmg 
of elemental iron per day but in this series no check was kept on 
whether or not the patient kept to this regime.
In the initial survey on age matched patients in early pregnancy 
and in the puerperium no difference was found between these groups and 
non-pregnant female subjects. A higher proportion of patients of less 
than 20 weeks gestation had lower ferritin levels despite iron therapy 
than non-pregnant subjects. This suggested that iron stores were 
being utilised early in pregnancy although erythropoiesis is not thought 
to increase until the fifth month of gestation (de Leeuw et al, I9 6 6).
It has been suggested that iron of the bone marrow is mobilised early 
in pregnancy (Hancock et al, I9 6 8). Svandberg (1975) has shown 
decreased absorption of both dietary iron and iron salts when compared 
to non-pregnant subjects. He concluded that absorption of food iron 
is less than the basal daily requirements at this time. In patients 
in thepuerperium the distribution of ferritin values was similar to that 
in non-pregnant subjects and indicated that iron supplements prevented 
a net loss of iron. There was no evidence of iron overloading as a 
result of therapy,which has been suggested by Taylor and Lind,(1979.
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Plasma ferritin, in normal pregnancy.
The basis of the physiological anaemia of pregnancy indicated 
by a progressive fall in haemoglobin concentration and haematocrit 
which are independent of iron supplementation^can only by answered 
by determining maternal iron stores throughout pregnancy. The expansion 
of the plasma volume which begins in the first trimester has been 
recognised for many years (Willcocks, 188I) and many have debated the 
importance of haemodilution in the production of anaemia.
In the present work (Kelly et al, 1977) serial plasma ferritin 
concentrations of normal pregnant patients on iron supplements indicated 
that iron stores decreased statistically from 26 weeks until term.
Earlier falls were found to occur in some subjects. The lowest 
concentrations were found between 31 to 35 weeks. The changes in 
ferritin parallel ,ed haemoglobin levels as both fell until 35 weeks 
before rising at term. Similar findings were later reported by Fenton 
et al (1977) who studied untreated and iron supplemented patients.
They found that ferritin concentrations fell in both groups from 12 weeks 
gestation but in the former group an increase at term did not occur.
Serum ferritin during pregnancy was also determined by van Eijk et al 
(1978) and they too found that concentrations fell with advancing 
gestation irrespective of iron therapy. Their patients who received 
supplements had higher levels than the untreated group. They did not 
record an increased ferritin concentration at term in the iron 
supplemented group, found in the other two studies although the 
haemoglobin increased.
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The early fall in ferritin is common to all three investigations 
suggesting an early mobilisation of iron stores. It is unlikely at 
this stage of gestation that mobilisation can be a result of fetal 
or placental requirements. It has been suggested that the increase 
in maternal red cell mass occurs in mid-pregnancy (de Leeuw et al,
1 9 6 6; Pritchard and Scott, 1970), Taylor and Lind (1976) have 
suggested that the decrease in mean red cell volume at 6 to 15 weeks 
gestation could reflect a period of marrow suppression. These 
findings suggest that maternal iron stores should not be utilised in 
early pregnancy. Alternatively Svandberg (1975) has shown that at 
this period of gestation iron absorption is less than in non-pregnant 
women and that pregnant women are in negative balance. Increased 
levels of erythropoietic activity have been found in plasma from 
13 weeks (Manasc and Jepson, I9 6 8). At less than 10 weeks 62.5 per 
cent of requirements are obtained from the diet and at 11 to 20 weeks 
3 8 .5 per cent (Svandberg, 1975)* The inadequate absorption of iron 
could stimulate the mobilisation of iron and reduce the stores. The 
fall in plasma ferritin reflects the reduction of iron stores and is 
supported by the work of Hancock et al (I968) who studied the bone 
marrow iron content. They found that in early pregnancy 75 per cent 
of women had depleted iron stores and 55 per cent lacked storage iron. 
They concluded that their findings reflected early mobilisation rather 
than exhaustion of iron.
In mid-pregnancy there is increased erythropoiesis which mobilises 
iron stores (de Leeuw et al, I9 6 6). The hormonal effect on 
erythropoiesis is not clear by HPL, present in increasing concentration 
at this time, enhances the effect of erythropoietin on erythropoiesis 
(Jepson and Friesen, I9 6 8).
Estrogen however impairs erythropoiesis although the effect is 
partly prevented by progesterone (Jepson, 1968). The fetus and 
placenta grow at an accelerated rate and therefore iron demands are 
high. Absorption of dietary iron increases and between 31 and 40 
weeks 1? per cent of dietary iron is absorbed. However Svandberg
(1975) has calculated that despite increased absorption, at 21 to 
30 weeks and at 3I to 40 weeks only 32 per cent i^ nd 46 per cent 
respectively of requirements are obtained from the diet. It would 
appear from the ferritin concentration in our subjects that despite 
iron supplement stores were increasingly utilised until 35 weeks.
After 35 weeks and until term the plasma ferritin levels increased 
in our iron supplemented subjects suggesting that either requirements 
had decreased and/or iron absorption could meet demands and partially 
replenish stores. Patients not receiving iron supplements do not 
show increased plasma ferritin concentrations between 35 and 40 weeks 
(Fenton et al, 1977; van Eijk et al, 1978) and as already noted 
absorption of dietary iron is inadequate at this time (Svandberg, 1975). 
MacKay et al (1956) have demonstrated iron in the placenta in early 
pregnancy and just prior to term which may suggest that requirements
are less than in mid-pregnancy. Changes in plasma volume could also
be responsible for the increased ferritin concentrations. If these 
occur independently of iron therapy the increase in ferritin should 
also be unrelated to suppl.ements. This does not occur, Despite 
the term increase in ferritin the concentrations are still significantly 
lower than in early pregnancy and support the earlier findings of gross 
depletion in bone marrow non-haem iron at term (de Leeuw, I966; 
Svandberg, 1973)«
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At term only one out of the 20 subjects studied serially 
had a haemoglobin level of less than 11g per dl. These results 
agree with previous reports (Jacobs, '1974) which stated that 6 per 
cent of patients maintained on oral iron had haemoglobin concentrations 
which were under 11 g per dl at term. It is therefore concluded that 
adequate iron was present to cover the requirements of pregnancy.
Serial ferritin concentrations however indicated that stores were 
severely depleted in six of the patients in whom the level v/as less than 
7o4ug per litre. This concentration was taken to indicate depleted 
iron stores. It was arrived at by adjusting the ferritin concentration 
of 9»3ug per litre which v/as found to be the lowest limit of normal in 
the non-pregnant group for the increase in plasma volume which is maximum 
at 34 weeks, Weir et al (1971) reported that in our population the 
mean maximum volume increase was from 3 to 3®75 litres, Jacobs et al 
(1972) have reported that in both sexes "a concentration below lOug 
per litre is associated with a low transferrin saturation and iron 
deficient erythropoiesis". It is recognised that the alteration in 
concentration of plasma constituents during pregnancy is rarely explained 
by dilution (Lind, 1975). Ferritin may be the exception. It appears 
to be present in plasma as an overflow from and proportional to organ 
stores. The results suggests that despite iron therapy many patients 
in late pregnancy may have poor iron reserves and would be unable to 
respond to haemorrhage in the perinatal period.
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Haemoglobin and -plasma iron changes in pregnancy
The haemoglobin levels determined in the serial study decreased 
until 35 weeks before rising until term and agreed with the report 
of de Leeuw et al (I9 6 6). Haemoglobin levels followed the variation 
in ferritin concentrations although there was no direct correlation 
between the two parameters. In similar studies of normal pregnant 
subjects receiving prophylacticiron the early pregnancy haemoglobin 
levels were identical to our mean value of 12,5g per dl but after 
the initial fall the increase occurred earlier at about 28 weeks 
(Svandberg 1975; Taylor and Lind, 1976; Sjostedt et al^1977î 
van Eijk et al, 1978), The later increase in haemoglobin in the 
present series may be explained by the early pregnancy ferritin 
concentrations which were much lower than those reported by Fenton 
et al, 1977 and van Eijk et al, 1978, Our population may have such 
poor reserves of iron, as shown by the much lower ferritin levels in 
early pregnancy that despite iron supplements the maximum maternal 
erythropoiesis cannot be attained at a time of rapid fetal growth.
The plasma iron concentrations did not vary throughout pregnancy 
but a significant fall was found in the sixth postnatal day in our 
patients which was also found in the serial study in thepuerperium. 
Plasma iron therefore did not reflect the changes in iron stores 
throughout pregnancy. Similar findings have also been reported 
(Hancock et al, I9 6 8; Fenton et al, 1977) but Svandberg (1975) and 
van Eijk et al (I9 7 8) described a fall in early pregnancy of serum 
iron. Transferrin was found to increase significantly very early in 
pregnancy and be maintained until the sixth postnatal day.
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van Eijk et al (19?8) also quantitated transferrin specifically 
and reported similar findings. However when transferrin was measured 
as total iron binding capacity a steady increase was found throughout 
pregnancy (Hancock et al, I9 6 8; Svandberg, 1975; Fenton et al, 1977).
A fall was recorded in the iron content of transferrin from 26 weeks 
until 35 weeks but thereafter an increase occurred. Similar findings 
were reported by Hancock et al (1968) but Svandberg (1975) demonstrated 
a rapid fall until 24 weeks when a constant level v/as maintained until 
term, Fenton et al (1977) reported little change in their subjects 
maintained on iron.
Iron stores in ThePi^^rperium.
Serial studies in the puerperium demonstrated that plasma ferritin 
increased until the sixth postnatal day to non-pregnant concentrations 
and that no statistically significant change occurred thereafter.
The findings suggested that the iron contained in the excess haemoglobin 
synthesised during pregnancy was rapidly returned to the stores after 
delivery. This is supported by the findings of Shepp et al (1972) 
who reported that the iron content of red blood cells v/as present in 
reticulo-endothelial ferritin within two days.
It was not possible to predict from the presenting ferritin 
concentration ..the subjects who would become iron deficient during 
pregnancy. The patients who had ferritin levels of less than 10ug 
per litre at term had early pregnancy ferritin levels of 20 .1 «
11.2ug per litre and patients with normal ferritin at term had initial 
concentrations of 32.2 - 26,3ug per litre (p<c0,10). Similar findings 
were reported by Fenton et al (1977) and Hancock et al (I9 6 8) stated 
that adequate iron in bone marrow in early pregnancy did not preclude 
iron deficiency anaemia in pregnancy*
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The increase in maternal haemoglobin mass accounts for about
,500mg of iron (de Leeuw et al, I9 6 6) if iron stores are adequate
during the period of maximum erythropoiesis. The average blood
loss at delivery in the present series was 197ml and contained
approximately 78mg of iron. Basal losses and iron lost in lochia
must also be considered^the total loss in thepuerperium could be
lOOmg during the first postnatal week. 400mg of iron should
therefore be returned to the stores. Walters et al (1973) determined
that 8mg of storage iron v/as equivalent to lug ferritin per litre
of plasma and the sixth day postnatal ferritin should therefore be
minimally 50ug per litre. However one must also account for stores
existing at delivery. The plasma ferritin was 13*9ug per litre
at 31 to 35 weeks, the period of maximum plasma volume expansion.
The plasma ferritin should therefore be 63*9ug per litre in the
puerperium. The concentration found was only 50 per cent of this value
and suggested that only 280mg of iron v/as recovered from red blood
cells* Iron metabolism is in a labile state and the non-haem iron
content of bone marrow is an unreliable idicator or iron stores at this
time (Beaton, 1974). Plasma ferritin may be similarly affected.
However the postnatal ferritin concentration was identical to that of
the non-pregnant control group. It is possible that the maximal
increase in red cell mass did not occur. This is supported by the
finding that our patients had lower haemoglobin levels than have been
reported by others and .that the increase in haemoglobin did not
occur until Jb to 4o weeks whereas others have reported increases
"
occurring at 28 weeks (Sjostedt et al, 1977)*
158
It is also possible that iron released in the purperium is not 
taken up initially by the normal storage depots but there is no 
supportive evidence.
Fenton et al (1977) also reported that 5 to 8 weeks after 
delivery that serum ferritin v/as not significantly different from 
first presentation and v/as twice thàt at term. Their ferritin 
concentrations throughout pregnancy and in thepuerperium were about 
50 per cent higher than our values. In thepuerperium the serum 
ferritin v/as 55ug per litre and accounts for the return of 500mg 
of iron to the stores from a maximal increase in red cell mass, 
van Eijk et al (1978) reported that patients maintained on 100mg 
elemental iron daily throughout pregnancy had ferritin concentrations 
12 weeks after delivery which were identical to term values and only 
53 per cent of the level at l4 weeks gestation. It is difficult 
to relate this finding to our own and that of Fenton et al (1977) 
other than by a high blood loss at delivery. It is unlikely to 
result from- sampling later in the postnatal period.
Minor degrees of anaemia (Hb 9*2-10.8g per dl) were found in 
12 patients antenatally and 50 per cent had ferritin concentrations 
which indicated depleted iron stores on the fourteenth postnatal day. 
This could indicate that despite correction of anaemia, stores were 
never formed and that expansion of the red cell mass had not been 
maximal and equivalent to the blood lost at delivery. These patients 
had normal haemoglobin levels at term and an average blood loss of 
231ml, equivalent to an iron loss of 92mg which was not significantly 
different from subjects who had maintained normal haemoglobin levels.
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In accounting for basal losses and iron content of lochia the total 
loss was in the region of 115mg* In order that the haemoglobin be 
normal despite a reduced red cell mass the expansion of plasma 
volume must have been reduced (de Leeuw et al, I9 6 6).
15 per cent of patients had postnatal anaemia but blood loss 
at delivery was similar to that of normal patients. 57 per cent of 
this group had ferritin concentrations less than 10ug per litre.
The plasma ferritin fell steadily throughout the entire postnatal 
period and suggested that absorption of dietary iron was not keeping 
pace with basal losses which are low at this time (Svandberg, 1975)»
The failure to maintain positive iron balance could be due to a low 
content of available iron in the diet or a fault in the intestinal 
absorption of iron. Almost 30 years ago Scoti.and Govan (1949) 
estimated that the average dietary iron content of our pregnant 
population was adequate at l6.7mg but its availability for absorption 
was not reported. The absorption of iron is normally increased 
postnatally and is approximately 11 per cent of dietary iron and 
independent of iron stores (Svandberg, 1975)» Assuming that with 
improved social-economic conditions the diet of our present day patients 
is at least as good as in 1948 and that the intake is maintained in 
thepuerperium, adequate iron should be absorbed.
There was no correlation between blood lost at delivery and 
plasma ferritin concentration but the blood loss of the group was small. 
When assessment was made of iron stores at delivery by taking account 
of plasma ferritin on the first postnatal day, the iron store size on the 
6th to 42nd day of the puerperium was proportionally smaller in the higher 
blood loss groups which is to be expected.
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Gestational changes in 2:3-DPG, related to plasma ferritin.
Oxygen transport to tissues is dependent on red cells 
haemoglobin concentration and its affinity for oxygen. The latter 
is determined by pH, carbon dioxide, temperature and 2:3-diphospho- 
glycerate (2:3-DPG) (Brewer, 19?4). There is an inverse correlation 
in normal and anaemic subjects between 2:3-bPG and haemoglobin 
concentration (Torrance et al, 1970). An increased concentration of 
2:3pDPG moves the oxygen dissociation curve to the right thus 
releasing more oxygen to the tissues at a given oxygen tension (Benesch, 
and Benesch, I9 6 9)°
Conflicting reports have been published regarding the concentration
of 2:3“LPG in the red cell during pregnancy. In the present series the
level increased between I6 and 24 weeks before falling until 28 weeks
and thereafter increasing until term. Postnatal values are lower than
at term but similar to early pregnancy concentrations. These values
>1
are in agreement with those of Forth and Bille Brahe (1971) who found 
that levels increased with gestation but as they did not measure 2:3-DPG 
between the twelfth and twenty-eighth week they could have missed the 
increase which occurs between the twenty-first and twenty-fourth week. 
Weiss et al (1976) also reported ah early increase in 2:3-DPG between 
19 and 22 weeks but found the decrease which followed was maintained until 
term. A third study (MacLennan et al, 1976) also reported an increase 
in 2:3“DPG betweenthe second and third trimester. Their second 
trimester group v/as not sub-divided and was reported as the average 
concentration between the weeks l4 to 2 6, they too could therefore have 
missed the peak at 23 weeks, 
r
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MacDonald and MacDonald (1977) have reported decreasing 2:3 DPG levels 
when they investigated patients serially at each trimester.
Compensatory increases in 2:3-DPG occur in anaemia (Torrance et 
al, 1970) and it was thought that changes in the organic phosphate in 
pregnancy may relate to changes in iron stores as indicated by plasma 
ferritin. The plasma ferritin concentrations in this group of patients 
followed the same pattern as that described earlier for 20 normal 
pregnancies studied serially. The concentration fell from early 
pregnancy until 36 weeks. A small increase then occurred and was 
maintained until term. An inverse relationship would be expected 
between plasma ferritin and 2:3-DPG were iron stores to influence 
2:3-DPG but no correlation was found. It would therefore appear that 
the changes in iron stores which talce place in normal pregnancy do 
not control the demonstrated changes occurring in 2:3“bPG during 
gestation. The major factors regulating 2:3-hPG in non-pregnent 
subjects are pH and the oxygenation state of haemoglobin which regulate 
the glycolytic enzymes required to synthesise the organic phosphate 
(Gerlach and Duhm, 1972)* These factors were not studied but as pH is 
known to increase in pregnancy as a result of the respiratory alkalosis 
this may be an important regulating factorC&ceds.et al, 1964),
The present results suggest that in subjects receiving iron 
supplements during a normal pregnancy that iron stores will be restored 
to pre-pregnancy levels in the purperium.
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Plasma Ferritin in Pathological Pregnancies
In a number of pathological conditions including liver disorders, 
chronic inflammation and malignancy iron metabolism is disturbed and 
raised plasma ferritin concentrations occur in non-pregnant subjects 
which are disproportionate to iron stores (Lipschitz et al, 1974)»
A high perinatal mortality and premature labour are associated with 
the low social-economic class who also have anaemia. It was therefore 
decided to determine plasma ferritin concentrations in pregnant 
patients with intercurrent pathology and to assess iron stores in 
antepartum haemorrhage and premature labour.
Liver disorders.
Plasma ferritin concentrations were raised and the difference 
was statistically significant from the control group in patients with 
idiopathic jaundice of pregnancy - recurrent intra-hepatic cholestatic 
jaundice of pregnancy. All patients had a mild degree of hyper- 
bilirubinaemia with raised aspartate and alanine transaminase find 
alkaline phosphatase activities. Most patients had pruritus. 
Individual cases of hepatocellular disease have been shown to have 
changes in serum transaminase activities accompanied by corresponding 
changes in serum ferritin (Jacobs and Worwood, 1975) but no correlation 
between serum ferritin and serum alkaline phosphatase and bilirubin 
have been found (Lipschitz et al, 1974). No correlation between 
plasma ferritin and the indices of liver function were found in the 
present series, Sherlock (1968) has described the hepatic histology 
as mild focal and irregular bile stasis. Although the mean ferritin 
was elevated 29 per cent of patients had iron deficient levels on first 
presentation.
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The plasma iron, transferrin and percentage transferrin saturation 
were not significantly different from the control group*
Lipschitz et al (1974) have described elevated serum ferritin 
levels in non-pregnant patients with liver disease, mainly viral 
hepatitis and alcoholic cirrhosis. The concentrations in their 
patients were ten times higher than in our pregnant patients who 
had a different and milder type of liver disorder. Elevation of 
serum ferritin has also been found in drug induced hepatic necrosis 
and in patients with surgical obstructive jaundice (Jacobs and Worwood,
1975).
It has been suggested that the increase seen in serum iron 
some days after the onset of viral hepatitis arises from damaged 
hepatocytes (Sussraan, 1974)* It would seem reasonable that in our 
patients the ferritin is also excreted excessively into the circulation 
by damaged hepatic parenchymal cells. The latter has been thought 
to occur in non-pregnant, jaundiced patients and the plasma ferritin 
concentration no longer reflects the iron stores (Lipschitz et al,1974). 
Pre-eclamptic toxaemia.
The toxaemic patients had increased plasma ferritin levels and 
in the severe group the concentrations were significantly higher.
Only 10 per cent of patients had depleted iron stores compared to 30 
per cent in the control group. The other parameters of iron metabolism 
were within normal limits.
Toxaemia can be complicated by jaundice (Sherlock, 1968) and 
we have shown in a separate study that gamma-glutamyl transferase 
(EC2.3 .2 .2) is elevated in this condition (Kelly and McEwan, 1978).
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The liver may therefore by the source of the raised plasma ferritin 
in toxaemia» Shorr (1954-55) in an extensive review of the vasoactive 
and anti-diuretic activities of ferritin has shown that in experimental 
and essential hypertension that ferritin is released by the liver under 
aerobic conditions into the blood stream» Liver ferritin is readily 
utilised in pregnancy (Wyllie and Kaufman, 1971) and we have shown that 
in normal pregnancy iron stores are low from mid-pregnancy (Kelly et al,
1977)* There could however have been a shift in iron from the red cell
1
to the reticuloendothelial compartment which would increase the plasma 
ferritin concentration (Jacobs and Worwood, 1975)» The raised 
ferritin could also be explained by the disseminated intravascular 
coagulation and haemoconcentration which is known to occur in toxaemia 
(Scott, personal communication) but could also arise as result of 
retarded feto-placental growth and the resultant reduction in the 
fetal demand for iron.
Chronic infections
Patients with infections, mostly of the urinary tract, had 
also significantly elevated plasma ferritin concentrations when initially 
investigated and these values were maintained until term. The results 
are in agreement with investigations of non-pregnant patients with 
inflammatory conditions (Lipschitz et al, 1974) but the concentrations 
in the present series were much lower. Only 8 per cent of patients 
had depleted iron stores at delivery» All othersindices of iron 
metabolism were identical to the control group unless anaemia was also 
present. The ferritin in these cases remained elevated although the 
plasma iron was reduced in comparison to normal pregnant patients.
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The raised plasma ferritin concentrations could be due to 
a shift of iron from the red cell to the reticuloendothelial 
compartment as already suggested in cases of idiopathic jaundice 
of pregnancy» Alternatively a number of conditions including acute 
and chronic infections and chronic inflammatory states are accompanied 
by a mild anaemia and an impaired release of iron from the 
reticuloendothelial system» These conditions are also associated 
with a lov/ serum iron concentration, percentage transferrin 
saturation and iron-binding capacity. In addition to a reduction of 
iron release there is also a shortened red cell survival time due 
to an extracorpuscular factor and an inadequate response to erythropoietin 
(Lynch, 1974).
Anaemia
Patients with iron deficiency anaemia or megaloblastic anaemia 
had respectively low and normal ferritin concentrations and both groups 
had comparable haemoglobin levels. In iron deficiency anaemia in non­
pregnant patients a mean plasma ferritin, of 5ug per litre was reported 
by Jacobs et al (1972) and 4ug per litre by Lipschitz et al (1974).
Our value of 8 ,6ug per litre was higher but the degree of anaemia was 
lower - 9«4g per dl. Plasma iron and the percentage transferrin 
saturation were lower and transferrin concentration higher than the 
control group as expected. In patients with megaloblastic anaemia 
the ferritin concentration was 3 5*2ug per litre and similar to that of 
normal patients.
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Patients with an increased red cell turnover, including those 
with megaloblastic anaemia have been reported as having elevated 
serum ferritin levels which were disproportionately increased in 
relation to bone marrow haemosiderin (Lipschitz et al, 19?4)» The 
blood films of a number of our patients indicated that iron deficiency 
was also present and may explain our normal ferritin values. Patients 
with megaloblastic anaemia but no evidence of iron deficiency had 
higher plasma ferritin levels which were not significantly different 
from normal.
One could speculate that the difference in ferritin levels 
between our pregnant patients and non-pregnant patients with 
megaloblastic anaemia is that vitamin B12 deficiency in pregnancy is 
usually of dietary origin. Primary B^^deficiency is unusual in 
women of child-bearing age (Scott, 1962), Folic acid deficiency 
results more from fetal demands than dietary deficiency as a higher 
incidence is found in multiple pregnancy (Scott, I962). It is there­
fore possible that when megaloblasic anaemia is detected after mid­
pregnancy the condition may have arisen over a relatively short time 
scale and that the resultant disturbance in iron metabolism is not 
maximal,
Intra-uterine growth retardation.
In patients with clinical signs of intra-uterine growth 
retardation (lUGR) and those who had biochemical signs of lUGR, such 
as a low plasma HPL or urinary excretion of oestriol, elevated plasma 
ferritin concentrations were found when compared to the control group.
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Patients with weight loss but no other signs of lUGR had normal 
plasma ferritin levels and may reflect the fact that not all 
patients were delivered of an LFD baby. In patients with clinical 
or biochemical signs of lUGR the feto-placental unit may not 
maxinally utilise iron and maternal stores may be augmented by 
prophylactic iron. This is supported by the evidence that there 
is a high incidence of iron deficiency anaemia in LFD infants 
irrespective of gestational age (Fomon, 1967) and might suggest that 
maternal iron deficiency is not a contributing factor but that there 
may be a failure in the placental uptake or fetal utilisation of 
iron.
Antepartum haemorrhage and premature labour.
Evidence from the literature suggests that API! and premature 
labour may be associated with iron deficiency (Scott,1962; Butler, 
1967). The patients with APH whom we investigated had normal plasma 
ferritin and transferrin concentrations although the plasma iron and 
percentage transferrin saturation were low. This may be due to the 
fact that patients had been admitted to hospital and treated for a 
number of days before blood was obtained for analyses, A serial 
study revealed a gradual increase in ferritin with time at a stage of 
gestation when plasma ferritin is decreasing. However although one 
could use this evidence and extrapolate back to the APH and suggest 
that iron stores were low there is no justification on the present 
findings. The reason for the low plasma iron and percentage 
transferrin saturation in the presence of a normal ferritin in APH 
subjects may be explained by the variation in degree of APH which 
was not assessed.
There v/as no evidence of iron deficiency in any of our patients 
admitted in premature labour* Specimens were however obtained some 
time after admission and the results in both the APH and premature 
labour groups may only reflect prompt and adequate iron therapy. 
Hyperemesis.
Low iron stores: were expected in subjects with hyperemesis due 
to the patient’s inability to maintain an adequate iron intalce.
Although the mean plasma ferritin concentration was within normal 
limits, 40 per cent of patients had lov; ferritin levels indicating 
depleted iron stores. At delivery only 20 per cent of patients were 
iron deficient indicating that treatment had been successful in half 
the group*
Multiple pregnancies.
It is suggested from the results in twin pregnancies that iron 
intalce was increased to cope with the increased requirements as the 
plasma ferritin was significantly elevated compared to normal singleton 
pregnancies* It is the practice when twin pregnancies are recognised 
in early pregnancy and the haemoglobin levels are at the lower limits 
of normal. to consider the patients as high risk candidates for 
anaemia* These patients then receive 300mg of elemental iron and 
15mg of folic acid per day. In early pregnancy 15 per cent and at 
terra only 5 per cent of patients had low ferritin levels and the mean 
term level was 44.0ug per litre compared to the normal singleton term 
value of 17.3ug per litre and reflects the adequacy of the regime*
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Diabetes.
No abnormalities of iron metabolism were detected in diabetic 
pregnancies*
It would appear that in pregnancy low concentrations of plasma 
ferritin may be interpreted as iron depletion but in toxaemia, 
recurrent intra-hepatic cholestatic jaundice of pregnancy, infections 
and megaloblastic anaemia the increased level may not reflect increased 
iron stores* The higher plasma ferritins found in pregnancies which 
show clinical or biochemical evidence of lUGR may reflect reduced 
utilisation of iron by the feto-placental unit®
The Relationship between Maternal and Cord 
Ferritin Concentrations at Term.
An investigation v/as undertaken into the correlation of maternal 
and cord ferritin concentrations as there are conflicting reports on the 
influence of maternal iron stores on fetal stores (Sturgeon, 1959? 
Lanzkowsky, I96I; Rios et al, 1975)e The prevalence of frank iron 
deficiency anaemia between 6 months and two years of age is well 
recognised (Slimes et al, 1974) and additional infants have normal 
haemoglobin levels but haematological evidence of anaemia which can 
be corrected by Iron supplements (Guest, 1948). It is therefore of 
importance to determine the effect of maternal iron stores on fetal 
stores and to find a parameter which will predict infantile iron 
deficiency anaemia.
Variability in indices of iron metabolism.
The biochemical indices & f  iron metabolism are elevated in cord 
serum. The serum iron and percentage transferrin saturation are 162 
per cent and 310 per cent respectively of maternal values and are in 
agreement with the work of Rios et al, (1975). The cord serum ferritin 
concentration of 175ug per litre is five times the maternal level of 
3 0.5ug per litre. The cord ferritin levels were greater than that 
of Slimes et al (1974) and Rios et e ü . (1975), lower than that of Fenton 
et al (1977) and in agreement with Hussain et al (1977) and van Eijk et al 
(1978) although the same order of magnitude between maternal and cord 
ferritin exists in all six studies.
There was no direct correlation between maternal and cord ferritin 
concentrations which is in agreement with'the findings of Rios et al 
(1975) and Hussain et al (1977).
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However when the patients were grouped according to whether the mother 
had low or above average ferritin levels there was a significant difference 
between the respective cord concentrations. Similar findings have 
recently been reported by Fenton et al (1977). Hussain et al (1977) 
found no correlation between maternal and cord ferritin levels but none 
of the mothers had deficient iron stores and the plasma ferritin 
concentrations were in excess of l6ug per litre. van Eijk et al (1978) 
studied 30 patients, 30 per cent of whom received iron supplements 
and found no significant difference in cord ferritin between the two 
groups. Low maternal ferritins were found by these authors but the 
small number of patients studied may account for the absence of 
correlation.
In the present work no difference was found in serum iron between 
cord sera associated with low or normal maternal ferritin concentrations 
and this is in agreement with others (Shott et al, 1972; Rios et al,1973 
and van Eijk et al, 1978). In contrast, Sisson and Lund (1938) in a 
study of circulating haemoglobin mass in the newborn concluded that
the more severe the anaemia in the mother the more this will be reflected 
in the infant at birth. It was calculated that in severe maternal 
anaemia the infant could be deprived of one quarter of its readily 
available iron store. It would therefore appear on the balance of 
evidence from the present work and that of the others described that there 
is probably no direct correlation between maternal and fetal iron stores 
unless the mother is severly depleted. The placenta may play a 
controlling role in limiting the passage of iron from mother to fetus.
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Infantile iron deficiency anaemia has been associated with 
children of high parity mothers (Shulman, I9 6I), light for dates and 
premature infants (Fomon, 196?) and infants of mothers who are a high 
medical risk and belong to the low socioeconomic class (Shott et al, 
1972), Scott et al (1975) have also shown that unmarried mothers aged 
15 to 22 years and all mothers over 40 years have a high incidence of 
iron and folic acid deficiencies. It was therefore thought that 
matehnal and cord ferritin concentrations should be analysed with 
respect to the known "at risk" groups.
The effect of parity on serum ferritin.
In our serial study of 20 patients throughout pregnancy we 
found no difference in ferritin concentrations between primigravidae 
and parous patients at under 20 weeks gestation but in the investigation 
of women at term there was a significant reduction in ferritin when 
patients with three or more previous pregnancies were compared to those 
of lower parity. The discrepancy between these findings is probably 
due to the larger number of parous patients in the study at term rather 
than the difference in gestation at the time of ferritin analyses.
The cord ferritin decreased with increasing maternal parity but this was 
not significant when analysed statistically. Shott et al (1972) 
found that parity did not core- late with cord serum iron, percentage 
transferrin saturation, haematocrit or haemoglobin.
The effect of gestational age on serum ferritin.
Shulman, I9 6I has shown that premature infants have an increased 
incidence of poor iron stores which is in. keeping with fetal iron stores 
being acquired in the third trimester (Fletcher and Suter, I9 6 9)»
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Our study investigated only . . infants born between 38 and 41 weeks 
and over this short period no statistical difference was found between 
the maternal or the cord ferritin concentrations^ f . f
The effect of social class on serum ferritin.
The highest incidence of infantile iron deficiency anaemia is 
associated with the "high medical risk, low socioeconomic class"
(Shott et al, 1972), No difference was found in maternal ferritin 
between the social classes 1 to 1V but It v/as significantly lower in 
class V, This may have been due to the high parity (three or more 
pregnancies) in the latter group which v/as 22,7 per cent in contrast 
to 9o7 per cent in the former group* 30 per cent of mothers in the 
low social class group had ferritin concentrations of less than 12ug 
per litre which was the percentage quoted by Shott et al,(1972)for iron 
deficiency anaemia in a comparable American population. We are also 
in agreement v/ith the same authors who found no correlation between 
parameters of iron metabolism in cord serum with respect to social 
class.
The effect of baby weight and maternal age on serum ferritin.
No correlation was found between baby weight and cord or maternal 
ferritin, serum iron or percentage transferrin saturation, hessel and 
Sills (1968) found a similar lack of correlation between cord serum iron 
and term baby weights. Placental weight did not correlate with either 
maternal or cord ferritin concentration.
• In the maternal age group 26 to 30 years there was a significant 
reduction in serum ferritin. No explanation for this finding was 
determined when results were analysed for high parity and low social 
class.
1Ü6
The age group J > G  to 41 years had the highest percentage of patients with 
high parity (60 per cent) and belonging to social class V (40 per cent). 
Our results indicate that when the maternal ferritin is less than 
10ug per litre 2 8 ,6 per cent of babies have cord ferritin concentrations 
of less than lOOug per litre in contrast to 15=8 per cent when the 
maternal ferritin is normal. Low maternal ferritin levels as expected, 
are associated with high parity and low social class but these factors 
are not solely responsible for low fetal iron stores. Although all 
patients received iron supplements Bonner et al,( I9 6 9)have shown that 
a number neglect to talce the tablets. In this series patients ferritin 
concentrations were not monitored throughout pregnancy and a lapse in 
taking the tablets early in the third trimester could not be ruled out.
If this were followed by a period of increased iron intake when admission 
to hospital for delivery was imminent the maternal ferritin could well 
be normal at term but fetal stores depleted.
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Plasma Ferritin in The Neonate
The physiological anaemia of infancy describes the fall in 
haemoglobin concentration over the first few weeks of life which occurs 
irrespective of iron supplements. It results from a fall in red cell 
mass and decreased erythropoietic activity rather than haemodilution 
or iron deficiency (Stockman and Oski, 1978), At 8 to 12 weeks the 
haemoglobin increases but if the infant has not received iron 
supplemented feeds the iron reserves will be depleted when the birth 
weight is doubled* The time at which iron deficiency limits the rate 
of haemoglobin synthesis is a function of the neonatal haemoglobin 
concentration and the rate of growth (Stockman and Oski, 1978). As 
iron deficiency anaemia of childhood is the most common nutritional 
deficiency of industrialised countries a knowledge of iron stores in the 
neonatal period could be valuable in determining the babies at risk and 
with this objective plasma ferritin was determined in the neonatal.period. 
Plasma ferritin in relation to gestation.
Plasma ferritin increases with advancing gestation and was found 
to be significantly elevated in term infants when compared to premature 
babies and both groups were much increased in relation to adult levels.
In term infants the plasma ferritin rose rapidly between delivery and 24 
hours later but thereafter the level was constant, A similar initial 
increase occurs in haemoglobin and haematocrit if the cord has not been 
clamped immediately and reflects a compensatory fall in plasma volume in 
response to the transfusion induced hypervolaemia and also the poor oral 
intake at this time (Sisson and Lund, 1938; Mentzer, 1978).
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Within the first few days of life haemoglobin returns to the cord
level but we found the ferritin concentration increased slightly.
59It has been shown that the Fe label of heat treated red cells 
appeared in serum ferritin 30 minutes after injection which suggests 
that circulating ferritin originates in the cells associated with red 
cell breakdown (Jacobs and Worwood, 1973) <» The breakdown of red cells 
which have a half-life of 80 to 100 days in the term infant compared to 
120 üays in the adult, could lead to an increase in plasma ferritin 
which may be modified by a readjustment of plasma volume.
No cord blood specimens were available from premature babies but 
the plasma ferritin increased gradually throughout the first week of 
life although it was not statistically significant until Day 7, 
thereafter the concentration was maintained until Day 3 6. Initially 
premature babies had lower ferritin concentrations than term infants 
but by Day 7 the situation v/as reversed® The rapid increase in ferritin 
in the preterm group could be due to rapid red cell breaj-cdown; the half- 
life of the red cell is 60 to 80 days and higher bilirubin concentrations 
are attained. Plasma volume changes may also be important as oedema 
which occurs in premature babies often disappears fairly rapidly. The 
plasma volume of term infants has been quoted as 42.7ml per Kg (Mollison 
et al, 1950) and alternately as 6l.0ral per Kg (Sisson and Lund, 1938) and 
of premature babies as 62ml per Kg (Schulman et al, 1934) but it is 
accepted that hypo- and hyper-volaemia occur in term and premature 
babies (Sisson and Lund, 1938).
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Plasma ferritin in relation to body weight.
There is a highly significant correlation between plasma 
ferritin and body weight but in the present series all but one of the 
twenty-one term and premature babies who were also light-for-dates had 
normal ferritin concentrations for gestation® These babies however 
are known to have lov/ iron stores at birth and a large percentage 
develop iron deficiency anaemia in infancy (Shott et al, 1972)® A 
significant increase in haemoglobin v/as found in premature light-for- 
dates infants when compared to non-retarded babies (Burrnan, 1974), 
Increased erythropoiesis in utero has been said to account for the 
polycythaemia seen in babies associated with placental insufficiency 
and intra-uterine hypoxia (Walker and Turnbull, 1933; Mentzer,1978)• 
Catabolism of the increased red cell mass could temporarily give rise 
to a normal plasma ferritin despite depleted organ stores. These 
infants are classically long, thin and wrinkled and appear to be 
clinically dehydrated and therefore haemoconcentration could also 
account for the normal plasma ferritin concentrations.
Publications on baby plasma ferritin concentrations are few. 
Siimes et al (1974) found a significant increase in ferritin at one 
month when compared to the cord level and Rios et al (1975) found that 
in term infants the level increased sharply during the first 24 hours 
and remained at high levels for the next six weeks. Only at three 
months did the ferritin significantly decrease. These results are 
similar to our own for term infants which differed from the values of 
premature babies who attained maximum concentrations on the seventh day.
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Neonatal plasma iron.
The plasma iron concentration did not follow the ferritin 
pattern of the neonatal period as low levels occurred in the first 
48 hours before increasing rapidly to levels which were maintained for 
one month. The cord levels of 27«0umol per litre were similar to those 
of de Leeuw et al (I9 6 6), Shott et al (1972) and Rios et al (1975) 
but lower than that of Sturgeon (1954). However the latter also 
found low serum iron concentrations within the first 48 hours in term 
infants followed by increasing levels for the next 11 days. A 
subsequent fall in serum iron was found at 4 months of age. As 
previously described we found no correlation between maternal and cord 
iron concentrations, Sisson and Lund (1958) reached similar conclusions 
when studying maternal levels at term and their babies at 5 to 5 days 
of age although a number of mothers had severe iron deficiency anaemia* 
They concluded that the determination of serum iron in the newborn did 
not indicate iron deficiency, "since it relates to current iron turnover, 
and is in such a sensitively balanced state that many factors can 
influence the values found at any one time," They reported that the 
maternal iron state did control the red cell volume and circulating 
haemoglobin mass and therefore the demands of the fetus were not entirely 
met at the mother's expense if she were anaemic. However there is 
evidence to suggest that the fetus does take precedence over the mother 
to obtain iron for haemoglobin synthesis and the formation of iron 
stores (de Leeuw et al, I9 6 6).
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Factors influencing iron stores in the neonate.
The plasma ferritin was found to increase with advancing 
gestation and birth weight* Weight has been shown to be an important 
factor in determining the total iron content at birth (Josephs, 1959) 
and in term infants the total body iron can vary by 80 per cent 
depending on body v/eight (Burrnan, 19?l). Cord haemoglobin and the time 
of clamping the cord have also been said to influence iron stores 
but Sisson and Lund (1958) found that neither immediate or delayed 
clamping of the cord influenced the total blood volume or the red 
cell volume by the fourth day.
The plasma ferritin would appear to differ from haemoglobin 
concentration in relation to gestation. It is claimed that haemoglobin, 
haematocrit and red cell count increase from 12 to 3^ weeks (Lubin,
1978)o Others have suggested that the cord haemoglobin does not 
change significantly during the last trimester quoting term haemoglobin 
levels of 17.1 1*8g per dl and premature levels of 1 7 .5 » 1,6g per
dl (stockman and Oski, 1978). However they have also found gestation 
to be reflected in the progressive fall in haemoglobin over the first 
one to three months when the rapidity of the decline and magnitude 
of the decrease depends on immaturity. The ferritin concentration 
in neonates of 27 to 30 weeks gestation was only 60 per cent of term 
values and in the 1.0 to 1.5 Kg babies the ferritin was 56 per cent of 
the concentration in the 3-8 to 4.0 Kg infants. Many premature 
babies appear oedematous and a dilutional effect may be partly 
responsible for the lower levels.
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The ferritin concentrations however do appear to reflect the total body 
iron content at birth as a value of 50mg for a 1*00 Kg infant and 
372mg for a 4.11 Kg infant have been reported (Josephs, 1959)  ^ The 
iron content of the bone marrow does not reflect iron stores in the 
neonate as little or no iron is found at birth in premature or term 
babies (Seip and Halvorsen, 1956).
5«7 per cent of babies had ferritin concentrations lower than the 
calculated limits® Only 5 per cent had values of less than 60 ug 
per litre at birth and would appear to reflect the ability of the fetus 
to accumulate iron irrespective of maternal stores. It has been 
reported that there is a reduction in plasma volume in the newborn 
of anaemic mothers (Sisson and Lund, 1958) therefore false elevations 
of plasma ferritin may occur in these babies.
Relationship between plasma ferritin and bilirubin.
The plasma ferritin concentration was found to correlate with 
the maximum bilirubin concentration. The serum ferritin did not 
correlate with bilirubin in adults with hepatitis (Lipschitz et al, 1974) 
but in the latter the source of circulating ferritin would appear to be 
the liver whereas in the neonate it arises from red cell catabolism.
In term infants the ferritin increased rapidly within twenty-four hours 
with only small increases occurring thereafter but in premature neonates 
the initial levels were significantly lower than in the mature group 
but rose throughout the first week reaching higher levels than at term.
The variation in plasma ferritin concentration particularly in 
the premature infant reflecis the changes known to occur in bilirubin.
1Physiological hyperbilirubinaemia of term infants is characterised 
by maximum concentrations of 200 umol per litre at 4 days and 
in premature babies maximum levels of 260 umol per litre attained at 
7 days. Hyperbilirubinaemia results from the increased circulating 
red cell mass at birth, the decreased red cell survival time, the 
increased enterohepatic circulation of bilirubin and the reduced 
activity of the hepatic glucuronyl transferase (Lubin, 1978)® The fact 
that the increase in plasma ferritin is greater rnd peaks later in 
premature infants than term babies could be explained on a similar 
basis to bilirubin metabolism. The uptake of the circulating ferritin 
by the liver, the main iron storage organ could be decreased at this 
time and unable to cope with the ferritin liberated from the breakdown 
of the increased red cell mass. This could result from immaturity 
of enzyme systems, a deficiency of intermediate compounds involved 
in iron storage or the system could simply be overwhelmed by the amount 
of ferritin presented. The latter may be more important £is the infant 
has already a high concentration of ferritin in the liver at birth. 
However in a series of four patients a rapid plasma ferritin turnover 
has been found in the neonate (Siimes et al, 1975)»
Plasma ferritin of the neonate appears to reflect previous studies 
of iron stores and both have been found to increase with advancing 
gestation and birth weight. However rapid changes in plasma volume and 
hepatic function which occur particularly in premature and light-for- 
dates infants, appear to be reflected in the marked variation in serial 
studies of individual babies.
,The term infant has a relatively stable ferritin concentration 
between Day 5 and Day 7 which may therefore give a more precise 
measure of iron stores* This however could only be confirmed by a 
long term follow up of these babies which was outwith the scope 
of the present work.
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The Ferritin Content of Fetal Organs
Little information is available on the storage of non­
haemoglobin iron during gestation (Loria et al, 1977) although almost 
ninety years ago Lapicque and Guillemonat (1889) described the "life 
curve" of the iron content of human and animal livers which they found to 
be high in the newborn, low in childhood and higher in adults*
The total iron content of the neonate has b^en found to be 
proportional to birth weight (Josephs, 1959) and as in the adult 
between 60 per cent (Burrnan, 197'!) and 75 per cent (Schulman, I9 6I) is 
found in the haemoglobin mass* Storage iron in the term neonate 
accounts.for l4 to 20 per cent of the total iron (Schulman, I9 6I; Burrnan,
1971) and 10 per cent is found in the tissue or parenchymal mass as
myoglobin iron (Schulman, I9 6I).
Adult storage iron in the form of ferritin and haemosiderin is 
found in significant amounts in the liver, spleen and bone marrow but 
in both term and premature infants little or no iron is found in the
II
latter at birth (Stockman and Oski, 1978). Bruckman and Zondek (1959) 
found that the non-haem iron content of the liver of the newborn was 
1.77g per Kg dry weight of tissue which is equivalent to 442ug per g 
of wet weight tissue calculated on their finding of a 75 per cent water 
content. He summarised the findings of other workers on the non-haem 
hepatic iron concentration determined by a variety of chemical means 
and found comparable results, Chang (1975) determin ed the non-haem 
iron content of term and preterm infants and found that the content
increased by 50 per cent after 55 gestational weeks*
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The content of the non-haem iron was 42mg in the terra infant and the
II
concentration was in agreement with Bruckman and Zondek (1959)« A 
late accumulation of storage iron which constitues 50 per cent 
of the total body iron also occurs in the rat (Morgan, 1961)0 Loria 
et al (1977) have recently completed a study of the accumulation of 
hepatic non-haem iron throughout gestation and at 59 to 41 weeks the
content was 40.5 (^56-0) mg* A limited number of reports are also
i
available on the non-haem iron content of kidney. It is said to be 
present in the ratio of liver to kidney as 9 to 1 in the newborn and.
M
5 to 1 in the adult (Bruckman and Zondek, 1959) but Chang (1975) found 
that in term and premature infants the ratio was 4o to 1.
Previous studies of storage iron in the developing fetus have 
been limited to determining the non-haem iron content of liver and 
kidney by quantitating the iron content after acid digestion. In the 
present study we applied a specific radioimmunoassay technique to 
determine the ferritin content of liver, heart and spleen. Ferritin 
was quantitated as it could be analysed with specificity, the iron 
content is more easily mobilised than haemosiderin (V/yllie and Kaufman, 
197l)and it may have other functions as yet unknown (Powell et al,1975) 
The ferritin content of fetal liver.
The concentration of ferritin in the liver of 56 to 40 week 
neonates was Img per g and the total ferritin content 1l8,5mg« Horse 
spleen ferritin contains 20 per cent and adult rat liver 2?®5 per cent 
iron (Harrison et al, 1974).
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The iron content of liver ferritin depends on the state of iron balance 
and can fall from 29 per cent in the newborn rat to 4,6 per cent at day 
18. Assuming an iron content for ferritin of 20 per cent the liver 
ferritin iron of our term infants is 0.2mg per g tissue, 2 5.7mg per 
organ or 9mg per Kg body weight* On the basis of earlier reports 
of total non-haem iron content of the human term liver (Bruckman and 
Zondek, 1959; Chang, 1975; Loria et al, 1977) the ferritin iron content 
would appear to represent about 50 per cent of the total non-haem iron, 
the figure reported by Harrison et al (1974) as the percentage of 
ferritin to haemosiderin in storage organs® Our ferritin iron content 
represents 69*7 per cent of the 54mg of total body storage iron 
calculated to be found in a 5*5Kg term neonate (Schulman, I9 6I). All 
studies have reported similar findings for the storage iron content of 
neonatal liver including Rhodesian African fetuses whose mothers had 
excess iron stores (Buchanan, I968). Chang (1975) has stated that 
such uniformity could suggest a mechanism in the placenta to prevent 
iron overload. He also considers that the variability in all reports 
of non-haem iron content of liver, irrespective of whether they are 
grouped according to body weight or gestation, indicates the variable 
iron status of the mother. Burrnan (1974) has said that total body iron 
of the fetus is independent of maternal iron stores and is determined 
by body weight, gestation and the time at which the cord is clamped®
The two statements are not incompatible as most of the total body iron 
is contained in the circulating haemoglobin and would be maintained at 
the expense of building up iron stores which are quantitatively much 
smaller and represent material not immediately required.
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The liver ferritin content correlated with body weight, organ 
weight and gestation. The weight of the baby appeared to be the most 
important factor. This has been reported in a study of premature and 
term babies who were of normal birth weight, light-for-dates (LFD) 
or hypertrophic (Loria et al, 1977)* The premature and LFD groups 
had low non-haem iron contents in the liver compared to normal weight 
infants. It was also found that hypertrophic babies had low levels 
and the suggestion was made that on reaching a normal gestational age 
the fetal storage iron was mobilised and lowered mainly by growth 
rather than gestation. The ferritin content of the liver was at 
least twenty-four times greater than in spleen and eighty times greater 
than heart, irrespective of gestation and would therefore appear to be 
the main iron storage organ. The fetus synthesised most ferritin 
between 36 weeks and term and infants born before this time would have 
less than 41 per cent of the term ferritin content, Chang (1973) 
found that premature babies born between 28 and 34 weeks had less 
than 50 per cent of the liver iron stores' of term babies, Loria et al 
(1977) found that preterm infants at 30 to 32 weeks had only 60 per 
cent of the liver weight and non-haem iron content of term babies. These 
results support the long held view that premature babies are at risk 
from iron deficiency anaemia arising in infancy due to low iron 
contents at birth. Iron supplements given earlier and in greater 
amounts than those given to terra babies in order to keep pace with the 
accelerated growth rate can prevent the condition (Schulman, I96I;
II
Lundstrom et al, 1977)*
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The concentration of ferritin in the liver unlike the total 
content did not relate to body weight, gestation nor organ weight.
The ferritin concentration fell between 30 and 35 weeks and in relation 
to body weight the concentration remained constant between 1,1 and 
2.0 Kg, Loria et al,(1977) also found no correlation between the 
non-haem iron concentration of liver and gestation and reported a 
falling concentration between 28 and 38 weeks. These results could 
not be due to an accelerated hepatic weight gain as this was 
relatively constant between 30 weeks and term. During this time 
however iron could be actively required and would not be available 
for storage at a rate commensurate with organ growth. The red cell 
mass of 46ml per Kg for premature infants of birth weight 1.07 to 
2 .3 0  Kg was similar to that found in term babies (Schulman and Smith, 
1954). The maximal rate of erythropoiesis could therefore be gained 
at the time when we note a fall in the rate in the accumulation of 
iron stores. The liver is the main erythropoietic organ in the second 
trimester and is still active at term so both maternal and fetal hepatic 
iron could be mobilised. There is evidence that the fetus can utilise 
its own iron stores in utero (Loria et al, 1977)® Fletcher and Suter 
(1969) have suggested that increased concentrations of iron might be 
found in the fetal liver in early pregnancy when fetal blood volume 
is small and at term when fetal erythropoiesis is decreased. The 
increase in the maternal red cell mass could also lead to smaller 
amounts of iron being available to the feto-placental unit as fetal 
parasitism is not total (Chang, 1973; Fenton et al, 1977).
Ferritin content of fetal heart*
Little information is available on the iron stores of the 
fetal heart. The isoferritins of heart are more acidic than liver 
but would appear to contain equivalent amounts of iron (Powell et al, 
'I975)» The heart ferritin content correlated with organ and baby 
weight but not with gestation. Little increase was noted in heart 
weight between 33 weeks and term but organ weight did correlate strongly 
with baby weight (r-0.87j p-<D,00l), The concentration of ferritin 
in the heart, unlike liver and spleen remained constant between 
24 weeks and term and suggests that in this organ ferritin may not 
serve as an iron storage compund but have an alternate function.
Little variation v/as noted in the non-haem iron concentration of 
maternal and fetal heart after the acute and chronic administration of
II
intravenous iron (Wohler, 1964). Pancreatic isoferritins contain 
little or no iron and therefore do not serve as iron storage proteins 
and have led to the consideration of alternative functions for 
ferritin (Powell et al, 1975).
Ferritin content of fetal spleen.
In the newborn the spleen is second only to liver in storage
iron content* The total ferritin content of spleen was.found to
correlate with baby and organ weight and gestation. At term the 
spleen contained only 4 per cent of the ferritin content of liver.
The spleen was found to contain only 1 per cent of the activity of liver 
after the administrations of plasma containing labelled iron to the 
mother (Fletcher and Suter, I9 6 9).
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On the basis of human fetal spleen containing equivalent amounts of
iron to horse spleen ferritin the iron content at 36 to 40 weeks
was OeSmg or 0®3mg per Kg body weight. Fetuses of less than 36 weeks
contained less than half the ferritin content of term infants although
the maximum rate of synthesis occurred between 50 and 35 weeks when
the ferritin content increased five fold* The spleen was the only
organ in which the concentration of ferritin correlated not only with
gestation but also with body weight (r=0 ®7 0; p'=ru.00l) suggesting that
there may be a more controlled synthesis of ferritin in spleen than in
liver or that the two organs may receive iron from different sources
and at varying rates* In support of the former it has been shown
u
that excess iron is taken up preferentially by the fetal liver (Wohler, 
1964)* The iron accumulating in the ferritin of the fetal spleen 
could result from the breakdown of fetal red cells* an amount which 
would increase with fetal growth* In the rat the fetal liver is the 
principal site of iron deposition and erythropoiesis® It has been 
suggested that the transfer of iron from the liver to other tissues 
is probably minimal but that erythroid cells entering the circulation 
could contribute to the iron content of the spleen (Orlic et al,1974). 
Possible functions of fetal organ ferritin.
Liver and spleen ferritin contain the greatest number of 
isoferritins in common but the iron content of a particular isoferritin 
varies with the tissue of origin (Powell et al, 1975)- It has been 
suggested that the isoferritin distribution and iron content may be 
related to metabolic differences in tissue ferritins (Gabuzda and 
Pearson, I9 6 9).
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Shepp et al (1972) has shown that two metabolically distinct 
pools of ferritin exist in bone marrow* The anabolic form accepts 
iron from transferrin and is an isoferritin characteristic of 
erythroid cells. The catabolic form accepts iron from haemoglobin 
and is an isoferritin of reticulo-endothetial cells. However both 
cells take up iron during erythroid cell maturation, regardless of 
the form of the administered iron. It is uncerLain whether erythroid 
ferritin is a precursor in the synthesis of haem or a form of storage 
iron which is not an intermediate in the synthetic process. Powell 
et al (1975) consider that the major iron containing isoferritin in 
spleen may be the catabolic ferritin of bone marrow whereas the major 
component in liver may represent anabolic ferritin in parenchymal cells. 
When isotopically labelled ferrous citrate was administered to rats 
ÎP utero the major fractions appeared in the parenchymal cells of 
liver which constituted 83 per cent of the total volume of adult rat. 
liver and lesser amounts in the erythroid cells of spleen (Orlic et al,
1974). "the differences in iron content in isoferritins common to 
different tissues may therefore reflect different cell populations in 
different tissues and organ variation in iron metabolism" - Powell et al, 
(1975). It is open to conjecture whether these studies of adult 
tissues can be applied to f etal organs. It would appear reasonable 
to assume that as the liver is a site of erythropoiesis in the fetus 
much iron would be found in the anabolic isoferritin. The only report 
of fetal spleen ferritin suggests that active iron uptake is associated 
with the erythroid cells of the organ (Orlic et al, 1974) and would 
therefore be in the anabolic form unlike the major isoferritin of adult 
tissue which is in the catabolic form.
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There is some evidence to suggest that under certain circumstances 
the spleen has erythropoietic activity.
Variation in ferritin content of fetal organs and relationships to 
the placenta®
The ferritin content of liver correlated with the content in 
spleen (r=0 .6 0; p-<0c005) and in the heart (r=0«66; p<c0.001).
Chang (1973) found a significant correlation between total storage iron
in liver and kidney with body weight and gestational age. He suggested
I
that they reflected similar findings between total body iron and body 
weight and gestation. However of the three organs only the 
concentration of ferritin in the spleen correlated with baby weight and 
gestation. These findings would also suggest that ferritin synthesis 
in these three fetal organs may be controlled by different mechanisms. 
There is evidence to suggest that the control of mobilisation of 
non-haem iron in the adult is organ specific. The iron content of 
adult kidney is little influenced by pathological consequences which
It
exhaust the hepatic iron stores (Bruckman and Zondek, 1939)* Morgan 
(1961) has reported that in normal lactating rats the non-haem iron of 
the spleen but not the liver is utilised. In contrast V/yllie and 
Kaufman (1971) found that the uptake and utilisation of iron was much 
greater in liver than spleen in the pregnant rat. The female rat in 
comparison to the male contains more ferritin iron in the liver and 
kidneys but the same concentration in the heart. The rate of ferritin 
synthesis in the female rat is twice that in the male but the breakdown 
is similar in both sexes.
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These differences are thought to result from the action of oestrogens 
on ferritin synthesis but others have suggested that hormones may have 
an indirect affect on iron absorption. Sex differences are not found 
in all species (Harrison et al, 1974)• The formation of iron stores 
and ferritin synthesis therefore appears to be organ and species 
specific.
The placental weight correlated only with the spleen ferritin 
content although the content of all three organs related to total body 
and organ weight. It has been reported that total body iron content 
related to body weight and gestational age but not to placental weight 
(Burrnan, 1974). When the ferritin content of four placentae was 
compared to that in the relevant fetal organs normal values for the 
appropriate gestation were found in three. The fourth placenta was 
larger than normal and contained a gross content of ferritin. The fetal 
liver was enlarged but the spleen and heart were normal. The ferritin 
content of liver and spleen were^rZSD of the gestational mean but well 
within normal limits for the weight of the baby. As the ferritin(p126-7) 
content correlates more closely with baby weight than gestation the 
ferritin content was considered normal in all three organs. The 
pregnancy resulted in a still-birth caused by intrauterine pneumonia. 
Bothwell et al (1958) have shown that infection in the rabbit impairs 
the transport of iron across the placenta and reduces the total turnover 
of plama iron and the percentage of iron going to the fetus. The 
latter statement v/as not in agreement with the present findings.
Adults with chronic infections have increased plasma ferritin 
concentrations (Lipschitz et al, 1974).
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In the present study increases associated with acute maternal 
infections have been found which could be explained by a shift 
in iron from red cell to reticulo-endothelial sites (Jacobs and 
Worwood, 1975)® The haemoglobin concentration was not quantitated 
in this fetus so there is no evidence to support the theory. No 
reasons could be found to explain the high placental ferritin
II
content^ Wohler (19^4) has shown that despite acute and chronic
administration of intravenous iron to rabbits that fetal organs were
not "inundated” with iron. The placenta appeared to act as a
barrier to the passage of excess iron to the fetus by storing the
metal, African babies whose mothers were commonly found to have
excess storage iron did not demonstrate any abnormalities of iron
metabolism (Buchanan, I9 6 8). Wohler (1964) has suggested that
excess non-haem iron in the rabbit placenta is present as haemosiderin
and that there is little variation in the ferritin content. However
u
he quoted the work of Goltner and Stark (I96O) who have shovm that in 
the human placenta the ferritin content increases but haemosiderin 
remains unchanged after 14 days of intravenous iron therapy. Our 
evidence supports the finding that increased ferritin can occur in the 
human placenta.
The effect of lUGR on organ ferritin content.
Intrauterine growth retardation can best be studied by comparing 
a group of light-for-dates (LFD) infants with a normal weight group 
of equivalent gestation. The five LI’D babies in the present series 
varied widely in gestational age and therefore an alternative approach 
was adopted.
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Individual LFD fetuses were compared with the mean for the equivalent 
gestation.
The body weight of all 26 fetuses correlated closely with the 
weights of liver, heart and spleen. In only one of the LFD group 
was the liver or spleen small and in two the heart was reduced in 
weight. This may reflect the wide variation in the group as a whole. 
Three of the five had low total ferritin contents of liver, heart and 
spleen but two had increased contents of heart and one an increased 
concentration but normal total content of the spleen.
In contrasting the content of normal and low weight organs 
independently of baby weight all but one of the six livers had low 
ferritin contents and concentrations and the sixth had a normal 
concentration but low total content. The five low weight spleens 
all had reduced total contents although two had normal concentrations. 
It would appear from the small numbers studied that in intrauterine 
growth, retardation the liver weight is frequently normal but the 
concentration and total content of ferritin are reduced. In small 
livers irrespective of baby weight, similar findings occur, LFD 
babies and normal weight babies with low weight livers would therefore 
require earlier and larger iron supplements than the normal weight 
group to prevent iron deficiency anaemia in infancy. The former 
group is easily identified but the latter would normally be un­
recognised. The latter may explain the development of anaemia in 
a normal weight, term infant who had received a routine diet.
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Low total body iron contents and lov; hepatic non-haem iron 
contents have been reported respectively by Burman (1974) and Loria 
et al (1977) in LFD babies but both have suggested that the concentration 
is normal. Our results support the former but we also found 
concentrations to be reduced. Two LFD fetuses had increased ferritin 
contents of the heart which quantitatively contribute little to the 
total body iron content. No h^art abnormalities were noted in 
either baby.
The organ ferritin content of twins.
In the present series twins had lower liver and spleen ferritin 
contents than singletons but this may only reflect that three of the 
seven were LFD and one set was extremely premature. The fetus whose
twin survived was of average birth weight and the ferritin content of 
liver and spleen were normal. When discrepancies existed in organ 
weights the larger organ frequently contained the higher ferritin 
content. However in one set of twins the spleens were of equivalent 
weight but one organ contained four times as much ferritin and in two 
paired hearts the one which weighed only 50 per cent of the other 
contained four times as much ferritin. The twins v/ho had a tv;in-to- 
twin transfusion iu utero had similar organ ferritin contents. This 
suggested that the process was not gradual or one would have found 
evidence of increased erythropoietic activity in the anaemic twin and 
a lower ferritin content in the liver. An increased ferritin content 
in the liver and spleen of the plethoric twin would have suggested 
increased red cell catabolism. It was therefore concluded that 
the episode was acute and resulted in the still-birth of both twins.
188
Vosburgh and Flexner (1950) in a study of guinea pig litter 
mates showed that there could be considerable differences in the 
amount of iron transferred to members of the same litter which was 
not related to body weight. He suggested that this reflected a 
complex mechanism which regulated iron transport across the placenta, 
The total amount of iron transferred from the mother to all fetuses 
is not affected by the size of the litter and newborn rats from 
large litters have low hepatic iron contents (Munro and Linder,19?8),
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PLACENTA!. FERRITIN
The presence of ferritin in the placenta has been reported by a number 
of authors (Tecce and Tecce, 1950; Latham and Vosburgh,.1950; Mazur 
et al, 1955). A placental protein, PP^, was isolated and purified 
from human placenta by Bohn (1973) and was identified as ferritin. It 
had a molecular weight (M.Wt.) of 450,000 to 500,000 and was composed 
of subunits of M.Wt, 20,000, The iron content was found to vary from 
12.8 to 2 5 .6 per cent depending on the Rivanol precipitate analysed. 
Ferritin in normal, term placentae.
The concentration of ferritin in normal term placentae was 6l*5ug 
per g of wet tissue. Our results agree with those of Mazur et al (1955) 
who quantitated the ferritin of three placentae by an immunochemical 
method and found them to contain 6 2 .5 and 75ug ferritin per g of 
tissue. Bohn (1973) also used an immunological technique and determined 
the concentration to be 29ug per g tissue, but suggested that the 
result may be low due to the single extraction procedure used. We 
found no difference in the ferritin concentration between the peripheral 
and central regions, A concentration gradient was however found between 
the maternal and fetal surfaces.
The non-haemoglobin iron concentration of human placentae has 
been reported as 10.5ug per g of wet tissue (HacKay et al,1958) and 
Apte et al, (1971) have found that the amount of non-haem iron as a 
proportion of the total placental iron to increase with iron intake. 
Control placentae were found to contain 10.4ug non-haem iron per g and 
after 60mg per day of iron supplements the placentae contained 22.3ug 
per go Our normal term placentae contained 12.3 ug ferritin iron per 
g of tissue calculated on the basis of placental ferritin containing 
20 per cent.
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It would therefore appear from the findings of MacKay et al (1958) 
and Apte et al (19?1) that in our placentae a high proportion of storage 
iron v/as present as ferritin. In contrast Wohler (1964) found the 
ferritin iron concentration to be 17 ug per g which constituted only 
17 per cent of the total non-haemoglobin iron. The latter would appear 
to be in conflict with the non-haemoglobin iron concentration reported 
by others. The rat term placenta contains 76.3 per cent of non-haem 
iron as ferritin, termed non-haem water soluble iron (Morgan, I961) 
and 7 1*0 per cent as determined by Kaufman and V/yllie (1972). These 
reports on rat placentae are more in keeping with our findings that a 
high proportion of non-haem iron is present as ferritin in the human 
placenta.
Placental ferritin in relation to gestation.
The present investigations determined that placental ferritin concentrations 
varied with gestation. It rose during the first trimester, remained 
constant throughout the second trimester and decreased to lov/ levels 
between 24 and 37 weeks. A second increase took place at term. The
total ferritin content remained constant between 24 and 37 weeks despite
the increase in placental weight, A 30 per cent increase followed 
between 37 weeks and term. At parturition the placental ferritin 
concentration was 6 per cent of the fetal liver and contained 34 per cent 
of the total ferritin content of liver,
MacKay et al (1958) in a histological study of the developing human
placenta found similar changes in the non-haem iron content in the first
and second trimesters by observing Prussian Blue stainable iron. In the 
third trimester low levels were found which were maintained until term.
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At delivery there v/as an increase in macrophages containing 
haemosiderm. The histological findings corresponded to the results 
they obtained by chemically quantitating non-haemoglobin iron. In 
the rat the non-haem iron content and concentration increased from day 
13 until day I7 and thereafter the concentration decreased although 
the content remained constant (Morgan, 1961)» The ratio of what v/as 
considered to be ferritin and haemosiderin remained constant throughout 
gestation, Kaufman and Wyllie (1972) extended the study of rat 
placental storage iron until parturition on day 21. They likewise 
found that ferritin iron concentration increased until day 17 and 
decreased thereafter until day 20, The total ferritin content followed 
a similar pattern. However, they further reported that between days 
20 and 21 a rapid increase in organ weight occured. The ferritin 
concentration was found to remain constant and there was 140 per cent 
increase in placenta], ferritin content. Haemosiderin was also deposited 
in amounts between 17 and 22 per cent of ferritin during the latter half 
of gestation, but in contrast to ferritin did not fall on day I9 .
The amount of ferritin iron in the placenta at parturition v/as I9 per 
cent of the total content of the feto-placental unit. In comparison 
we found that human placental ferritin constituted 24 per cent of the 
ferritin of the feto-placental unit. The rat fetus is known to contain 
more storage iron than the human fetus (Morgan, I9 6 1).
The placental ferritin content at term did not relate to the 
ferritin content of liver or heart, but did correlate with spleen.
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The total fetal iron content has been found to relate to gestational, 
age and body weight rather than placental weight (Burman, 19?4) and 
as most non-haem iron is found in the fetal liver our findings would 
appear to agree with the statement.
Ferritin in abnormal placentae.
Nylander (1953) has suggested that the passage of iron to the 
fetus is controlled by placental ferritin. The ferritin content of 
term placentae which weighed less than 500g was significantly lower 
than the term control group. The concentration and concentration 
gradient between the maternal and fetal surfaces were similar in both 
groups. There would therefore appear to be normal iron transfer per 
gramme of placental tissue but the total amount of iron transferred to 
the fetus would be reduced. Low iron stores would be found in these 
infants. In term placentae of normal weight but considered abnormal 
due to the low maternal HPL concentration or urinary oestrogen 
excretion the ferritin concentration, concentration gradient and total 
ferritin content were similar to the control group.
Transfer of iron.
The mechanism by which iron is transferred from mother to fetus 
is ill defined. In studying placental transfer a knowledge of the 
placental type is of prime importance. It is much greater in the 
haemochorial than the epitheliochorial or endotheliochorial and therefore 
findings in animals cannot always be applied to humans. It has been 
suggested that it is possible to correlate iron transfer and placental 
types to phylogenetic assemblages of separate ancestry extending back to 
the late Cretaceous period about 75 million years (Seal et al,1972).
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In 1942, Pommerenke et al, suggested that in humcuis there v/as a 
direct and rapid transfer of iron and that the maternal plasma v/as 
the source of fetal iron. These findings were later substantiated 
by work in the guinea pig (Vosburgh and Flexner, 1950; Wong and Morgan 
1973) in the rat (Nylander, 1953; Kaufmann and Wyllie, 1972) and in 
the rabbit (Bothv/ell et al, 1958; Baker and Morgan, 1969)0
The uptake of maternal transferrin bound i m n  is thought to be 
similar in the placenta and developing red cell (Laurell and Morgan, 
1964). It has been shown in vitro that transferrin is taken up by 
placental binding sites in the rat and that the amount bound is 
proportional to the concentration and independent of degree of 
saturation with iron (Laurell and Morgan, 1964). Similarly iron 
uptake was also found to be proportional to concentration and 
independent of transferrin concentration. In contrast it has been 
reported in the rabbit that iron saturated transferrin is taken up 
more readily than iron free transferrin by the placenta in vivo and 
that similar findings have been described in human reticulocytes 
(Baker and Morgan, I9 6 8), It has also been suggested that human 
placental binding sites may work more efficiently at lower levels of 
iron saturation than those of red cell precursors and therefore iron 
was directed to the fetus when the mother was iron deficient (Fletcher 
and Suter, 1969)* In the rabbit the ability of the placenta to bind 
transferrin iu vivo increased with advancing gestation, but the uptake 
of the maternal liver, spleen and bone marrow v/as unaltered, (Baker 
and Morgan, I9 6 8),
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The two binding sites on transferrin are generally accepted as 
having similar affinities for iron, but not all agree as physico­
chemical differences between sites have been reported (Fletcher and 
Huehns, 196?; Jacobs, 1977)* Functionally different binding sites 
have been suggested by Fletcher and Suter, (1969) as the reason for 
most of the placental iron being delivered to the liver before being 
mobilised for erythropoiesis. However, work on the rat has shown 
no evidence of selective unloading of iron as a result of selective 
uptake even in iron depleted or iron overloaded animals (Pootrakul 
et al, 1977)* The passage of proteins from mother to fetus is 
highly selective and in the human, transferrin can cross the placenta 
in some instances, but little or no maternal transferrin is present 
in fetal plasma at birth (Glasser, I9 6 8). Morgan (1964) found rat 
placenta to be more permeable to transferrin than human or guinea 
pig, but Fletcher and Suter (I9 6 8) and Wong and Morgan (1973) have 
reported that transferrin does not cross the human or guinea pig 
placenta.
Iron uptake is an important function of the placenta, but the 
stimulus for the removal of iron from the maternal plasma to the fetus 
is unknown (Glasser et al, I9 6 8), The uptake of iron does parallel 
fetal demands but it has been shown to continue in the absence of the 
fetus (Bothv/ell et al, 1958). Placental hypertrophy occurs in severe 
iron deficiency and has been considered advantageous to the fetus who 
may initiate the stimulus but the response is dependent on maternal 
nutrition (Beischier et al, 1970)•
195
When iron supplements are given the placental uptake is increased and 
may therefore be influenced by the availability of iron (Apte et al,
1971). Following haemorrhage the placenta responds like 
reticuloendothelial and mucosal cells by increasing iron transport, 
(Bothweel et al, 1958). The accumulation of fetal iron would therefore 
appear to be controlled by complex mechanisms and influenced by fetal 
size, a placental factor and maternal iron metabolism, Glasser et 
al, (1968) found that in the rat, placental growth and the rate 
of iron transfer were major factors in determining the amount of iron 
found in the placenta. They concluded that tlie control of iron 
clearance from the maternal circulation could be due to the maturation 
of an independent placental iron transfer system. In addition there 
was a mechanism which allowed a more rapid rate of removal of iron 
from the placenta by the fetus.
Results from the present study show that the placenta contains a 
significant proportion of the ferritin of the feto-placental unit and 
by deduction that it also constitutes much of the non-haem iron content 
of the placenta. The rapid decrease in the concentration of placental 
ferritin in mid-pregnancy occurred at a time when ferritin was being 
rapidly synthesised by the fetal liver.
Regulation and localisation of placental ferritin.
A ferritin concentration gradient was found in most placentae 
between the maternal and fetal surface, irrespective of pathology.
HPL throughout gestation and HCG at 25 to 29 weeks were also noted to 
have similar concentration gradients. Other workers have reported 
similar findings for HPL (Gau and Chard, 1975).
These were related to the amount of trophoblast per unit area.
Trophoblast was found to decrease towards the fetal surface and the 
blood flow was similarly reduced. They concluded that the rate of HPL 
synthesis v;as primarily controlled by the rate of blood flow past the 
trophoblast cells. Ferritin synthesis could likewise be controlled 
by the rate of blood flow which would vary the amount of iron available 
for uptake. Electron micrographs in the present work demonstrated that 
ferritin of the normal term placenta was localised in the syncytiotrophoblast 
in the granular or rough endoplasmic reticulum of the villi. Wohler 
(1964) using a specific method also identified ferritin in the 
syncytiotrophoblast of human placentae. Bothwell et al . (1958) 
reported i.ron in the deeper tips of the rabbit fetal villi which were 
in contact with the maternal venous sinusoids. These results are in 
contrast to the work of McKay et al (1958) who, using the classical 
Prussian Blue staining method for iron, found placental non-haem iron 
to be greatest in the second trimester and localised in large granules 
in the villi at the junction of the cytotrophoblast and Langhan's layer, 
Histocheraical observations by McKay et al (1958) determined a rapid fall 
in iron content during the third trimester although at term there was 
an increase in macrophages or Hofbauer cells, which contained haemosiderin. 
They suggested that as the preparations also stained for phosphate that 
the iron staining compound was ferritin, Haemosiderin also contains 
phosphate and therefore they could not differentiate the compounds on 
this basis. The finding of iron in large granules also suggest-sthat 
they were visualising haemosiderin rather than ferritin which gives 
a diffuse staining pattern with a Prussian Blue stain.
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Tixey Localised iron at maxima]concentratioms single particles in the 
connective tissue of the villous stroma. Regular lines of granules 
at the junction of the cytotrophoblast and connective tissue were 
found in only one third of the villi. One expects to find a more 
uniform distribution of any substance which plays an active role in 
fetal development. This type of easily stainable iron is frequently 
found in placentae and is probably haemosiderin from necrotised tissue 
(Govan,
We found that a high proportion of placental ferritin was 
attached' to the ribosomes of the endoplasmic reticulum in contrast 
to the findings in rat liver tissue (Redman, 1969; Munro and Linder 
1978). Redman (1969) found that free ribosomes made 7 to 20 times 
more ferritin than did attached ribosomes which appeared to synthesise 
all secretory proteins including albumin. His work was confirmed by 
Munro and Linder (1978) who also found that the smaller portion of 
ferritin which may be secreted into the circulation was synthesised by 
membrane bound ribosomes. They also found that only free ribosomes 
could be induced by iron to synthesise ferritin and raised the question 
as to v/hy the secreted ferritin which was not induced by iron, reflected 
iron stores. Electron micrographs of human liver and intestinal 
mucosa of subjects with haemochromatosis have shown vesicles packed 
with ferritin (Munro and Linder, 1978).
The siting of ferritin on the rough endoplasmic reticulum suggests 
that in common v/ith other proteins synthesised on the same site in the 
liver, it may be secreted by the placenta.
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The tissue is bathed by maternal blood and ferritin could therefore , 
be released into the maternal circulation. Such a mechanism would 
have no place in the formation of fetal iron stores although it could 
be important in preventing excess iron deposition in the feto­
placental unit. However, in the rat liver the ribosomes of endoplasmic 
reticulum do not synthesise ferritin in response to iron and in both 
the liver and the intestinal mucosa excess iron appears in ferritin 
packed vesicles. Thornburg and Faber (1976) have demonstrated in the 
rabbit placenta that there was no mechanism for the active transport 
of ferritin although it could diffuse passively from both the fetal 
and maternal circulations into the organ. Discrimination of molecular 
size was a function of the endothelium of the fetal capillary. We 
found no evidence of ferritin in the placenta other than in the surface 
layer of the syncytiotrbphoblast “see p I37 ,
Ferritin iron can be released by reducing agents including sodium 
dithionite at acid pH and by the chelating agent, desferrioxamine at 
physiological pH but there is no evidence that the primary control 
mechanism utilises a chelator for the biological release of iron 
(Harrison et al, 1974). An enzyme, ferrireductase, present in liver 
has been shown to catalyse the anaerobic reduction of ferritin iron in 
the presence of a flavin mononucleotide and NADH, The enzyme is 
inhibited by oxygen (Osaki and Sirivech, 1971). Shorr (1955-56) 
showed that anoxia caused the release to the circulation of iron from 
ferritin in liver and suggested that the lov/ oxygen tension in the 
placenta (Walker and Turnbull, 1955) provided ideal conditions for the 
storage of iron from the maternal plasma and its transfer across, the 
placental membranes to fetal blood.
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The siting of ferritin in the syncytiotrophoblast at least in term 
placentae suggests that in order that ferritin iron can reach the 
fetal circulation it must first be liberated in the ferrous form and 
transferred in a low molecular weight compound. If maternal hypoxia 
were to occur it would appear from the siting of ferritin that iron 
could enter the maternal plasma more directly than fetal blood but 
this is thought not to occur (Bothwell et al, 1958)» However, we 
did find that in some types of maternal pathology, particularly 
severe PET high ferritin concentrations were present in the maternal 
circulation.
Placental ferritin in the control of iron transport.
The function of ferritin in plasma is unknown (Kaufman and Wyllie,
1972) but it has been suggested as a controller of iron transport across 
the placenta (Nylander, 1955; Wôhler 1955; Heilrneyer 1958)', as a 
temporary store for fetal use (Kaufman and Wyllie, 1972) and as a 
barrier to prevent excess iron being transported to fetal tissues 
(Wühler, 1964).
In a small study Fletcher and Suter (1969) have shown that iron 
transfer from mother to fetus is very rapid in early and late human 
pregnancy although decreased rates have been shown to occur at term in 
the guinea pig (Wong and Morgan, 1975). This rapid rate of transfer 
would suggest that iron did not mix with a large placental pool 
(Bothwell et al, 1958). However, Goltner and Stark (I96O) have shown 
that in human pregnancy, after a single intravenous injection of iron 
to the mother, placental ferritin is increased in relation to the 
time elapsed and concomitantly the fetal serum iron increased.
zWhen the placental ferritin began to fall the fetal serum iron 
continued to increase suggesting that ferritin played an active role 
in iron transport. Wong and Morgan (1975) have suggested that non- 
haem iron may represent the transit iron pool in the guinea pig.
Recently it has been suggested that a fraction of the total cell 
ferritin takes part in the absorption of iron in the rat. The ferritin 
in the cytosol of the mucosal cells represents only one-third of the 
total cell ferritin but due to the constancy of iron distribution 
between this ferritin fraction and "free" iron, cytosol ferritin 
could represent an extension of the free iron pool and would therefore 
take part in the active transfer of iron to the serosal surface 
(Munro and Linder, 1978).
In studying the gestational changes of placental ferritin we 
found that in the first trimester placental ferritin concentrations 
attained term levels and by the end of the second trimester, which 
was the earliest assessment of fetal ferritin, the concentration in 
the liver was only half that at term. In contrast, the fetal organ 
ferritin increased most significantly when the placental concentration 
was lowest. Between 54 and 56 gestational weeks the hepatic ferritin 
content increased by 156 per cent when the placental concentration was 
only 57 per cent and the total content was 59 per cent of term levels. 
After 58 weeks the placental ferritin concentration doubled, the hepatic 
concentration was not increased but the content rose by 57 per cent and 
gained the same amount of ferritin as in the previous period when the 
placental concentration was low. If as would seem logical the size 
of a transit pool were inversely proportional to the rate of transfer 
our findings prior to term could be explained by ferritin being part 
of the iron transit pool.
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However, at term the placental ferritin concentration increased 
■which could have resulted from a reduction in iron transport to 
the fetus or to an increase in iron from the maternal circulation. The 
former hypothesis would appear to be false as the rate of ferritin 
synthesis in the fetal liver was similar to that in the proceeding 
period. Placental ferritin may therefore not be part of the iron 
transport pool and this conclusion is supported by the lack of 
correlation between placental and fetal liver ferritin. However, 
it has been suggested that in the rat mucosa only a fraction of the 
total ferritin is part of the free iron pool and a similar situation 
may also exist in the placenta (Munro and Linder, 1978)0  
Placental ferritin as a fetal iron store.
The function of ferritin as a fetal iron store would be a 
better explanation of the gestational changes found in the placenta.
The mechanism for the placental uptalee of iron would appear to mature 
earlier than the fetal utilisation and lead to increasing ferritin 
concentrations in the first half of pregnancy. When fetal uptake 
increased the placental concentration fell until late pregnancyi 
Although the placental ferritin content increased at term when it 
appears from our limited figures that the rate of iron transfer 
remains maximal, more iron may be available to the feto-placental 
unit at this time. This is suggested by the decrease in maternal 
plasma volume (Hytten and Paintin, I965) while the haemoglobin remains 
constant and the increase in maternal plasma ferritin (Kelly et al, 
1977). The intestinal absorption of iron remains elevated (Svanberg, 
1975) and therefore more iron is made available to the fetus unless it 
is stored by the mother.
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This does not appear to happen as the maternal bone marrow is often 
depleted of iron at term (de Leeuw et al, 1966; Svanberg, 1975)»
Wohler (1964) reported that when iron was given over a l4 day 
period the placental ferritin increased but the placental haemosiderin 
and fetal serum ironv/ere unaltered. Similar results showing increased 
placental non-haem iron have been reported after iron supplements have 
been tal-cen by the mother in the last trimester (Apte et al, 1971 ) »
Morgan (I9 6I) has shown that a decrease in the non-haem iron 
concentration of the placenta occurred at the same time as the iron 
transfer to the rat fetus was maximal. Kaufman and V/yllie (1972) also 
showed that the amount of ferritin and haemosiderin in the rat placenta 
varied with gestation, but only ferritin decreased when storage iron 
began to accumulate in the fetus. They concluded that the placenta
appeared to retain iron in excess of fetal needs because the capacity
of the fetal plasma and tissue receptors were exceeded or fetal 
utilisation lagged behind the availability of iron. It would also 
appear from these studies that placental ferritin is in equilibrium 
with transit iron as suggested by Wohler (1964),
The stimulus for tiie utilisation of placental iron is unlcnown.
It is unlikely to occur by passive diffusion as fetal plasma iron exceeds
the maternal level from 20 weeks. The percentage iron saturation of
fetal transferrin also remains high throughout fetal life due to a 
persisting low transferrin concentration (Fletcher and Suter, I969)»
In the adult intestinal absorption is regulated by total body iron stores 
and the rate of erythropoiesis (Jacobs, "1978).
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-These states are unlikely to regulate mobilisation of placental 
iron as the fetal organ ferritin concentration and total content 
increase with advancing gestation. However, unlike the liver with 
large iron stores the bone marrow of the neonate contains no iron 
(stockman and Oski, 19?8) and may therefore exert a constant and 
increasing stimulus for iron transfer as the fetus increases in size.
I In the present work the placenta of a severly rhesus sensitised 
fetus with evidence of an increased rate of erythropoiesis, was 
enlarged but had a normal ferritin concentration. The rate of red 
cell formation did not appear to influence the placental ferritin 
concentration. Factors which regulate iron absorption in the adult 
do not appear to play a significant role in the fetal utilisation of 
placental ferritin iron(Table 4,16-Fetus No.4) ,
Fetal and maternal transferrin bind iron at the same rates (Fletcher 
and Suter, I969). In the rabbit the fetal protein does not appear to 
bind to the placental surface (Baker and Morgan, 1969) although it 
has been shown that transfer of iron from the placenta is slower into 
a transferrin free solution than into plasma (Laurell and Morgan, 1964), 
The passage of iron from the placenta is active and is not merely a 
passive transfer down a concentration gradient.
The rate of placental iron transfer is greatly inhibited by maternal 
hypoxia (Wong and Morgan, 1975) a condition which Shorr (1955-56) has 
suggested would be ideal for the reduction of ferritin iron and the 
release of iron into the circulation.
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Walker and Turnbull (1953) have shown that there is a decreased fall 
in oxygen content and saturation of fetal blood near term and it is 
therefore possible that ferritin iron could be utilised at a time when 
the normal route for iron transfer is inhibited®
It is unlikely that ferritin, due to the size of the molecule 
could be transported to the fetal vessels before liberating iron® It 
is possible that iron would be mobilised on site in the syncytiotrophoblast 
before being transported in a smaller molecular form. If the latter 
part of the pathway v/as also that of the normal transfer of iron.then 
after mobilisation further transport would be inhibited by hypoxia.
However, if a high concentration accumulated iron could pass into the 
fetal circulation by simple diffusion®
Placental ferritin in the prevention of fetal iron overload„
The function of the placenta as a barrier to the passage of excess 
iron was suggested by Wohler (1957) v/ho visualised that the barrier 
could only be overcome by a gross excess of iron although Pribilla (1954) 
had reported true penetration of administered iron. Chang (1973) 
suggested that a mechanism existed to prevent fetal iron overload and 
sited Rhodesian African fetuses v/ho had no excess iron stores although 
they occurred frequently in the mothers. Burman (1974).also concluded 
that a placental iron barrier existed although iron in the organ was 
available to the fetus®
Wohler (1964) gave large amounts of iron in the form of Fe iron 
saccharate and sorbitol to rabbits and found that despite high plasma 
iron concentrations in the mother and increased iron deposits in maternal 
organs, the accumulation in the fetal liver was small®
He concluded that penetration of the placental barrier had not 
occurred.
It is possible that the mechanism which prevents the passage of 
excess iron from the placenta to the fetus is similar to that in the 
small intestine® The electron micrographs which identified ferritin 
in the syncytiotrophoblast resembled the distribution of ferritin in 
the small intestine of iron loaded subjects® The control of intestinal 
iron absorption is not completely understood but it would appear to be 
related to the iron content of mucosal cells (Turnbull, 1974). It 
had earlier been suggested that to prevent iron absorption in excess 
of requirements iron was incorporated into ferritin in the mucosal cells 
(Crosby, 1963; Worwood and Jacobs, 1972). When iron first enters the 
mucosal cells it is present in a labile pool and is probably protein 
bound. Alternatively it may be transferred across to the serosal 
surface, possibly as a small molecular weight chelate (Munro and 
Linder, 1978) or synthesised into haem compounds and incorporated into 
ferritin (Jacobs, 1977). The regulation of iron absorption by serosal 
transfer is not understood but it would appear to be port of an 
equilibrium between plasma and the exchangeable iron in all tissues.
It therefore appears that when iron stores are large, the serosal 
transfer of iron is decreased and intracellular iron is incorporated 
into ferritin. This mechanism may well operate in the placenta. The 
localising of ferritin in the syncytiotrophoblast of the villi would 
support this theory as excess iron would be immediately incorporated 
into ferritin, thus preventing further penetration of the organ.
The possibility of a placental mechanism existing to prevent the 
passage of excess iron to the fetus was illustrated by a 29 v/eek(p.13l) 
placenta which contained a gross excess of ferritin® Although the 
fetal organs contained above average amounts of ferritin the content 
was not excessive® Flexner (1954) demonstrated that the placenta had 
a large reserve capacity to retain iron when he found that of all the 
substances studied only iron and phosphate saturated the placenta.
The gestational variation in placental ferritin concentration also 
suggests that iron in excess of fetal needs is being taken up by the 
placenta in the first trimester and at term. In order to prevent 
overloading the fetus, iron is retained by the placenta. Although 
the ferritin concentration in fetal liver is low in early gestation 
compared to term, the ability of the fetus to store iron may be 
limited by the ability of the liver to remove iron from the circulation, 
or by the immaturity of the pathway for ferritin synthesis (Siimes et al,
1975)» The plasma iron remained relatively constant throughout 
gestation but more iron may be presented to the placenta in early and late 
pregnancy as both the maternal iron saturation of transferrin and plasma 
ferritin concentration decreased between these stages of gestation.
It is therefore possible that iron may be presented in excess of 
fetal needs in early pregnancy when systems for the accumulation of iron 
stores are immature, and also at term when excessive amounts of iron 
are presented due to decreased maternal requirements. Placental 
ferritin may therefore operate as a "store" and as a"sink" by taking up 
iron at a time of plenty for the future use of the fetus and also by 
retaining iron which would otherwise overload the fetal organs.
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These studies of the ferritin concentration in the maternal and 
fetal circulations, in fetal organs and in the placenta do no more than 
describe for the first time in human pregnancy the collective picture 
of the changes which occur in relation to 'gestation. The factors 
which control the uptake of iron by the placenta, its mobilisation by 
the fetus and the variation in relation to maternal pathology remain 
unknown.
Ferritin would now appear to be more than a storage protein. The 
cytosol ferritin of the rat mucosal cell is in equilibrium with iron in 
transit to the serosal surface and a heat stabl.e factor is present in 
high concentrations in the plasma of subjects with haemochromatosis 
(Munro and Linder, 1978). These factors suggest that ferritin in the 
circulation and in the cell may regulate iron metabolism.
It is tempting to suggest, from the localisation of ferritin in 
the placenta that the syncytiotrophoblast functions in a similar fashion 
to the small intestine in the uptake and transfer of iron. The newer 
techniques of translating messenger ribonucleic acid of the free and 
bound ribosomes and recovering the ferritin fractions by gradient 
elution could determine the intracellular sites of ferritin synthesis 
and the subunit type. A study of the isoferritins of the placenta 
and their relation to gestation could also yield information on the 
changing role of ferritin in the placenta.
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